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Abstract 
Background: Cognitive theories posit that cognitive control deficits promote depression 
by reducing ability to self-regulate under stress. When activated by stress and accessible to 
working memory, negative cognitive content and structure (i.e., schemas), may interfere with 
cognitive control abilities, resulting in even greater declines in executive functioning. Moreover, 
burgeoning evidence indicates that social stress upregulates inflammation, resulting in a pro-
inflammatory phenotype that drives depression pathogenesis. However, cognitive mechanisms 
underlying this process are not well understood. An objective of this study was to examine 
depression-related deficits in cognitive control and their association with poor self-regulation. 
Another purpose was to evaluate the role of cognitive vulnerability in determining stress-induced 
declines in cognitive control. This study was the first to investigate the role of cognitive control 
and cognitive vulnerability (content, structure, and rumination) in shaping both resting-state and 
stress-induced upregulation of pro-inflammatory cytokines. Method: A clinical sample of 
currently depressed (n=40), remitted depressed (n=69), and healthy control (n=57) participants 
completed measures of cognitive content (core beliefs, dysfunctional attitudes), self-schema 
structure, rumination, depressive symptoms, and a battery of affective cognitive control tasks 
assessing inhibition, updating, and shifting. Salivary levels of four pro-inflammatory cytokines 
(IL-8, IL-6, IL-1β, and TNF-α) and updating abilities were assessed before and after a laboratory 
social stress induction. Depressive symptoms were evaluated at 2-week and 6-month follow-up. 
Results: Depressed individuals evinced deficits in inhibition and updating, which were 
associated with rumination, but not in shifting. As hypothesized, core beliefs and self-schema 
structure predicted declines in updating abilities following stress, and several cognitive control 
and vulnerability variables were related to baseline and stress-induced changes in cytokines. A 
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fairly consistent pattern of findings emerged whereby deficits in cognitive control were 
associated with greater resting-state and stress-induced inflammation among individuals with 
low, and not high, cognitive vulnerability. Moreover, greater inflammatory reactivity to the 
stressor predicted decreases in depressive symptoms at follow-up. Conclusion: Cognitive 
content and structure are important in determining stress-induced declines in cognitive control, 
and inflammation represents a biological pathway through which cognitive vulnerability and 
cognitive control may influence depression. Theoretical and clinical implications of findings and 
directions for future research are discussed.  
 
Keywords: Cognitive Control, Cognitive Vulnerability, Depression, Social Stress, Cytokines, 
Inflammation, Inhibition, Shifting, Updating 
 
 
 iii 
Summary for Lay Audience 
Background: Cognitive control refers to the ability to control the contents of current awareness. 
Theories of depression suggest that poor cognitive control interferes with emotion regulation 
during stress and that this promotes low mood. During stressful experiences, negative memories 
and thoughts may enter current awareness, further reducing cognitive control and resulting in 
poorer self-regulation, including ruminative thinking. Moreover, evidence indicates that social 
stress upregulates inflammation, which may promote depression. However, cognitive 
mechanisms underlying this process are not well understood. The current study examined 
cognitive control and rumination in individuals with current and past diagnoses of depression, as 
well as never-depressed individuals. Another goal was to examine the role of negative thinking 
in shaping declines in cognitive control under stress, and the role of cognitive control and 
negative thinking in influencing both resting-state and stress-induced upregulation of 
inflammation. Method: A total of 166 participants completed measures of negative thinking, 
rumination, depressive symptoms, and a battery of cognitive control tasks. Salivary levels of four 
inflammatory markers and cognitive control abilities were assessed before and after a laboratory 
social stress induction. Depressive symptoms were evaluated at 2-week and 6-month follow-up. 
Results: Depressed individuals showed deficits across several facets of cognitive control, and 
these were associated with rumination. Negative thinking predicted declines in cognitive control 
abilities following stress, and several cognitive control and negative thinking variables were 
related to baseline and stress-induced changes in inflammation. A fairly consistent pattern of 
findings emerged whereby deficits in cognitive control were associated with greater resting-state 
and stress-induced inflammation among individuals with low, and not high, negative thinking. 
Moreover, greater inflammatory reactivity to the stressor predicted decreases in depressive 
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symptoms at follow-up. Conclusion: Negative thinking is important in determining stress-
induced declines in cognitive control, and inflammation represents a biological pathway through 
which negative thinking and cognitive control may influence depression. Theoretical and clinical 
implications of findings and directions for future research are discussed. 
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Introduction 
Depression is a common and debilitating disorder, with over 3.5 million Canadians 
experiencing an episode at some point in their lifetime (Statistics Canada, 2013). Not only is the 
disorder chronic, with the average episode of Major Depressive Disorder (MDD) lasting 20-30 
weeks on average (Keller et al., 2013; Rohde, Lewinsohn, Klein, Seeley, & Gau, 2013), but rates 
of recurrence are high, such that 50% of individuals with a first onset of depression go on to 
experience a further episode (Rohde et al., 2013), ultimately experiencing an average of 5-9 
episodes over their lifetime (Kessler & Walters, 1998; Kessler, Zhao, Blazer, & Swartz, 1997). 
Despite numerous evidence-based treatments for depression, effect sizes for pharmacological 
and psychotherapy treatment outcomes are only moderate (Cuijpers, 2017), and relapse and 
recurrence are common (Kupfer, Frank, & Wamhoff, 1996). Better understanding the predictors 
and maintaining factors of depression has therefore become a key concern.   
Diathesis-stress models of psychopathology have long underscored the importance of life 
stress as a causal mechanism for the onset and recurrence of depression. Indeed, the best 
proximal predictor of depression is a severe life event, and those major life events involving 
social threat result in the shortest time to onset (Slavich, Thornton, Torres, Monroe, & Gotlib, 
2009). However, many individuals experience severe interpersonal life events and do not go on 
to become depressed. After experiencing a stressful life event, individuals with depression are 
thought to be more reactive to stress than others due to a poor ability to effectively regulate 
emotional responses, thereby leading to persistent negative mood. In fact, given that the cardinal 
symptoms of depression are sustained negative affect or loss of pleasure, depression has been 
characterized as primarily a disorder of emotion dysregulation (Gotlib & Joormann, 2010). 
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Fundamental to emotion regulation are cognitive control abilities. Cognitive control 
abilities are comprised of executive functions (e.g., inhibition) that gate information in and out of 
working memory, permitting the individual to focus on information relevant to the current task at 
hand (Joormann & Arditte, 2014). However, under conditions of stress, negative cognitive 
vulnerabilities, including dysfunctional attitudes, core beliefs, and schemas, are activated in 
depression-prone individuals (Dozois & Beck, 2008), making them accessible to working 
memory. This may increase the load on cognitive control functions for individuals with 
depression, potentially impacting on their ability to regulate affective and biological responses. 
Consistent with this novel idea, depression is associated with deficits in cognitive control, and 
evidence is strongest for deficits in cognitive control of negative affective stimuli (e.g., sad 
words or images; Joormann & Tanovic, 2015). In turn, these deficits are related to poor emotion 
regulation. This includes use of rumination (i.e., passive and repetitive negative thinking about 
the causes, consequences, and meaning of low mood) as a maladaptive and misguided attempt to 
improve mood (Joormann & Tanovic, 2015).  
A striking finding is that the very stressors that are most predictive of depression (i.e., 
interpersonal events involving social threat or loss), also provoke immune system responding, 
with emerging evidence suggesting that chronic activation of the immune system is highly 
depressogenic (Slavich & Irwin, 2014; Slavich & Sacher, 2019). Psychoneuroimmunology 
research and theory suggest that when social stressors are interpreted as threatening, the immune 
system upregulates and redistributes cytokines, protein molecules that are the key mediators of 
the immune response, in order to protect the body from potential wounding. However, cognitive 
mechanisms underlying this process are not well understood. An intriguing possibility is that 
cognitive control and cognitive vulnerability may be implicated in shaping immunological 
 
 
3 
activity. Cognitive control abilities are critical for self-regulation during stress and, when 
activated by stress and accessible to working memory, negative cognitive content (e.g., 
dysfunctional attitudes, core beliefs), structures (i.e., schemas), and processes (e.g., rumination) 
may interfere with cognitive control abilities, resulting in even greater declines in executive 
functioning. As such, cognitive control and cognitive vulnerability appear to be likely 
moderators of the stress-cytokine link.   
Despite compelling theory and evidence to support these dynamics, very little research 
has examined how various forms of cognitive control, cognitive vulnerability, and inflammation 
interrelate under conditions of social stress or in the context of depression. A goal of the present 
dissertation was to replicate and extend prior research by comprehensively examining 
depression-related deficits in cognitive control of negative stimuli, both at baseline and following 
a social-evaluative laboratory stressor, in a clinical sample of currently depressed, remitted 
depressed, and healthy control participants. The association of these deficits with poor emotion 
regulation, in terms of greater trait rumination, was also investigated. Another purpose was to 
evaluate the role of cognitive content and structure in determining declines in cognitive control 
following stress, when these executive functions are most needed for self-regulation. 
Additionally, a further key objective was to investigate the role of cognitive control and 
cognitive vulnerability (i.e., cognitive content, structure, and process) in shaping both resting-
state and stress-induced upregulation of pro-inflammatory cytokines. Given that inflammation is 
posited to be a risk factor for the onset and course of depression, the link between resting-state 
and post-stress changes in cytokines with depressive diagnoses at baseline and with depressive 
symptoms at baseline, two-week, and six-month follow-up was also investigated.  
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The literature on cognitive control is first reviewed, including types of cognitive control, 
their association with emotion regulation (particularly rumination), and how abilities vary in the 
context of depression and stress. Preliminary evidence for a link between cognitive control, 
depressive cognitive content, and inflammatory activity is discussed. The role of inflammatory 
responses to social threat in the context of depression is then reviewed, as is the relatively 
unexplored role that cognition (both content and process) may play in determining 
immunological reactivity to stress.    
Cognitive Control 
Cognitive control determines an individual’s moment-to-moment experience by gating 
information in and out of working memory, and therefore influences how events are experienced 
and responded to (Joormann & Tanovic, 2015). Working memory is a limited capacity system 
that reflects the contents of awareness, including the current focus of attention and temporary 
access to select representations, in order to facilitate current cognitive processes (Joormann & 
Arditte, 2013). Given the restricted capacity of working memory, continuous and efficient 
updating of contents is essential. Cognitive control encompasses executive functions that enable 
individuals to control contents of working memory by directing attention, overriding dominant 
cognitive responses, and inhibiting the processing of irrelevant information. These abilities allow 
for goal-directed behaviour, such as carrying out complex tasks, making decisions, and 
implementing cognitive and behavioural strategies to effectively adjust emotional and 
behavioural responses as situations unfold (Banich, 2009). Cognitive control is therefore critical 
for effective functioning and self-regulation during changing, novel, or stressful situations.  
Cognitive control subsumes the executive control processes of working memory, 
including inhibition, shifting, and updating. These functions selectively gate access of 
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information into working memory, prevent intrusion of goal-irrelevant information, and discard 
no longer relevant content (Joormann & Tanovic, 2015). Deficits in any of these functions results 
in the experience and poor resolution of interference and are linked with poor emotion regulation 
and depression (Joormann, 2010; Whitmer & Gotlib, 2012). A key distinction is between 
cognitive control deficits, or broad impairments in cognitive control across a range of stimuli, 
and cognitive control biases, which are impairments specific to affective stimuli and that result 
from prioritizing the processing of emotional (typically negative) information. Impairment in 
inhibiting activations of mood-congruent negative content from working memory (e.g., 
representations of depressive symptoms; Baddeley, 2013) likely plays an important role in the 
amplification of the experience of aversive symptoms and events, development of prolonged 
negative self-focused or goal-irrelevant thoughts, sustained negative affect, and poor recovery 
from negative mood, all of which are indicators of poor emotion regulation. Furthermore, 
impairments likely make it difficult to focus on current tasks, as individuals cannot inhibit or 
disengage from prepotent responses, resulting in issues with concentration and decision-making 
commonly reported in individuals with MDD.  
To conduct a comprehensive investigation of the relation of cognitive control with 
cognitive vulnerability and inflammation, the current thesis examined depression-related deficits 
across the three major facets of cognitive control: inhibition, shifting, and updating. Accordingly, 
the literature on depression-related impairments for each of these types of cognitive control are 
reviewed next. Tasks commonly used to assess each type of cognitive control, as well as findings 
for biases among individuals with dysphoria or with current or remitted depression, are 
described. Given that rumination is thought to constitute a maladaptive emotion regulation 
strategy, associations of cognitive control with rumination are believed to be indicative of 
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emotion regulation problems (Joormann & Stanton, 2016). Therefore, relations of rumination, as 
well as other forms of emotion regulation, with each type of cognitive control are discussed. 
Inhibition. Inhibition, the ability prevent the processing of irrelevant information in 
working memory and to override prepotent or dominant responses (Joormann & Tanovic, 2015), 
can be assessed using a variety of methods, including the Emotional Stroop Task, the Cued 
Emotional Conflict Task, the Negative Affect Priming Task, and the Emotional Flanker Task 
(Joormann, 2004). To better illustrate how inhibition is conceptualized and assessed, and to 
provide important background context for findings on depression-related inhibitory deficits, the 
design of key inhibitory tasks is described.  
The Emotional Stroop asks participants to identify the colour of a word when a negative 
emotion word or neutral word is presented (e.g., Compton et al., 2011), such that longer response 
latencies on negative word trials are an indicator of deficits in inhibition. The task has also been 
adapted using faces, whereby an emotional word is presented alongside an emotional or blurred 
face, and participants are required to either inhibit the facial expression in order to report the 
emotion represented by the word, or to inhibit the word to report the emotion expressed by the 
face. The Cued Emotional Conflict Task requires participants to respond to an upcoming 
presentation of a face by identifying the emotion it is displaying, identifying the opposite 
emotion, or by pressing an unrelated button. Performance on trials asking individuals to label the 
emotion opposite to what the face is displaying is indicative of inhibitory ability. In contrast, the 
Negative Affect Priming Task presents participants with a target and distractor word during each 
trial, and measures response times to positive and negative targets that were distractors or were 
closely related to distractors (e.g., same valence) on the last trial, and therefore had previously 
been deemed irrelevant. Shorter reaction times responding to targets that were previously 
 
 
7 
distractors (and therefore should be inhibited) are indicative of weak inhibitory abilities. Finally, 
the Emotional Flanker Task asks participants to indicate whether a given word is positive or 
negative while ignoring flanking distractor stimuli presented simultaneously and of varying 
valence. Interference is measured as the difference in response time on trials where distractors 
are congruent versus incongruent with the target stimulus in valence, with longer response times 
for incongruent compared to congruent trials denoting poor inhibition.  
There is good evidence for inhibitory biases in depression. For example, individuals with 
dysphoria and depression exhibit deficits inhibiting negative, not positive, words on the Negative 
Affect Priming Task. This bias is associated with trait rumination, even after controlling for 
depressive symptoms (Joormann, 2004, 2006; Joormann & Gotlib, 2010). Findings have also 
been replicated in a study that used a Negative Affect Priming Task with faces as stimuli, which 
found evidence for poor inhibition for sad faces and intact inhibition for happy faces in 
depressed individuals (Goeleven, DeRaedt, Baert, & Koster, 2006). Similarly, Saunders and 
Jentzsch (2014) found that participants with depression exhibited deficits on an Emotional face 
Stroop, but not on an unemotional version of the task. A meta-analysis of studies using the 
Emotional word Stroop found that depressed individuals show significant slowing on trials with 
negative words compared to neutral or positive words, whereas control participants did not show 
this difference (Epp, Dobson, Dozois, & Frewen, 2012). Furthermore, using the Emotional 
Flanker Task, Zetsche, D’Avanzato, and Joormann (2012) found that currently depressed 
individuals evince marginally greater interference for negative distractor words as compared to 
controls, although interference was not associated with depressive symptoms in a nonclinical 
sample (Zetsche & Joormann, 2011). Moreover, compared to healthy controls, individuals with 
depression also demonstrate slower reaction times and attenuated N450 event related potentials 
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(which are thought to be involved in detecting discrepancies that require inhibitory control; 
Munakata et al., 2011) when inhibiting negative images in the Cued Emotional Conflict Task 
(Vanderhasselt et al., 2012). Finally, neuroimaging research provides converging evidence, with 
findings suggesting that individuals with depression and those who ruminate need to recruit 
greater cognitive resources in order to inhibit negative material (Vanderhasselt et al., 2013).  
Evidence for inhibitory impairments in individuals with remitted depression is more 
mixed. Whereas Ardal and Hammar (2011) found that individuals with MDD demonstrate 
inhibitory deficits on the original Stroop even at 10-year follow-up (Ardal & Hammar, 2011), 
their analyses did not account for whether participants were acutely depressed at follow-up. A 
number of studies using the Emotional Stroop have not found evidence for inhibitory biases 
among individuals with remitted depression (Gotlib & Cane, 1987; Hedlund & Rude, 1995; 
Merens, Booij, & Van Der Does, 2008; Wekking, Bockting, Koeter, & Schene, 2012). However, 
Vanderhasselt and De Raedt (2009) found that, although performance on the original Stroop did 
not differ among individuals with past depression and nondepressed controls, reduced N450 
event related potentials during the original Stroop persisted during remission and were associated 
with number of past episodes. Furthermore, Joormann (2004) found that remitted depressed 
individuals showed a marginally significant difference in inhibitory ability on the Negative 
Affect Priming Task relative to controls, whereas Joormann and Gotlib (2010) found no negative 
affect prime effect amongst remitted depressed individuals.  
Inhibitory biases appear to be a risk factor for the development of depression. Biases are 
observed in healthy first-degree relatives of individuals with MDD (Lisiecka et al., 2012) and 
prospectively predict depressive symptoms (Kertz, Belden, Tillman, & Luby, 2016; Zetsche & 
Joormann, 2011). Compton et al. (2011) examined potential mechanisms that may explain the 
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link between poor inhibition and subsequent depression, and found that longer reaction times 
after an error on the Emotional Stroop predicted negative affect and reduced task-focused coping 
in response to daily stress, whereas greater executive control was associated with a tendency to 
use problem-focused coping to manage daily stressors. Importantly, this finding speaks to the 
critical role cognitive control has in determining self-regulation under stress.  
Inhibitory biases are evident in depression across a range of tasks, indicating that 
individuals with depression have difficulty keeping irrelevant affective material, (particularly 
negative irrelevant material), out of their working memory. Impairments in inhibition may lead 
to depression as a result of poor self-regulation following stress. Along these lines, inhibition has 
also been linked to a tendency to ruminate, as inhibitory biases make it difficult to prevent 
intrusions of irrelevant, mood-congruent negative material in working memory. Additionally, 
rumination may interfere with the ability to recruit the cognitive resources needed to engage 
inhibitory abilities.  
Updating. Whereas inhibition comprises the ability to prevent irrelevant information 
from entering working memory, updating is the continuous monitoring and manipulation of the 
contents of working memory, whereby information is added or removed. The ability to flexibly 
and efficiently remove information that is not or is no longer relevant to goals optimizes task-
focused attention and self-regulation, and prevents perseverative thinking following negative 
events or mood states. There are a number of measures used to assess updating, including the 
Working Memory Manipulation Task, a modified Sternberg task, a variety of directed forgetting 
tasks, and the Emotional N-back Task. 
The Working Memory Manipulation Task (Joormann, Levens, & Gotlib, 2011) presents 
participants with lists of three positive, negative, or neutral words, and participants are required 
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to memorize words in the order presented on some trials, and in reverse order on other trials. 
Participants are then shown a probe word that was presented in the list and asked to indicate 
whether the word was first, second, or third, counting in the order they were instructed to 
memorize. Updating is assessed as differences in response times between forward and backward 
trials. Individuals with depression show more difficulty manipulating information in working 
memory on this task as compared to controls, particularly when content is negative. Of note, this 
effect was associated with rumination (Joormann et al., 2011).  
Joormann and Gotlib (2008) used a modified Sternberg task that simultaneously presents 
participants with two lists of emotional words that they are instructed to memorize. Participants 
are then cued as to which list is relevant for an upcoming recognition memory task. On each trial 
of this task, participants indicate if a probe word came from the relevant list. The authors found 
that individuals with MDD have difficulty removing negative (not positive) emotional words 
from working memory, as indicated by longer latencies in rejecting intrusion probes from a 
previously relevant list relative to novel probes. Response latencies reflect the strength of 
residual activation of the contents of working memory declared no longer relevant and the ability 
to remove irrelevant information from working memory. Importantly, longer response latencies 
were associated with trait rumination, even after controlling for depressive symptoms. 
Impairment on this task appears to be specific to emotional content, as differences between 
depressed participants and controls were not found in a version that uses neutral stimuli 
(Joormann, Nee, Berman, Jonides, & Gotlib, 2010). Further research using this task has found 
that individuals with MDD have more difficulty removing emotional words from working 
memory than do those with social anxiety disorder or healthy controls, suggesting that updating 
impairments may have some specificity to depression (Yoon, LeMoult, & Joormann, 2014). 
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Similarly, Joormann and colleagues (2010) asked participants to complete an ‘ignore’ 
task where they were instructed to memorize a series of words and ignore other words, and a 
‘suppress’ task in which they were told to forget previously memorized words. Participants were 
then presented with words and asked to indicate if a word was one that they were instructed to 
remember. Compared to nondepressed participants, individuals with depression demonstrated 
longer latencies for negative words they were instructed to suppress, indicating that individuals 
with depression have difficulty removing negative material from working memory. This effect 
was not found for words they were instructed to ignore. Notably, longer latencies in the 
suppression condition were associated with trait rumination. Similarly, Joormann and Tran 
(2009) found that individuals high in rumination exhibited reduced forgetting of negative words, 
even after controlling for depressive symptoms.  
An intentional forgetting task asks participants to learn a series of word pairs consisting 
of a neutral noun (target) and emotional adjective (cue), which imbues the targets with an 
emotional valence. Participants are then presented with the cue words and practice recalling or 
suppressing the associated targets. Recall for targets is then assessed. Studies have found that 
individuals with dysphoria and depression show greater recall of suppressed words (particularly 
those that are negative), compared to control participants, indicating difficulty with updating 
(Joormann, Hertel, Brozovich, & Gotlib, 2005; Joormann, Hertel, LeMoult, & Gotlib, 2009). 
Again, this impairment is associated with self-reported rumination (Hertel & Gerstle, 2003). 
Neuroimaging data also provide converging evidence for updating difficulties in depression, as 
indicated by greater recruitment of cognitive resources in a directed forgetting and modified 
Sternberg task (Berman et al., 2011; Foland-Ross et al., 2013). 
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In the Emotional N-back task (Chatham et al., 2011; Levens & Gotlib, 2010), participants 
are shown a series of emotional and neutral words one at a time and are asked during each trial to 
indicate whether or not the word matches the word that appeared a specified number of trials 
previously. This task assesses participants’ ability to continuously update working memory with 
emotional information and requires participants to not only remove information from working 
memory (similar to the tasks reviewed above), but to also add new information. Using this task, 
Pe, Raes, and Kuppens (2013) found that among healthy individuals, rumination increases high 
arousal negative emotions only in those with poor updating ability. This finding suggests that it 
is the combination of both poor updating and a tendency to ruminate that results in negative 
affect. There are also versions of the N-back task that use emotional faces and ask participants to 
indicate if the emotional expression of a face matches the expression of the face presented two 
trials earlier. Individuals with MDD are slower to discard sad faces and faster to discard happy 
faces in this version of the task (Levens & Gotlib, 2010).  
A paucity of research has examined updating biases in individuals with remitted 
depression. Using the Working Memory Manipulation Task, Liu, Zhou, Wang, Jiang, and Liu 
(2017) found that individuals with remitted depression evinced impaired updating abilities for 
negative material, compared to controls, and unimpaired ability to manipulate positive material. 
Furthermore, individuals with remitted depression showed greater event related potential 
amplitudes in response to negative pictures, suggesting that they needed to allocate more 
cognitive resources to updating and that depression may leave a “scar” (Lewinsohn, Steinmetz, 
Larson, & Franklin, 1981) on updating abilities. Similarly, Levens and Gotlib (2015) found that 
remitted depressed individuals were slower to disengage from sad faces than happy faces using 
the faces version of the Emotional N-back task.  
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In summary, there is evidence that individuals with dysphoria, depression, and remitted 
depression demonstrate biases in updating ability across various tasks. These findings indicate 
that depression is associated with difficulty monitoring information in working memory and 
efficiently adding or removing content, particularly negative content, in order to achieve task 
goals. In turn, updating biases are associated with perseverative negative thinking (i.e., 
rumination), likely due to poor ability to discard negative content from working memory.  
Shifting. Shifting is the ability to flexibly switch between tasks or mental sets (Joormann 
& Tanovic, 2015; Miyake et al., 2000), and is commonly measured using the Affective 
Flexibility Task (Genet, Malooly, & Siemer, 2013) or Internal Shift Task (De Lissnyder, Koster, 
Everaert, et al., 2012). The Affective Flexibility Task requires participants to categorize pictures 
based on an affective or a non-affective rule. Each trial includes a picture and indicates which 
kind of rule to apply. Difference in reaction times between trials preceded by a trial using the 
same rule versus trials preceded by those using the other rule are indicative of shifting ability. 
This task allows for the assessment of continuous switching between discrete tasks. In contrast, 
the Internal Shift Task involves counting the number of angry and neutral faces presented in a 
block of trials, and participants press a button to indicate they have updated their count after each 
trial. Shifting is assessed as the change in reaction time for the button press between trials where 
the preceding trial featured a different stimuli valence, versus trials preceded by faces of the 
same category. 
Shifting biases for emotional stimuli have been documented in depression. Individuals 
with depression demonstrated poor shifting compared to individuals without depression in a 
go/no-go task using emotional stimuli, but did not evince deficits when stimuli were neutral 
(Murphy, Michael, & Sahakian, 2012). Research using the Internal Shift Task found that 
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adolescents with dysphoria exhibited shifting impairments for emotional stimuli, particularly 
when shifting from negative to neutral stimuli. There were no impairments for non-emotional 
information (Wante, Mueller, Demeyer, Naets, & Braet, 2017). Similarly, Ravizza and Delgado 
(2014) found that dysphoric individuals are less able to improve task switching speed based on 
performance feedback on a task using neutral stimuli. Furthermore, compared to healthy 
controls, individuals with MDD showed impaired shifting on the Internal Shift Task. Of 
particular interest, shifting biases were associated with rumination regardless of neutral or angry 
stimuli valence (De Lissnyder, Koster, Everaert, et al., 2012), a finding that has also been 
observed in nonclinical samples using the Internal Shift Task (Beckwé, Deroost, Koster, De 
Lissnyder, De Raedt, 2014) and a task switching paradigm that involves switches between 
variations of the same task (Owens & Derakshan, 2013). De Lissnyder, Koster, Derakshan, and 
De Raedt (2010) similarly found shifting impairments in individuals with moderate to severe 
depressive symptoms as well as individuals with high trait rumination using an affective shift 
task. Neuroimaging findings also provide complementary evidence for shifting dysfunction in 
depression (Beevers, Clasen, Stice, & Schnyer, 2010), as indicated by deficits in recruiting 
cortical regions needed for shifting. Very little research has examined shifting biases in remitted 
depressed individuals. However, there is some evidence to suggest that shifting deficits are stable 
outside of depressive episodes, with general shifting impairments found in a sample of remitted 
depressed individuals (Preiss et al., 2009).  
Evidence suggests that shifting impairments may be a risk factor for depression (Kertz et 
al., 2016). This relation appears to be driven by emotion regulation problems, including 
rumination, that arise from shifting biases (De Lissnyder, Koster, Goubert, et al. 2012; Demeyer, 
De Lissnyder, Koster, & De Raedt, 2012; Rochat, Billieux, & Van der Linden, 2012). Shifting is 
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relevant to emotion regulation because it allows individuals to better allocate attention by 
switching attention away from negative emotional material, and toward positive or goal-relevant 
material. When individuals have poor shifting ability, they may perseverate on negative 
information. For example, using the Affective Flexibility Task, Genet and colleagues (2013) 
found that difficulties task-switching away from the affective aspects of negative affective 
stimuli was related to increased rumination as assessed using a daily diary measure, whereas 
difficulties task switching away from the affective aspects of positive stimuli was related to 
decreased rumination. This finding indicates that flexibility is adaptive for negative, and not 
necessarily for positive, stimuli. In a related study, Malooly, Genet, and Siemer (2013) found 
that better performance switching to the neutral aspects of negative images or the positive 
aspects of positive images was related to greater effectiveness of reappraisal in reducing negative 
affect during a sad film clip.  
Extant research indicates that individuals with dysphoria and depression evince biases in 
switching between tasks or mental sets. Preliminary research also suggests that individuals with 
remitted depression may show shifting impairments. Furthermore, the literature on shifting 
reports robust relations with rumination, likely resulting from inflexibility switching processing 
away from or toward affective aspects of stimuli.  
Cognitive Control in Demanding Contexts 
Demanding and stressful contexts may lead to state reductions in cognitive control as 
individuals with depression become cognitively overloaded, thereby leading to greater difficulty 
with effortful self-regulation, such as the selection of nondominant responses (e.g., reappraisal), 
and resulting in prolonged processing of negative, goal-irrelevant content (i.e., rumination). 
Consistent with this idea, burgeoning evidence indicates that, while there is evidence that it is 
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trait-like and remains fairly stable over time (Miyake & Friedman, 2012), executive control can 
become impaired in demanding or stressful contexts. A number of studies using laboratory 
stressors have found temporary declines in executive control (Plessow, Kiesel, & Kirschbaum, 
2012; Schoofs, Preuss, & Wolf, 2008; Schoofs, Wolf, & Smeets, 2009; see Shields, Sazma, & 
Yonelinas, 2016 for a meta-analytic review). For example, Levens, Muhtadie, and Gotlib (2009) 
found that individuals with depression performed as well as nondepressed participants in a low-
interference condition of the Recency Probes Task. In this task, participants are shown three 
words, and are then presented with a word and asked to indicate if it has just been shown, 
therefore requiring updating from trial to trial. However, in a high interference condition 
whereby participants were asked to complete another task simultaneously (i.e., counting the 
number of words that fit a category across trials in a block), therefore also requiring shifting 
between tasks, participants with depression performed significantly more poorly than 
nondepressed individuals. Similarly, Doumas, Smolders, Brunfaut, Bouckaert, and Krampe 
(2012) found that individuals with depression performed more poorly than did nondepressed 
individuals on a working memory task, and performance progressively decreased as difficulty 
increased during a concurrent task of postural control. Furthermore, Schoofs, Preuß, and Wolf, 
(2008) found that individuals who were exposed to a social-evaluative laboratory stressor (the 
Trier Social Stress Task, or TSST; Kirschbaum, Pirke, & Hellhammer, 1993) evinced deficits in 
updating on the N-back task compared to those in a control condition. 
Stress-induced changes in cognitive control may be especially informative for predicting 
stress reactivity and depression. Quinn and Joormann (2015a) found that poor performance on 
the N-back task after undergoing the TSST was correlated with current depressive symptoms in 
an undergraduate sample. This relation was moderated by trait rumination, such that only 
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individuals with a tendency to brood showed a relation between reduced executive control under 
stress and depression. Interestingly, change in N-back task performance from pre- to post-stress 
induction was unrelated to changes in self-reported affect, and pre-stress updating was unrelated 
to depressive symptoms. In a subsequent study of undergraduates, Quinn and Joormann (2015b) 
found that a decrease in cognitive control following the TSST predicted an increase in depressive 
symptoms during final exams, suggesting that a decline in executive functioning during times of 
stress, when these functions are most needed for self-regulation, may make some individuals 
more vulnerable to depression. Given that trait executive control was not a predictor of 
subsequent depressive symptoms, the authors suggested that the degree to which executive 
control is influenced by stress is a better predictor of mood during stress than is trait executive 
control. However, the generalizability of this finding is limited by the nonclinical nature of the 
sample. Quinn and Joormann (2015b) also found that change in N-back task performance was 
not related to change in affect.  
Given evidence that stress-induced changes in cognitive control may represent a separate 
construct from trait cognitive control, and that declines in cognitive control under stress may be 
particularly important for understanding stress reactivity, the current thesis examined stress-
induced changes in cognitive control in addition to baseline measures. 
Cognitive Control and Cognitive Content/Structure 
Cognitive control deficits result in difficulty gating and manipulating the contents of 
working memory such that, in the context of depression, working memory becomes overrun with 
mood-congruent, goal-irrelevant thoughts. As such, it would be expected that individuals with 
greater negative thought content that could be activated by low mood would demonstrate the 
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largest deficits in cognitive control after experiencing stress, and that this would result in even 
more difficulty with self-regulation and stress reactivity.  
Beck proposed a hierarchical organization of cognition, with self-schemas, or cognitive 
structures comprised of organized self-representations, representing the deepest level of thinking 
(Beck & Dozois, 2011, 2014). Schemas allow individuals to efficiently interpret and organize 
incoming information and consist of content elements, such as core beliefs, as well as 
organizational properties. Core beliefs and their organization develop over time through life 
experience and become increasingly consolidated as they act to filter information and guide the 
appraisal of life events (Dozois & Rnic, 2015). Negative experiences, such as maltreatment, can 
result in a depressotypic schema structure characterized by tightly interconnected negative 
beliefs about self (e.g., worthlessness, unlovability). When activated by stress, the negative belief 
structure may impact more surface-level, accessible cognitions, such as negative automatic 
thoughts and dysfunctional attitudes, (i.e., beliefs in contingencies for achieving happiness, 
approval from others, and success).  
Only one study has examined the relation of cognitive control and cognitive content. 
Vergara-Lopez, Lopez-Vergara, & Roberts (2016) found a marginally significant effect, such 
that individuals with a tendency to make negative attributions, and who showed poor shifting of 
emotional content on the emotional Wisconsin Card Sorting Task, reported a greater tendency to 
ruminate. Additionally, attenuated resting state connectivity in the cognitive control neural 
network mediates the relation of remitted depression status with cognitive risk factors, including 
brooding, negative attributional style, and negative automatic thoughts (Stange et al., 2017). This 
finding also points to a link between cognitive control and negative cognitive content in 
depression. Cognitive content that is implicated in depression (Gotlib & Joormann, 2010), and 
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may be made more accessible in working memory as a result of control deficits, include core 
beliefs and dysfunctional attitudes. The organization of this content may also be important, such 
that more tightly interconnected negative material may be more likely to interfere with executive 
control processes.  
Cognitive Control and Biological Reactivity 
Impairments in executive control following stress are associated with sympathetic 
nervous system (SNS) and hypothalamic-pituitary-adrenal (HPA) activation (e.g., Qin, Hermans, 
van Marle, Luo, & Fernández, 2009). Furthermore, altered activation of the dorsal anterior 
cingulate cortex (dACC) has been implicated in difficulties with updating in individuals with 
depression (Foland-Ross et al., 2013). Strikingly, SNS, HPA axis and dACC activation are 
implicated in immunological reactivity to social stress, which has been posited as a major 
contributor to the onset and course of depression, at least in some individuals.  
Very little research has examined the relation of cognitive control with immune 
responses. Shields, Kuchenbecker, Pressman, Sumida, and Slavich (2016) randomly assigned 
participants to an emotional stressor (watching an upsetting video) or a control condition 
(watching an unemotional video). Salivary levels of pro-inflammatory biomarkers (i.e., 
interleukin-1β [IL-1β], interleukin-6 [IL-6], and interleukin-8 [IL-8], described below) were 
measured before and after participants watched the video. Cognitive control was then assessed 
using the faces version of the Emotional Stroop. Participants who viewed the emotional video 
exhibited increases in IL-1β, IL-6, and IL-8, and better cognitive control predicted less 
pronounced inflammatory responses for individuals in the emotional stress, and not control, 
condition. This study is limited in that it examined only one facet of cognitive control 
(inhibition), and only assessed it post-stress. Furthermore, a recent study reported preliminary 
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evidence that stress-induced declines in updating are associated with increases in IL-6, and 
marginally associated with increases in IL-1β, following a variation of the TSST in a small 
nonclinical sample of 16 adults (Quinn, Stanton, Slavich, & Joormann, 2019). The nature of the 
relation of various facets of cognitive control with inflammatory responding, particularly in the 
context of depression and cognitive vulnerability, remain important questions. Moreover, 
although cognition is thought to determine immunological reactivity to social stress (Slavich & 
Irwin, 2014), very little research has examined this association, and the current thesis therefore 
aims to fill some of these gaps in the literature. As a key and under-researched component of 
stress reactivity, inflammatory processes in depression are discussed next. 
Inflammatory Processes in Depression 
The Social Signal Transduction Theory of Depression (Slavich & Irwin, 2014; Slavich & 
Sacher, 2019) posits that social adversity upregulates inflammation, resulting in a pro-
inflammatory phenotype that drives depression pathogenesis. Slavich and Irwin (2014) argue that 
humans have a conserved transcriptional response to adversity (CTRA) that is evolutionarily 
adaptive and is represented by skewing of the basal gene expression profile, involving activation 
of pro-inflammatory immune response genes and the downstream production of pro-
inflammatory cytokines (i.e., small protein molecules that are the main effectors of the immune 
response; see Slavich & Cole, 2013). The CTRA serves to enhance wound healing and to combat 
bacterial infections in the event of a physical altercation, but at the cost of reciprocal 
downregulation of antiviral immune response genes involved in antibody production, thereby 
resulting in heightened risk for viral infection and inflammation-related disease. Moreover, pro-
inflammatory cytokines elicit profound changes in behaviour and affect, including anhedonia, 
sad mood, fatigue, psychomotor retardation, and social-behavioural withdrawal (Slavich & 
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Irwin, 2014; Slavich & Sacher, 2019), all core symptoms of depression. A model of 
physiological pathways involved in the CTRA is presented in Figure 1. 
The immune system has evolved to respond not only to existing wounds and infections, 
but to proactively respond in advance of these to prepare the body for wounding in advance of 
assault, which could result in a pathogen-related infection. This speaks to the importance of 
cognition in eliciting the CTRA response. The neuro-inflammatory link means that CTRA can be 
activated by perceived threats, including social conflict, evaluation, rejection, isolation, and 
exclusion. When the CTRA is chronically activated, a pro-inflammatory phenotype results, 
which may drive the initial pathogenesis and recurrence of depression, and may result in somatic 
conditions commonly comorbid with depression, such as asthma, rheumatoid arthritis, chronic 
pain, metabolic syndrome, cardiovascular disease, obesity, and neurodegeneration (e.g., Barton, 
2008; Calder, 2006).  
The CTRA involves the innate immune system, which is comprised of immune cells that 
circulate to detect pathogens (Medzhitov, 2007). The acute phase of innate immunity involves 
local and systemic increases in inflammatory activity occurring over minutes or hours. When the 
innate immune system is activated, a signaling cascade is triggered that results in production of 
cytokines. Cytokines coordinate communication among cells and alter neurochemical and 
neuroendocrine processes that affect physiology and behaviour, and in this sense function 
similarly to hormones and neurotransmitters (Jain & Mills, 2007).  Some cytokines, such as IL-8, 
IL-6, IL-1β, and tumor necrosis factor-α (TNF-α) are pro-inflammatory, whereas others are anti-
inflammatory. Cytokines cause local redness, heat, swelling, and pain. In addition, IL-6 induces 
the production of C-reactive protein (CRP), which also increases body temperature, heart rate,  
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Figure 1. Physiological pathways underlying the CTRA, and hypothesized associations of 
cognitive control deficits and cognitive vulnerability. (1) Cognitive control deficits (inhibition, 
shifting, updating, stress-induced changes in updating) and cognitive vulnerability (process, 
content, and structure) may interfere with self-regulation ability during interpersonal 
experiences, resulting in social stressors being perceived as threatening. Threatening social 
stressors are represented in neural pathways that process pain, which include the anterior insula 
and dorsal anterior cingulate cortex (dACC). These brain regions project to lower areas that 
initiate and modulate inflammation via the (2) hypothalamic-pituitary-adrenal axis, (3) 
sympathetic nervous system (SNS), and (4) efferent vagus nerve. (5) Activation of these 
pathways results in production of glucocorticoids (e.g., cortisol), epinephrine, norepinephrine 
(NE), and acetylcholine (Ach). Glucocorticoids and acetylcholine interact with receptors on 
cytokine producing cells to result in anti-inflammatory effects. In contrast, epinephrine and 
norepinephrine up-regulate inflammatory gene expression in cytokine producing cells, resulting 
in the production of pro-inflammatory cytokines, such as interleukin-8 (IL-8), interleukin-6 (IL-
6), interleukin-1β (IL-1β), and tumor necrosis factor-α (TNF-α). Pro-inflammatory cytokines 
signal the brain to promote behavioural, cognitive, and emotional changes that comprise 
symptoms of depression (e.g., anhedonia, sad mood, fatigue, altered appetite and sleep). 
Cytokines communicate with the brain by (6) passing through permeable or incomplete regions 
of the blood-brain barrier and by (7) stimulating the afferent vagus nerve, which conveys 
information to brain areas that regulate motivation, mood, activity, and arousal. Activation of 
these pathways is self-promoting and can result in neuro-inflammatory sensitization and 
persistent activation of the CTRA. ACTH = adrenocorticotropic hormone. (Figure adapted from 
Slavich & Irwin, 2014). 
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and respiratory rate, and causes fever to accelerate wound healing (Poon, Ho, Chiu, & Chang, 
2013). As noted above, cytokines also promote social-behavioural withdrawal, as this allows the 
organism to recuperate and reduces likelihood of an infection being spread to conspecifics 
(Murphy, 2011).  
Converging evidence highlights the role stress plays in elevating inflammation. Early life 
stress (e.g., maltreatment) and stressful life events occurring in adulthood (evidence is strongest 
for those involving conflict, threat, isolation, and rejection; see Kiecolt-Glaser, Gouin, & 
Hantsoo, 2010) are both associated with elevated concentrations of inflammatory biomarkers, 
and this has been replicated in individuals with depression (see Slavich & Irwin, 2014, for 
review). Moreover, laboratory-based social stressors, which provide the greatest internal validity 
and allow for careful monitoring of immune responses, have been found to trigger inflammatory 
responses.  
The most popular paradigm for assessing stress reactivity in the laboratory is the TSST, 
which asks participants to prepare and present a speech and perform difficult mental arithmetic 
in front of a panel of socially rejecting raters. Studies using the TSST and modified versions of it 
have found greater production of TNF-α in individuals who had performed in front of raters 
versus those who had not. Importantly, those who reported feeling evaluated in either condition 
evinced greater increases in TNF-α production, even when controlling for perceptions of 
challenge, control, and difficulty, indicating that cognitions regarding the social component of 
the task (i.e., evaluation by others) play an important role in immune system reactivity 
(Dickerson, Gable, Irwin, Aziz, & Kemeny, 2009). Research has also found that self-reported 
fear during the TSST resulted in greater levels of the pro-inflammatory marker sTNF-R11 
(Moons, Eisenberger, & Taylor, 2010), greater perceived stress during the TSST predicted 
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greater increases in IL-1β (Yamakawa et al., 2009), and increases in anxiety and anger during a 
public speaking task similar to the TSST resulted in increases in circulating IL-6 (Carroll et al., 
2011). Furthermore, studies that have examined moderators of inflammatory responses to acute 
laboratory stressors have found effects for early life stress (Carpenter et al., 2010), trait 
loneliness (Jaremka et al., 2013), and depression status (Miller, Rohleder, Stetler, & Kirschbaum, 
2005), such that history of early stress, greater loneliness, and current depression are all 
associated with greater stress-induced production of inflammatory biomarkers. Difficulty 
maintaining a positive cognitive-affective state during the TSST was similarly associated with 
greater circulating IL-1β, which in turn predicted increasing depressive symptoms over the 
following year and mediated the link between cognitive-affective response to the TSST and 
subsequent depression (Aschbacher et al., 2012). Notably, emotion regulation abilities needed to 
maintain a positive cognitive-affective state are determined in part by executive control 
processes, suggesting that these may play an important role in the degree of biological reactivity 
to stress. Finally, Giletta and colleagues (2018) found that adolescents with a history of peer 
victimization and with greater levels of hopelessness evinced greater increases in IL-6, IL-1β, 
and TNF-α following the TSST, highlighting the role of negative cognitive content in 
determining cytokine reactivity to stress. In sum, feeling evaluated during the TSST, greater fear 
or negative affect during the TSST, trait loneliness, early life stress, depression, difficulty 
maintaining a positive cognitive-affective state, and greater hopelessness combined with a 
history of victimization all predict a greater pro-inflammatory response to the TSST. All of these 
moderators may be driven by underlying cognitive vulnerability (see Dobson & Dozois, 2008). 
However schemas, core beliefs, and dysfunctional attitudes have not been examined in relation 
with inflammation, highlighting a key gap in the field.  
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All humans have adapted to be sensitive to detecting social threats, and the experience of 
social stress appears to ‘piggyback’ on the neural pathways involved in the experience of pain 
(Kross, Berman, Mischel, Smith, & Wager, 2011). Slavich, Way, Eisenberger, & Taylor (2010) 
found that salivary cytokine concentrations in response to the TSST were associated with neural 
responses to ostracism elicited by a computer game (Cyberball) as assessed using fMRI. More 
specifically, greater activity in the bilateral anterior insula and dACC was related to greater 
sTNF-RII responses, suggesting that individuals who are more neurologically sensitive to 
rejection also have greater inflammatory responses to social stress. Moreover, these brain regions 
are known to be engaged during experiences of physical pain, suggesting that rejection is 
experienced as ‘social pain.’ An inflammatory challenge study that involved administering 
randomly assigned participants with a bacterial endotoxin found that increases in IL-6 resulting 
from injection of the endotoxin were associated with greater activity in the anterior insula and 
dACC when playing Cyberball, and brain activity in these regions mediated the relation of 
increases in IL-6 with endotoxin-induced depressive mood (Eisenberger, Inagaki, Rameson, 
Mashal, & Irwin, 2009). This study suggests that inflammatory activity leads to a greater neural 
social pain response. Together, the findings of these two studies suggest a bidirectional, self-
promoting link between inflammation and pain-related brain regions, such that individuals with 
greater baseline inflammation may be more sensitive to social threats, and this sensitivity may 
result in greater inflammatory reactivity during social stress. Slavich and Irwin (2014) refer to 
this process as neuro-inflammatory sensitization. 
Whereas the brain communicates to the immune system via the SNS and HPA axis, 
research has also found that cytokines communicate with the brain via cellular, molecular, and 
neural mechanisms (see Slavich & Irwin, 2014). For example, cytokines can pass through 
 
 
26 
permeable or incomplete regions of the blood–brain barrier, and can stimulate primary afferent 
nerve fibers in the vagus nerve (see Figure 1), which in turn relays information to brain systems 
that regulate mood, motor activity, motivation, sensitivity to social threat, and arousal and lead to 
neurochemical cascades, including release of norepinephrine, dopamine, and serotonin (Anisman 
& Merali, 2002; Camacho-Arroyo, López-Griego, & Morales-Montor, 2009). Inflammatory 
challenge studies using rodent models have found that these communication pathways with the 
central nervous system allow cytokines to induce cognitive, emotional, and behavioural 
alterations that are collectively referred to as sickness behaviours (Hart, 1988), and that include 
several hallmark somatic and vegetative symptoms of depression (sad mood, anhedonia, fatigue, 
psychomotor retardation, altered appetite and sleep, impaired cognition, and social-behavioural 
withdrawal; Anisman & Mathieson, 2005; De La Garza, 2005; Pecchi, Dallaporta, Jean, Thirion, 
& Troadec, 2009). 
Given that stress upregulates cytokines, and cytokines signal the brain to induce a 
depressive state, it is unsurprising that converging research indicates that inflammation is 
associated with the pathogenesis of depression. Not only does depression frequently co-occur 
with numerous inflammatory diseases (Barton, 2008; Calder, 2006), but it is also associated with 
higher circulating levels of IL-1, IL-6, TNF-α, CRP (Dowlati et al., 2010; Hiles, Baker, de 
Malmanche, & Attia, 2012; Howren, Lamkin, & Suls, 2009; Kuo et al., 2005; Zorrilla et al., 
2001), and reduced IL-10, an anti-inflammatory cytokine (Dhabhar et al., 2009). Longitudinal 
studies have found that increases in IL-6 and CRP prospectively predict depressive symptoms 
(Gimeno et al., 2009; van den Biggelaar et al., 2007), and depressive symptoms predict 
inflammation (Stewart, Rand, Muldoon, & Kamarck, 2009). Some evidence exists suggesting 
that antidepressant medications reduce concentrations of IL-1β, IL-2, and IL-6 (e.g., Hernández 
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et al., 2008), and conversely, cytokines reduce levels of serotonin by decreasing availability of 
the serotonin precursor tryptophan (e.g., Schwarcz, Bruno, Muchowski, & Wu, 2012). 
Depression is also associated with decreases in antiviral immunity (Irwin et al., 2013), consistent 
with persistent activation of the CTRA. Moreover, research examining depressogenic effects of 
typhoid vaccination and immunotherapy (e.g., IFN-α for hepatitis C or cancer) indicate that these 
naturalistic inflammatory challenges elicit depressive symptoms in humans, and there is evidence 
that the effects are mediated by increases in cytokines such as IL-6 and TNF-α (e.g., Brydon et 
al., 2008; Raison & Miller, 2011). Administration of bacterial endotoxin similarly causes 
depressive symptoms, including feelings of social disconnection (Eisenberger, Inagaki, Mashal, 
& Irwin, 2010), which are associated with changes in IL-6 and TNF-α (Hannestad, DellaGioia, 
Ortiz, Pittman, & Bhagwagar, 2011). Moreover, immune challenges are associated with 
activation in brain regions implicated in modulating mood, motivation, motor control, and 
reward processing, and that are associated with depression (see Slavich & Irwin, 2014; Slavich & 
Sacher, 2019). Other evidence for the role inflammatory processes play in causing depression 
comes from double-blind, placebo controlled studies demonstrating that anti-inflammatory 
agents are effective in reducing depressive symptoms (Müller et al., 2006; Raison et al., 2013; 
Tyring et al., 2006). Altogether, these disparate lines of research provide strong evidence for the 
important role immune functioning plays in depression.  
Slavich and Irwin’s (2014; Slavich & Sacher, 2019) Social Signal Transduction Theory 
of Depression explains how perceptions of social threat are transduced to inflammation and 
ultimately, depression. Social threat is represented in brain regions including the anterior insula 
and dACC as painful experiences, and project to the lower level brain regions of the 
hypothalamus and brainstem, which modulate HPA axis and SNS activity. SNS activity in turn 
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leads to cytokine production and resulting affective, cognitive, and behavioural changes, a 
process that is adaptive when occurring intermittently, but when activated too frequently, can 
become self-promoting as a result of neuro-inflammatory sensitization. Slavich and Irwin (2014) 
posit that neuro-inflammatory sensitization leads not only to heightened inflammation following 
stress, but also exaggerated perceptions of social threat. When this neuro-inflammatory response 
to threat becomes entrenched, it increases risk for depression and likely other physical diseases 
associated with inflammation.  One component of this theory that has received relatively sparse 
attention is how individual differences in cognition may influence perceptions and experiences of 
social stressors (which include not only true threats, but also those that are symbolic, anticipated, 
or imagined), and therefore, the strength of the immune response.  
The Current Study 
A growing body of research indicates that inflammation plays an important role in the 
pathogenesis of depression; however, very few studies have examined cognition (content or 
process) as a predictor of stress-related cytokine upregulation. Given that cognitive control 
determines individuals’ moment-to-moment experience of the world in terms of what they are 
thinking, and not thinking, about, as well as their ability to respond flexibly, it is a particularly 
intriguing construct to investigate in the context of stress and depression. The experience of 
negative affect following stress activates negative schemas, thereby allowing mood-congruent 
cognitions to enter working memory, such that individuals with greater negative cognitive 
content that is highly interconnected are those likely to have the most content active and 
accessible to working memory. This may overload cognitive control resources, particularly for 
those with greater cognitive vulnerability, such that the interaction of cognitive content and poor 
cognitive control likely results in greater resting-state cytokines (likely indicative of a 
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persistently activated CTRA or neuro-inflammatory sensitization) and immune reactivity to a 
social stressor. Cognitive control may also interact with a tendency to ruminate, as once the 
process of rumination begins, it may introduce greater cognitive content into working memory, 
further interfering with executive functioning and self-regulation. The current study is the first to 
examine predictors of stress-induced cognitive control deficits. It is also the first to examine how 
cognitive control and cognitive vulnerability influence baseline inflammation and acute 
inflammatory responses to social stress. It is among the first to investigate whether 
immunological stress reactivity predicts depression over time using a longitudinal design. 
The current study examines how various diatheses (cognitive content, structure, and 
control) predict cognitive (stress-induced cognitive control impairment) and immunological 
responses to a laboratory social-evaluative stressor. The study included participants with a range 
of depressive symptoms by recruiting individuals with current and remitted depression as well as 
never-depressed controls. Participants completed measures of cognitive content and structure 
(dysfunctional attitudes, core beliefs, schemas) and a battery of cognitive control measures using 
affective stimuli to assess inhibitory (Emotional Stroop), updating (Emotional N-back task), and 
shifting (Affective Flexibility task) impairments. The Emotional Stroop task was used in the 
current study given the large body of research demonstrating its effectiveness in capturing 
depression-related inhibitory biases (Epp et al., 2012). The N-back was selected as it is the only 
task to assess continuous monitoring, addition, and removal of contents of working memory 
(Schoofs et al., 2008; Quinn & Joormann, 2015a, 2015b). Further, the Affective Flexibility Task 
was used to assess shifting given that it measures continuous switching across discrete tasks 
rather than shifts in focus, and is thereby most consistent with conceptualizations of shifting 
(Miyake et al., 2000). Participants also provided a saliva sample after a period of relaxation. 
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Following exposure to the TSST, participants completed the N-back task a second time to assess 
stress-induced cognitive control biases. Updating was selected as the facet of cognitive control to 
examine stress-induced changes given past research documenting meaningful post-stress changes 
using the N-back (e.g., Schoofs et al., 2008, Quinn & Joormann, 2015a, 2015b).  Participants 
provided a second post-stressor saliva sample, and also returned to the lab two weeks and six-
months later to complete a measure of depressive symptoms, as well as other measures as part of 
the larger study. 
Mounting evidence supports the validity of salivary cytokines in 
psychoneuroimmunology research. Research has found that salivary cytokines are responsive to 
acute emotional and physiological stress, and that they increase on a faster time scale and are 
more detectable than cytokines in serum and plasma (see Slavish, Graham-Engeland, Smyth, & 
Engeland, 2015). Like cytokines in serum, salivary cytokines can influence neural activity via 
afferent nerves (Dantzer, O'Connor, Freund, Johnson, & Kelley, 2008), and are associated with 
activation of the anterior cingulate cortex, which is involved in emotional processing (O'Connor, 
Irwin, & Wellisch, 2009). Importantly, salivary cytokines are associated with 
psychopathology (Keller, El-Sheikh, Vaughn, & Granger 2010). The cytokines that were 
assessed were IL-8, IL-6, IL-1β, and TNF-α. These are all pro-inflammatory cytokines that are 
involved in the acute phase of innate immunity and that have been found to increase in saliva 
following stress. These cytokines are mediators of systemic inflammation and are associated 
with the pathophysiology of several health conditions as well as depression (Mikova, Yakimova, 
Bosmans, Kenis, & Maes, 2001; Slavich & Irwin, 2014; Slavich & Sacher, 2019).  
A number of diverse and novel hypotheses were tested:  
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1. Deficits in cognitive control for affective stimuli will be evident in both the depressed 
and remitted depressed groups compared to the control group. 
2. Deficits in cognitive control will be associated with a greater tendency to ruminate. 
3. The TSST will result in decreased updating abilities across all groups.  
4. Depressotypic cognitive content (dysfunctional attitudes and core beliefs) and structure 
(self-schema organization) will predict stress-induced changes in updating abilities, as 
negative content would be activated by the lab stressor, thereby causing greater 
impairment in cognitive control as tightly interconnected negative representations are 
activated. This is expected to result in more information to inhibit and control as 
compared to those without tightly interconnected negative schemas.  
5. The TSST will result in increases in cytokines. 
6. Greater baseline and post-stressor cytokines are anticipated in individuals with depression 
and remitted depression.  
7. Deficits in inhibition, shifting, and updating, as well as stress-induced deficits in updating 
(all of which are anticipated in individuals with current or past depression), will predict 
greater baseline inflammation (which may be indicative of neuro-inflammatory 
sensitivity), as well as greater cytokine reactivity, in terms of higher pro-inflammatory 
cytokine concentrations both pre- and post-stressor. Given that difficulty shifting away 
from positive affective information has been associated with greater adaptive emotion 
regulation ability and decreased rumination, deficits in this facet of shifting are expected 
to be associated with lower inflammation. Responding to social threat with rapid 
updating or shifting toward goal-relevant information, and with inhibition of distracting, 
negative thoughts or information as the event unfolds, allows the individual to select 
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adaptive behaviours rather than getting “stuck” on thoughts and feelings about the 
interaction, and may result in less cytokine reactivity. Any differences in findings across 
types of cognitive control for predicting baseline inflammation or the immune response to 
stress will be examined in an exploratory manner. See Figure 1 for a visual model of 
Hypotheses 7-10. 
8. Depressotypic cognitive content and structure and rumination will predict baseline 
inflammation and inflammatory reactivity, as individuals with negative schemas are 
likely to make negative automatic appraisals about the threatening nature of stressors, 
thereby triggering an immune response.  
9. Cognitive content (dysfunctional attitudes, core beliefs) and rumination will interact with 
cognitive control deficits to predict greater baseline inflammation and stress reactivity as 
indicated by increased inflammatory biomarkers. Individuals with greater negative 
cognitive content and poorer cognitive control are expected to show the greatest 
cytokines. 
10. Cognitive control and cognitive organization will interact to predict baseline and stress-
induced inflammation. Specifically, individuals with more tightly interconnected negative 
cognitive content and poorer cognitive control will evince the greatest cytokines.  
11. Finally, inflammatory indices of stress reactivity are expected to predict greater 
depressive symptoms at follow-up.  
Methods 
Participants 
A sample of 177 individuals were recruited through public advertisements. These 
included posters (see Appendix A) distributed around campus and in the community, including 
 
 
33 
physician’s offices, health clinics, private therapy practices, hospitals, bus stops, grocery stores, 
community centres, gyms, places of worship, libraries, and coffee shops. Participants were also 
recruited from posts on social media (i.e., Facebook) and referrals from local mental health 
clinicians. The sample was comprised of three groups: individuals with current depression, 
individuals with remitted depression, and healthy, non-clinical controls. To be eligible to 
participate, individuals were required to meet Diagnostic and Statistical Manual of Mental 
Disorders – 5 (DSM-5; American Psychiatric Association, 2013) criteria for current or remitted 
MDD or Persistent Depressive Disorder (PDD), or to have never met criteria for any depressive 
diagnosis, including premenstrual dysphoric disorder. Additional inclusion criteria were that 
participants were 18 years or older, fluent in English, and had a smartphone with a data plan or 
regular access to internet in order to complete measures as part of the larger study. Exclusionary 
criteria involved having any current or remitted psychosis, bipolar disorder, or cyclothymic 
disorder, or having cardinal symptoms of MDD (i.e., clinically significant low mood or 
anhedonia for two weeks) without ever meeting full criteria for MDD or PDD. Exclusionary 
criteria also included having a medical condition or regularly taking medications known to 
influence inflammation locally in the mouth or systemically. Use of antidepressant medication 
was not an exclusionary criterion. Individuals were excluded if they reported bleeding gums, 
gum disease (i.e., periodontal disease, gingivitis), a chronic inflammatory disease (e.g., arthritis, 
thyroid problems, chronic active hepatitis, chronic peptic ulcer, asthma, tuberculosis, ulcerative 
colitis, Crohn’s disease, chronic sinusitis), cancer or other neoplastic disease, a sleep disorder 
diagnosis (i.e., insomnia, hypersomnolence disorder, sleep apnea, narcolepsy), were pregnant, 
trying to become pregnant, or breastfeeding, or had undergone an organ transplant. Participants 
were also excluded if they reported undergoing chemotherapy or radiation therapy, or taking 
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immunosuppressant or immunomodulator medication (e.g., tacrolimus, interferon), or any Non-
Steroidal Anti-Inflammatory drugs (NSAIDs) on a daily basis (e.g., naproxen, aspirin, 
ibuprofen).  
Individuals interested in participating were asked to complete an online form for initial 
eligibility screening (see Appendix B). This form included questions about participants’ age and 
medical exclusionary criteria. A total of 1,164 individuals completed the online form, and 704 
were eligible based on initial screening. These individuals were then contacted by telephone for 
further screening. Telephone screening included a detailed review of all medical and health-
related exclusionary criteria with individuals in order to further screen for any conditions or 
medications they may not have accurately endorsed on the online form. In cases where it was 
unclear whether a participant met exclusion criteria, the principal investigator (KR) consulted 
with a collaborating researcher who is a professor of biochemistry at the Robarts Research 
Institute in London, Ontario.  
Participants were also administered modules of the Structured Clinical Interview for 
DSM-5 (SCID-5; First, Williams, Karg, & Spitzer, 2015) to establish diagnoses and diagnostic 
eligibility for the study. A total of 211 individuals were eligible after completing phone 
screening and invited to participate in the study. The remaining 493 individuals who passed 
online screening either completed telephone screening but were not eligible for the study, were 
not reached after multiple attempts, or indicated they were no longer interested or available to 
participate. The study was completed in one online battery of measures (Phase 1) and three 
laboratory sessions (Phases 2-4). Of the 211 participants who passed phone screening, 177 
completed the baseline battery of measures and attended the first laboratory session (Phases 1 
and 2). A total of 172 participants returned to the lab two weeks after the first laboratory visit 
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(Phase 3), and 144 participants returned 6 months after the first visit (Phase 4) to complete the 
Beck Depression and Inventory (BDI-II; Beck, Steer, & Brown, 1996b) as well as other 
measures as part of the larger study (see Appendix C for a description of the larger study). Of the 
full sample of 177 individuals who completed Phases 1 and 2, 11 had no current or remitted 
depressive diagnoses, but did have other current or remitted mental disorder diagnoses. These 
individuals were excluded from the analyses as they did not represent healthy, non-clinical 
controls. This resulted in a final sample of 166 participants (119 women, 47 men). See Figure 2 
for a flow diagram of participants through each phase of the study. An a priori power analysis 
indicated that with a = .05, and power = 0.80, this sample size was adequate to detect moderate 
effects (d = 0.5), which were anticipated across hypotheses based on effect sizes reported in past 
research (e.g., Epp et al., 2012; Giletta et al., 2017; Shields et al., 2016; Quinn & Joormann, 
2015a, 2015b). 
The final sample consisted of 40 currently depressed, 69 remitted depressed, and 57 non-
clinical controls. Among the currently depressed individuals, 34 had a diagnosis of current MDD 
(among these, 11 also had current PDD and 9 had remitted PDD) and 6 had current PDD (all 6 
also had remitted MDD). All 69 individuals in the remitted depressed group had remitted MDD, 
and 12 participants in the remitted depressed group also had remitted PDD. Participants were 18-
65 years old, with a mean age of 26.09 (SD = 8.96). 
Measures 
Baseline measures.  Structured Clinical Interview for DSM-5 (SCID-5; First, 
Williams, Karg, & Spitzer, 2015). Individuals were administered the Mood, Anxiety, Obsessive-
Compulsive and Related Disorders, Trauma- and Stressor-Related Disorders, and Psychotic 
Screening modules of the SCID-5 to determine diagnostic status and eligibility, as well as to  
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Figure 2. Flow diagram of participants through each phase of the study. SCID-5 = Structured 
Clinical Interview for DSM-5. BDI-II = Beck Depression Inventory-II. DAS = Dysfunctional 
Attitude Scale. RRS = Ruminative Response Styles Questionnaire. PDST = Psychological 
Distance Scaling Task. YSQ = Young Schema Questionnaire. TSST = Trier Social Stress Test. 
PANAS = Positive and Negative Affect Scale.   
Control participants removed from
analyses due to anxiety diagnosis (n = 11) 
Online Screening (n = 1,164)
• Medical Screening
Phone Screening (n = 704)
• Medical Screening
• SCID-5
Phase 1: Online Battery of Measures (n = 211)
• Demographics/Health Questionnaire
• BDI-II
• DAS
• RRS
• PDST
• YSQ
Phase 2: Laboratory Visit (n = 177)
• TSST and Saliva collection
• Emotional N-back
• Affective Flexibility Task
• Emotional Stroop
• PANAS
Phase 3: Two-Week Follow-Up Laboratory Visit 
(n = 172)
• BDI-II
Phase 4: 6-Month Follow-Up Laboratory Visit 
(n = 144)
• BDI-II
≤ 1 week later
Ineligible (n =460 ) 
Ineligible, no longer interested, or could 
not be reached (n = 493) 
Did not complete 
Phase 1 (n = 34) 
Lost to follow-up 
(n = 5) 
Lost to follow-up 
(n = 28) 
Final Sample (n = 166)
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gather relevant clinical information such as number of past depressive episodes, age of 
depression onset, and comorbid diagnoses. The SCID-5 is a semi-structured interview that is 
widely considered to be the gold standard for diagnostic assessment, and its reliability and 
validity in detecting psychopathology has been well-documented (e.g., Lobbestael, Leurgans, & 
Arntz, 2011; Williams et al., 1992). Inter-rater reliability (Kappa coefficients) range from .61 to 
.80 for MDD diagnoses, .59 to .83 for social anxiety disorder, .44 to .75 for generalized anxiety 
disorder, .65 to .67 for panic disorder, .60 to .65 for obsessive compulsive disorder, and .77 to 
.88 for posttraumatic stress disorder (Lobbestael et al., 2011; Zanarini et al., 2000). Studies 
examining ‘best-estimate diagnoses’ (Spitzer, 1983) performed by experts and based on 
longitudinal assessment of all data available (e.g., family informants, medical records, 
observations) have found superior validity of the SCID compared to standard clinical diagnoses 
made at intake (Basco et al., 2000; Fennig, Craig, Tanenberg-Karant, & Bromet, 1994; Fennig, 
Naisberg-Fennig, Craig, Tanenberg-Karant, & Bromet, 1996; Kranzler, Kadden, Babor, Tennen, 
& Rounsaville, 1996;  Kranzler et al. 1995).  
SCID-5 interviews were conducted by the principal investigator and PhD-level clinical 
psychology students. Training consisted of reviewing the SCID-5 Users Guide, viewing the 
training videos, and completing a SCID-5 interview while being observed by an experienced 
SCID-5 interviewer. Supervision on the SCID-5 was provided by a licensed clinical 
psychologist.  
Beck Depression Inventory-II (BDI-II; Beck, Steer, & Brown, 1996). The BDI-II is a 
21-item instrument that assesses the presence and severity of unipolar depressive symptoms in 
the past two weeks.  Individuals rate each item on a 4-point scale from 0 (lack of 
symptomatology) to 3 (high symptomatology), with summary scores ranging from 0 to 63. The 
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BDI-II has been widely used with adult and clinical samples and is recognized for its strong 
psychometric properties. Past research reports internal reliability (Cronbach’s alpha) estimates of 
.91-.92 (e.g., Beck et al., 1996; Dozois, Dobson, & Ahnberg, 1998) and good convergent and 
discriminant validity, as indicated by high associations with other measures of depression (i.e., 
the Hamilton Rating Scale for Depression, the depression subscale of the SCL-90-R) and lower 
associations with measures of anxiety (i.e., the Hamilton Rating Scale for Anxiety, anxiety 
subscale of the SCL-90-R; Beck et al., 1996; Steer, Ball, Ranieri, & Beck, 1996). The internal 
consistency (Cronbach’s alpha) of the BDI-II in the current sample was α = .95 at baseline, .95 at 
Phase 3, and .96 at Phase 4.  
Dysfunctional Attitude Scale - Form A (DAS-A; Weissman, 1979; Weissman & Beck, 
1978). This 40-item self-report questionnaire measures the presence and intensity of 
dysfunctional attitudes. The DAS-A asks participants to rate their agreement on a 7-point Likert 
scale (1 = fully disagree; 7 = fully agree) with statements concerning approval from others (e.g., 
“What other people think of me is very important”), prerequisites for happiness (“It is difficult to 
be happy unless one is good looking, intelligent, rich and creative”), and perfectionistic standards 
(“If I am to be a worthwhile person, I must be truly outstanding in at least one major respect”). 
Scores range from 40-280. The DAS-A has good psychometric properties, including high 
internal consistency (Cronbach’s alpha = .86 - .91), split-half reliability of .90-.95 and test-retest 
reliability of r = .73 over six weeks (Oliver & Baumgart, 1985; Weissman, 1979). Past research 
also supports the concurrent validity of the DAS, as indicated by its association with measures of 
depressive severity, cognitive distortions, and negative automatic thoughts (Dobson & Shaw, 
1986; Hamilton & Abramson, 1983; Hollon, Kendall, & Lumry, 1986). Coefficient alpha in the 
present sample was α = .94. 
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The Psychological Distance Scaling Task (PDST; Dozois & Dobson, 2001). The PDST 
is a computer-administrated cognitive task that assesses cognitive organization (i.e., self-schema 
structure). Participants simultaneously rate the self-descriptiveness and valence of adjectives by 
placing them on a grid, such that the x-axis measures self-relevance (very much like me at the far 
right of the axis to not at all like me at the far left of the axis) and the y-axis measures valence 
(positive at the top of the axis, negative at the bottom). Each adjective appears one at a time at 
the center of the grid. Participants are asked to consider both axes as they place each adjective on 
the grid, using the computer mouse and visually presented pointer. Participants complete 4 
practice trials, followed by 80 trials. The 80 adjectives consist of 20 words from each of the 
following categories: achievement positive (e.g., successful, capable); achievement negative 
(e.g., incompetent, deficient); interpersonal positive (e.g., encouraged, comforted); and 
interpersonal negative (e.g., unwanted, rejected). Words were presented in random order and 
have been matched for emotional intensity, imaginability, word length, and word frequency 
(Dozois 2007; Dozois & Frewen, 2006). Coordinate points for each adjective are used to 
calculate interstimulus distances among positive and negative self-referent adjectives. Smaller 
distances among adjectives are indicative of greater consolidation and interconnectedness of self-
referent content, whereas large distances are indicative of less consolidation. Past research 
supports the psychometric properties of this task, including high convergent and discriminant 
validity (Dozois, 2002; Dozois & Dobson, 2001, 2003). 
Young Schema Questionnaire-Short Form 3rd Edition (YSQ-S3; Young, 2005). The 
YSQ-SF is a 90-item self-report questionnaire that assesses 18 core beliefs: Emotional 
Inhibition, Emotional Deprivation, Mistrust/Abuse, Social Isolation/Alienation, 
Defectiveness/Shame, Abandonment/Instability, Failure, Dependence/Incompetence, 
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Vulnerability to Harm or Illness, Enmeshment/Undeveloped Self, Subjugation/Invalidation, 
Entitlement/Grandiosity, Insufficient Self-Control/Self-Discipline, Self-Sacrifice, and 
Unrelenting Standards/Hypercriticalness, Approval-Seeking/Recognition-Seeking, 
Negativity/Pessimism, and Punitiveness. Participants rate the self-descriptiveness of each 
statement on a 6-point scale from 1 (completely untrue of me) to 6 (describes me perfectly), with 
total scores ranging from 90-540. Subscale scores can also be computed for each schema. This 
instrument has strong psychometric properties in both clinical and nonclinical samples, including 
high internal consistency for the total score (Cronbach’s alpha = .91) and 6-month test-retest 
reliability across schemas, as well as convergent validity with a measure of schema modes 
(Calvete, Orue, & González-Diez, 2013; Phillips, Brockman, Bailey, & Kneebone, 2019). 
Internal consistency (Cronbach’s alpha) for the total score in the current sample was α = .97. 
Ruminative Response Styles Questionnaire (RRS; Nolen-Hoeksema & Morrow, 1991). 
The RRS is a 22-item self-report questionnaire that assesses the tendency to respond to low 
mood by ruminating about its causes, consequences, and symptoms. Items are rated on a 4-point 
scale from 1 (almost never) to 4 (almost always), with possible summary scores ranging from 22-
88, and higher scores indicating a greater tendency to ruminate. The RRS has been used 
extensively in community and clinical samples, and has good internal reliability (α = .89-.90) and 
test-retest reliability (r = .80 over five months and .67 over one year; Nolen-Hoeksema, 2000; 
Nolen-Hoeksema & Morrow, 1991; Nolen-Hoeksema, Parker, & Larson, 1994). There is 
evidence that the RRS has convergent validity, as it is associated with daily diary measures of 
rumination (Nolen-Hoeksema, Morrow, & Fredrickson, 1990), and predictive validity, as 
evinced by its relation with subsequent depressive symptoms and episodes (Nolen-Hoeksema, 
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2000; Nolen-Hoeksema, Parker, & Larson, 1994; Treynor et al., 2003). Internal consistency was 
α = .93 in the present sample.  
Demographic and health questionnaire. Participants completed a demographic 
questionnaire (see Appendix D) that queried about their age, sex, ethnicity, educational 
attainment, and marital status. Information was also collected on health-relevant behaviours (i.e., 
smoking, alcohol consumption), use of hormonal contraceptives, menstrual cycle, current 
medications, and whether participants were receiving therapy or have in the past. This 
information was collected for sample description and to assess for potential covariates.  
Laboratory measures. Saliva collection and cytokine assays. Salivary cytokines are 
ideal for examining immunological stress reactivity because they are clinically relevant and 
increase on a faster time scale than do cytokines in serum or plasma. Moreover, cytokine levels 
tend to be higher in saliva than in blood and are therefore more detectable (Slavish et al., 2015). 
The cytokines IL-1β, IL-6, IL-8, and TNF-α were assessed as these are known to be responsive 
to emotional or social stressors. 
Saliva was collected using the passive drool method and SalivaBio Collection Aids 
(Salimetrics, Carlsbad, CA). Participants were asked to provide 2ml of saliva at each collection. 
Immediately after collection, 20 microliters of protease inhibitor (Thermo Scientific Halt 
Protease Inhibitor Cocktail, Rockford, IL) were aliquoted into each sample, which was then 
vortexed. Cryovials of saliva were stored in cryostorage boxes in a -20 degree Celsius freezer. At 
the end of each day, samples were transported on ice to a -80 degree Celsius freezer at Robarts 
Research Institute for long-term storage. Following the completion of data collection, samples 
were shipped on dry ice to Salimetrics (Carlsbad, CA) where they were assayed using the 
Salimetrics multiplex salivary cytokine electrochemiluminescence assay on the Meso Scale 
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Discovery platform (MSD; Rockville, MD). The manufacturer reports an assay detectability 
range of 0.0314 – 380.000 pg/mL for TNF- α, 0.0195-589.000 pg/mL for IL-1β, 0.0491-736.000 
pg/mL for IL-6, and 0.0201-574 pg/mL for IL-8. All samples were tested in duplicate for greater 
reliability.  
The Salimetrics multiplex assay is specifically optimized and validated for use with 
saliva, which represents a significant advantage over multiplex assays or enzyme-linked 
immunosorbent assays (ELISAs) developed and validated for use with serum or plasma. Given 
limited options available for multiplex assays optimized for saliva, the majority of past research 
on salivary cytokines has used assays designed for serum or plasma, which can lead to problems 
with matrix interference (i.e., the effect that other substances in the sample have on the assay’s 
ability to detect the target protein) and missing or invalid data. Cytokine values were logarithmic 
transformed to correct for skewness before analysis. Only one saliva sample (collected post-
stressor) had undetectable levels of cytokines.  
Emotional N-back Task (Chatham et al., 2011). This task assesses updating abilities for 
affective stimuli. In each trial, participants are shown an emotionally-valenced word on a screen 
for 500ms followed by a blank screen shown for 2,500ms. A sample of trials is presented in 
Figure 3. During each trial, participants are asked to indicate as quickly and accurately as 
possible whether or not each word matches (i.e., target trial) or does not match (i.e., nontarget 
trial) the word presented two trials earlier by pressing a corresponding computer key labelled 
“yes” or “no.” A total of 120 trials are completed, and the total number of errors is indicative of 
updating ability (Kopf, Dresler, Reicherts, Herrmann, & Reif, 2013). Words used in this task 
were selected from the Affective Norms of English Words list (Bradley & Lang, 1999). Negative 
and positive words are matched on arousal ratings and word length, and significantly differ in  
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Figure 3. Example series of trials in the N-Back task. Words are presented one at a time, and 
participants are asked to identify whether or not each word is a target (i.e., matches the word 
presented two trials previously). The third trial is a target in this example. (Figure adapted from 
Quinn & Joormann, 2015a, 2015b).  
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valence ratings (Quinn & Joormann, 2015a, 2015b). This task has good construct validity and 
reliability (Jaeggi et al., 2010; Miyake & Friedman, 2012). 
Affective Flexibility Task (Genet, Malooly, & Siemer, 2013). This task assesses the 
ability to shift between processing affective and neutral components of emotionally evocative 
stimuli. Participants are asked to sort a series of 160 affective pictures by valence or by the 
number of people in the picture. Pictures were drawn from the International Affective Picture Set 
(IAPS; Lang, Bradley, & Cuthbert, 2008). Genet et al. (2013) selected 40 pictures from each of 
four categories based on reliability of categorization and valence ratings on a 9-point scale (1 = 
negative, 9 = positive) according to pilot data. Categories include negative pictures with one or 
no people (mean valence = 2.79), negative pictures with two or more people (mean valence = 
2.65), positive pictures with one or no people (mean valence = 7.38), and positive pictures with 
two or more people (mean valence = 7.39). All negative pictures had a mean valence between 2 
and 4, and positive pictures had a mean valence between 6 and 8.  
During task administration, pictures are presented one at a time surrounded by a coloured 
frame. In each trial, participants are asked to sort the picture according to valence or number of 
people depicted. These correspond to affective and nonaffective categorization rules, 
respectively. Cues for how to sort each picture are provided on the left and right side of the 
frame (“+” and “-” for positive and negative, “≤1” and “≥2” for one or no people and two or 
more people), and participants indicate their response by pressing one of two adjacent computer 
keys. Participants are instructed to place their index and middle fingers of their right hand on the 
two computer keys and to respond as quickly and accurately as possible. The cues for how to sort 
the stimuli were shown on a white or gray frame, and each frame colour corresponded to one of 
the sorting rules. Participants were randomized into one of eight versions of the task which 
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counterbalances which frame colour corresponds to which cue, as well as the mapping of the cue 
categories onto the two response keys, across participants. In each trial, a fixation cross is shown 
in the center of the screen for 250ms before the stimulus is presented. Stimuli remain on the 
screen until the participant makes a response, with no time limit imposed. The screen is then 
blank for 250ms until the next trial begins (see Figure 4 for a sample trial sequence). Participants 
completed two 24-trial practice blocks with the experimenter present to answer any questions. 
One practice trial asked the participants to sort the image based on the affective rule, and the 
other asked them to sort based on the nonaffective rule. This was followed by two blocks of 160 
trials each. Cue and picture category change from trial to trial based on a pseudorandom 
sequence, with an equal number of switch (from one categorization rule to the other) and no-
switch trials. 
The cost of switching is calculated as the difference in reaction times between switch and 
repetition trials. Four outcome variables are computed, including negative and positive 
nonaffective switch costs, and negative and positive affective switch costs. Nonaffective switch 
costs represent the cost associated with switching from the affective and toward the nonaffective 
rule when the image is negative (Negative Nonaffective Switch Cost) or positive (Positive 
Nonaffective Switch Cost). Specifically, Negative Nonaffective Switch Costs are computed by 
subtracting reaction times on trials in which the nonaffective rule was repeated and the picture is 
negative from reaction times on trials in which the cue switches to the nonaffective rule and the 
picture is negative. Positive Nonaffective Switch Costs are computed the same way for trials in 
which the picture is positive.  
Negative Affective Switch Costs and Positive Affective Switch Costs were calculated as 
the costs of switching from the nonaffective to the affective rule when the picture was negative  
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Figure 4. Example series of trials in the Affective Flexibility Task. Pictures are presented one at 
a time, and participants are asked to categorize them according to an affective (valence) or 
nonaffective (number of people depicted) rule.  
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or positive, respectively. In particular, Negative Affective Switch Costs were computed by 
subtracting reaction times on trials in which the affective rule was repeated and the picture was 
negative from reaction times on trials in which the cue switches to the affective rule and the 
image is negative. Positive Affective Switch Costs were computed the same way with trials in 
which pictures were positive. For all four outcome variables, lower switch costs are associated 
with greater switching ability. Examples of negative nonaffective, positive nonaffective, negative 
affective, and positive affective switch trials and positive and negative repetition trials are 
presented in Figure 5.  
Emotional Stroop (see Mitterschiffthaler et al., 2008). This task assesses the ability to 
inhibit neutral and affective information irrelevant to task goals. A lowercase word in coloured 
font is presented in the center of the screen with a black background. Participants are asked to 
indicate the colour of the font (red, green, blue, yellow) as quickly and accurately as possible by 
pressing a corresponding computer key, with response options mapped onto the first two fingers 
of each hand. A fixation cross is shown in the center of the screen for 500ms before the stimulus 
is presented. The stimulus is shown until the participant responds, and then a blank screen is 
shown for 500ms until the next trial begins (see Figure 6 for a sample trial sequence). 
Mitterschiffthaler and colleagues (2008) selected sad and neutral words from two lists of 
emotional and neutral words (Bradley & Lang, 1999; John, 1988), and words were matched for 
frequency, pronounceability, and word length. Neutral and sad words differed significantly in 
valence. 
Participants first complete a 40-trial training session in order to learn the mapping of each 
colour with its corresponding computer key. Stimuli for the training trials were ‘XXXXXX,’ and 
participants were instructed to indicate the colour of the font by pressing the correct computer  
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Figure 5. Examples of trial types in the Affective Flexibility Task. Note that for a negative 
affective or nonaffective switch, the preceding trial did not need to also be a negative image. The 
same is true for positive affective and nonaffective switches. Figure is adapted from Genet, 
Malooly, & Siemer, 2013. 
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Figure 6. Example series of trials in the Emotional Stroop Task. Words are presented one at a 
time, and participants are asked to indicate the colour of the font the word is presented in. 
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key. Participants were provided with accuracy feedback after each trial. Participants had a 30 
second break after completing the training session. They then completed a 40-trial block of 
neutral words, followed by another 30 second break. Finally, participants completed a 40-trial 
block of negative emotional words. Font colours were shown in a pseudo-random order, such 
that the same colour was never repeated over two consecutive trials. Each word was only shown 
once, and was presented in a random order within its block. Longer latencies for neutral or sad 
words are indicative of poor inhibition.  
Trier Social Stress Test (TSST; Kirschbaum et al., 1993). The TSST is a commonly 
used laboratory social-evaluative stress induction. Participants are brought into an interview 
room with two individuals (who are research assistants) seated across from them at table. 
Participants are informed that these are members of a selection committee from the human 
resources department at the local hospital. A selection committee member informs participants 
that they are to deliver a 5-minute speech that serves as a mock job interview, and that they have 
ten minutes to prepare for it. Participants are told that the speech will be videotaped for video 
analysis of their performance, and informed that they are not permitted to use notes or cue cards 
during the speech. Participants are then led to another room and given 10 minutes to prepare. 
Afterward, participants are led back to the interview room to deliver their speech. Participants 
who complete their speech in less than five minutes are encouraged to continue. Those who still 
have difficulty filling the time are asked a series of interview questions. After the 5-minute 
speech portion of the TSST, the participant is asked to perform mental arithmetic in front of the 
committee members by subtracting the number 13 from 2,083 as quickly as possible and without 
making mistakes. If the participant makes an error, a research committee member asks the 
participant to restart the task. Participants who do not make errors are also periodically asked to 
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restart the task. The mental arithmetic portion of the task is five minutes long. Research 
assistants who are acting as selection committee members are trained to maintain a neutral 
expression throughout the TSST and to refrain from providing minimal encouragers to 
participants (e.g., nodding, smiling). Past research has found that the TSST reliably elicits a 
subjective and physiological stress response (e.g., Kirchbaum et al., 1993; Vors, Marqueste, & 
Mascret, 2018). 
Positive and Negative Affect Scale (PANAS; Watson, Clark, & Tellegen, 1988). This 
20-item self-report measure assesses negative and positive affect states. Participants indicate the 
extent to which they are currently experiencing emotional states (e.g., hostile, excited) ranging 
from 1 (very slightly or not at all) to 5 (extremely), with possible summary scores ranging from 
10-50. The PANAS has good reliability (Cronbach’s alpha = .85-.89) and construct validity, as 
indicated by associations with measures of depression and anxiety (Crawford & Henry, 2004). 
Cronbach’s alpha in the present sample was α = .88 for positive affect and α = .86 for negative 
affect at pre-stress, and α = .91 for positive affect and α = .92 for negative affect at post-stress. 
Procedure 
The study included initial online eligibility screening, followed by a more detailed 
telephone screen. The study was comprised of an online battery of measures (Phase 1), followed 
by three laboratory sessions (Phases 2-4) that occurred over a 6-month time frame. Participants 
were presented with a letter of information at each phase of the study (see Appendix E) and 
provided written consent to participate at each phase (see Appendix F). At the end of each phase, 
participants were provided with a debriefing form (see Appendix G), which included local and 
online mental health resources. At the end of Phases 2-4, participants were also debriefed 
52 
 
verbally and had an opportunity to ask questions about the study. Participants received $20 as 
compensation for participation in each phase of the study.  
Screening. Individuals interested in participating in the study were asked to complete 
initial online screening to assess age and health-related exclusionary criteria (see Appendix B), 
followed by a telephone screen which included further assessment of health-related exclusionary 
criteria, and the SCID-5 interview to establish diagnostic status and eligibility. Telephone 
screens were conducted by the principal investigator (KR) and PhD-level clinical psychology 
students trained on the SCID-5.  
During online screening, individuals were asked if they had a current sore or lesion in 
their mouth, if they had dental work in the past two weeks, or if they currently had an acute 
condition (e.g., cold, flu, tonsillitis, bronchitis, sinus infection), or symptoms consistent with a 
cold or infection. Individuals who endorsed these items were contacted for telephone screening, 
but their first laboratory session was scheduled for later in time to ensure at least two weeks had 
elapsed since dental work and/or that they had fully recovered from their acute condition or oral 
lesion before coming in for the first laboratory session.  
After phone screening was complete, eligible individuals were provided with instructions   
for preparing for saliva collection. Instructions were presented verbally at the end of the phone 
screen, and in written format over email. Specifically, participants were asked to refrain from 
physical exercise during the day of the appointment and to avoid taking antihistamines or anti-
inflammatory medications (e.g., ibuprofen) for 24 hours before their appointment, as these can 
influence cytokine levels. Participants were also asked not to drink anything besides plain water 
and not to eat, smoke, chew gum, or brush their teeth for one hour before their appointment, as 
these could affect the quality and purity of saliva samples. Moreover, participants were 
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encouraged to drink a full glass of plain water within an hour of coming to the lab to increase 
hydration levels and make saliva collection quicker and easier for them. Finally, participants 
were also encouraged to try to have a full night’s sleep the night before the study to limit the 
impact of sleep deprivation on cytokine levels or cognitive control abilities.   
Phase 1. One week before their first scheduled laboratory appointment, participants were 
emailed a link to the online battery of baseline questionnaires, including the demographic 
questionnaire and measures related to depressive symptoms (BDI-II), cognitive content (DAS-A, 
YSQ-S3), cognitive organization (PDST) and rumination (RRS), as well as other measures as 
part of the larger study.  
Phase 2. Participants were run one at a time for Phase 2. Upon arrival at the laboratory, 
participants were taken to a testing room. After obtaining informed consent, participants were 
asked whether or not they had exercised that day, taken an antihistamine or anti-inflammatory 
medication in the past 24 hours, or had drunk fluids besides plain water, eaten, smoked, chewed 
gum, or brushed their teeth within the past hour. Participants (n = 3) who had eaten, drank, 
smoked, chewed gum, or brushed their teeth within the past hour were asked to wait until an 
hour had elapsed since they had broken the protocol before commencing the study. No 
participants reported same-day exercise or having recently taken antihistamines or anti-
inflammatory medications in the past 24 hours.  
Participants then completed a mouth rinse with water to remove any food particles. Next, 
they completed a 10-minute quiet relaxation period in which they were invited to sit quietly or to 
read books and magazines that were provided. The intention of the relaxation period was to 
allow participants to adjust to the laboratory setting in order to obtain a valid baseline 
measurement of salivary cytokines. Following the relaxation period, participants were provided 
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with makeup wipes to remove any lip products and were given instructions for saliva collection. 
The experimenter waited outside the testing room during saliva collection and recorded the 
salivary flow rate (i.e., the time it took for participants to provide 2ml of saliva) using a 
stopwatch. After processing the saliva sample for storage, the experimenter then measured the 
participant’s height and weight. 
Participants then completed the battery of cognitive control tasks. Tasks were displayed 
on an ASUS ® 22” monitor with 1920 × 1080 resolution and widescreen (16:9) aspect ratio. 
They first completed the N-back, followed by the Affective Flexibility Task and the Emotional 
Stroop task. The N-back was administered first as it is requires sustained attention for a 
prolonged duration and is therefore most sensitive to fatigue effects. The Emotional Stroop was 
administered last as it is more robust to fatigue effects (E. Hampson, personal communication, 
December 3, 2017). Next, the PANAS was administered to obtain information on baseline affect. 
The experimenter then led the participant to an interview room in the laboratory where 
instructions for the speech component of the TSST were provided by two research assistants, 
who were introduced to the participant as members of the human resources department at the 
hospital. The experimenter then led the participant back to the testing room for the 10-minute 
preparation period for the speech component of the TSST. At the end of the preparation period, 
the experimenter brought the participant back into the interview room, where he or she 
completed the speech and arithmetic tasks. At this point, participants were not permitted to have 
any water to ensure that post-stressor saliva samples would not be diluted. After completion of 
the TSST, participants were led back to the testing room, where they were asked to complete the 
N-back a second time, followed by the second administration of the PANAS to obtain 
information on post-stressor affect. Participants were then asked to provide a second saliva 
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sample, and the experimenter recorded salivary flow rate. Four participants refused to complete 
the TSST. Although these participants were invited to continue in the study, they were not asked 
to complete the post-stressor N-back or PANAS, or to provide a second saliva sample. The order 
of post-stressor tasks was chosen such that participants would complete the N-back directly after 
the stressor, when negative cognitive content is most likely to be highly activated. Saliva was 
collected last to allow sufficient time (approximately 40 minutes since the beginning of the 
stressor) for cytokine reactivity to be captured (Giletta et al. 2017; Newton et al. 2017). 
Participants were then debriefed, and a risk assessment was conducted if the participant had 
scored a 2 or 3 on item 9 of the BDI-II (endorsing suicidal ideation). Participants were then 
debriefed about this portion of the study.  
Phase 2 sessions were run by research assistants trained by the principal investigator 
(KR). Each research assistant was shadowed by the principal investigator for a minimum of two 
participant sessions before running participants independently. All Phase 2 sessions were run 
between 12:00 – 7:30pm in order to experimentally control for diurnal variations in cytokines 
(e.g., Ghazali, Steele, Koh, & Idris, 2017; Izawa, Miki, Liu, & Ogawa, 2013). 
Phase 3. Two weeks after Phase 2, participants returned to the laboratory and completed 
a second administration of the BDI-II, as well as a brief interview as part of the larger study. All 
Phase 3 study sessions were conducted by the principal investigator (KR).  
Phase 4. Participants returned to the laboratory 6 months after their Phase 2 appointments 
and completed the BDI-II, as well as interviews as part of the larger study. Phase 4 study 
sessions were run by the principal investigator (KR) or PhD-level clinical psychology students.  
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Results 
A priori study hypotheses were tested at a significance level of p < .05, and marginally 
significant findings were identified at a significance level of p < .10. As appropriate, follow-up 
tests were conducted for both significant and marginally significant findings. Analyses were 
conducted in IBM SPSS Statistics Version 25 and Mplus Version 8.3. See Appendix H for a 
glossary summarizing terms, acronyms, and variables used in the study.  
Preliminary Analyses 
Demographic, health, and clinical information. The sample consisted of 40 currently 
depressed, 69 remitted depressed, and 57 non-clinical controls. Demographic information for 
participant groups and the full sample is presented in Table 1. A univariate analysis of variance 
(ANOVA) or chi-square test was conducted, as appropriate, to test for differences across 
diagnostic groups on each demographic variable. Currently depressed, remitted depressed, and 
control participants did not significantly differ in age, ethnicity, years of education, level of 
educational attainment, or marital status, all ps > .05. However, age and ethnicity approached 
significance. Follow-up Tukey tests for age indicated that individuals in the currently depressed 
group were marginally older than those in the control group (mean difference = 4.22, SE = 1.83, 
p = .058). Furthermore, an inspection of standardized residuals for ethnicity indicated that there 
were marginally more Asian participants in the control group (z = 1.6) and fewer in the currently 
depressed group (z = -1.4). The chi-square test comparing groups in terms of the proportion of 
individuals of each sex was significant, χ2(2) = 8.61, p = .014. Inspection of standardized 
residuals indicated that a greater proportion of control participants were male (z = 2.0) than 
would be expected under the null hypothesis of independence between diagnostic group and sex.  
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Table 1  
Demographic Characteristics of Currently Depressed, Remitted Depressed, and Control Participants 
 
Variable 
Currently 
Depressed 
(n = 40) 
 Remitted 
Depressed 
(n = 69) 
Control 
(n = 57) 
Full Sample 
(n = 166) 
F/ χ2 
 
Sex 
     Male n (%) 
     Female n (%) 
 
10 (25.0) 
30 (75.0) 
 
13 (18.8) 
56 (81.2) 
 
24 (42.1) 
33 (57.9) 
 
47 (28.3) 
119 (71.7) 
 
8.61* 
Age M (SD) 28.63 (10.05) 26.01 (9.60) 24.40 (6.85) 26.09 (8.96) 2.66† 
Ethnicity  
      White n (%) 
      Asian n (%) 
      Other n (%) 
 
26 (65.0) 
9 (22.5) 
5 (12.5) 
 
38 (55.1) 
23(33.3) 
8 (11.6) 
 
21 (36.8) 
28 (49.1) 
8 (14.0) 
 
85 (51.2) 
60 (36.1) 
21 (12.7) 
 
9.00† 
Years of Education M (SD) 15.14 (2.78) 15.55 (2.41) 15.64 (2.32) 15.49 (2.46) .46 
Educational Attainment 
Partial high school, 10th or 11th grade n (%) 
High school graduate n (%) 
Partial college, at least one year of             
specialized training n (%) 
College or university graduate n (%) 
Graduate or professional training n (%) 
 
1 (2.5) 
9 (22.5) 
14 (35.0) 
 
14 (35.0) 
2 (5.0) 
 
1 (1.4) 
18 (26.1) 
17 (24.6) 
 
24 (34.8) 
9 (13.0) 
 
0 (0.0) 
19 (33.3) 
9 (15.8) 
 
22 (38.6) 
7 (12.3) 
 
2 (1.2) 
46 (27.7) 
40 (24.1) 
 
60 (36.1) 
18 (10.8) 
 
7.82 
Marital Statusa 
    Single and Never married   n (%) 
    Living with partner n (%) 
    Common-law n (%) 
    Married n (%) 
    Separated n (%) 
    Divorced n (%) 
 
28 (70.0) 
8 (20.0) 
1 (2.5) 
1 (2.5) 
2 (5.0) 
0 (0.0) 
 
51 (73.9) 
5 (7.2) 
3 (4.3) 
8 (11.6) 
1 (1.4) 
1(1.4) 
 
46 (80.7) 
2 (3.5) 
1 (1.8) 
6 (10.5) 
1 (1.8) 
1 (1.8) 
 
125 (75.3) 
15 (9.0) 
5 (3.0) 
15 (9.0) 
4 (2.4) 
2 (1.2) 
 
13.29 
aNo participants reported being widowed. 
†p < .10; ⁎p < 0.05. 
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Biological and health characteristics of the full sample and separate participant groups are 
presented in Table 2. Participant groups did not differ in number of alcoholic drinks consumed 
per week, or the number of hours participants slept the night before Phase 2, all ps > .05. Among 
female participants, there was no significant difference across groups in use of hormonal 
contraceptives or length of time since last menstrual cycle, ps > .05. There were significant 
differences in body mass index index (BMI) across participant groups, F(2, 163) = 4.79, p = 
.010, ηp2  = .056. Follow-up Tukey tests indicated that control participants had significantly lower 
BMI scores than did remitted depressed participants (mean difference = -2.57, SE = 1.06, p = 
.043), and currently depressed participants (mean difference = -3.48, SE = 1.22, p = .014). The 
difference between currently depressed and remitted depressed participants was nonsignificant 
(mean difference = 0.90, SE = 1.18, p = .723). A chi-square test also indicated a significant 
difference in smoking status, χ2(2) = 19.89, p < .001. Examination of the standardized residuals 
indicated that a greater number of currently depressed individuals were current smokers (z = 3.6) 
than would be expected under the null hypothesis of independence between participant group 
and smoking status.  
Clinical characteristics across participant groups are presented in Table 3. The currently 
depressed group had a mean BDI-II score in the ‘severe’ range, whereas remitted depressed and 
control groups had mean BDI-II scores in the ‘minimal’ range (Beck et al., 1996). As 
anticipated, BDI-II scores significantly differed across diagnostic groups, F(2, 163) = 78.54, p < 
.001, ηp2  = .491. Follow-up Tukey tests confirmed that currently depressed participants had 
greater depressive symptoms than remitted depressed (mean difference = 14.36, SE = 1.75, p < 
.001) and control participants (mean difference = 22.67, SE = 1.81, p < .001). Remitted 
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Table 2  
 
Biological and Health Characteristics of Currently Depressed, Remitted Depressed, and Control 
Participants 
 
 
 
Currently 
Depressed 
(n = 40) 
 Remitted 
Depressed 
(n = 69) 
Control 
(n = 57) 
Full Sample  
(n = 166) 
F/ χ2 
 
Body Mass Index (BMI) M 
(SD) 
27.54 (5.87) 26.64 (6.68) 24.06 (4.89) 25.97 (6.06) 4.79* 
Using hormonal 
contraceptives:a 
    Yes n (%) 
    No n (%) 
 
 
9 (30.0) 
21 (70.0) 
 
 
23 (41.1) 
33 (58.9) 
 
 
12 (36.4) 
21 (63.6) 
 
 
44 (37.0) 
75 (63.0) 
1.04 
Menstrual Cycle:a 
   Having period now 
   < 2 months ago 
   2-12 months ago 
   More than 12 months ago 
   Unknown 
 
3 (10.0) 
19 (63.3) 
4 (13.3) 
4 (13.3) 
0 (0.0) 
 
6 (10.7) 
35 (62.5) 
4 (7.1) 
11 (19.6) 
0 (0.0) 
 
5 (15.2) 
25 (75.8) 
1 (3.0) 
1 (3.0) 
1 (3.0) 
 
14 (11.8) 
79 (66.4) 
9 (7.6) 
16 (13.4) 
1 (0.01) 
7.60 
Smoking: 
   Current Smoker n (%) 
   Nonsmoker n (%) 
 
11 (27.5) 
29 (72.5) 
 
4 (5.8) 
65 (94.2) 
 
1 (1.8) 
56 (98.2) 
 
16 (9.6) 
150 (90.4) 
19.89*** 
Number of alcoholic drinks 
consumed per week M (SD) 
2.53 (5.29) 1.86 (2.40) 1.79 (2.58) 1.97 (3.36) .66 
Number of Hours Slept 
Before Phase 2 M (SD)  
7.80 (1.76) 7.80 (1.23) 7.42 (1.22) 7.68 (1.37) 1.47 
aPercentages are calculated based on proportion of total female participants in each group 
(current depressed: n = 30, remitted depressed: n = 56; controls: n = 33).  
*p < 0.05; **p < .01, ***p < 0.001.  
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Table 3  
 
Clinical Characteristics of Currently Depressed, Remitted Depressed, and Control Participants 
 
 Currently 
Depressed 
(n = 40) 
 Remitted 
Depressed 
(n = 69) 
Control 
(n = 57) 
BDI-II at Phase 1 M (SD) 27.12 (10.91) 12.76 (9.73) 4.46 (5.18) 
Core Beliefs M (SD) 302.76 (59.97) 242.77 (51.65) 190.64 (44.65) 
Dysfunctional Attitudes M (SD) 151.00 (34.66) 129.82 (33.40) 110.84 (28.32) 
Rumination M (SD) 63.78 (10.66) 56.93 (11.61) 41.03 (12.11) 
Negative Social Organization 0.87 (0.31) 1.10 (0.42) 1.33 (0.50) 
Negative Achievement Organization 0.81 (0.39) 1.23 (0.55) 1.47 (0.52) 
Age of first depression onset M (SD) 16.39 (6.77) 17.49 (5.99)  
Depression history: 
     First episode n (%) 
     Recurrence n (%) 
     Unknown n (%) 
 
3 (7.5) 
37 (92.5) 
0 (0.0) 
 
21 (30.4) 
46 (66.7) 
2 (2.9) 
 
Number of Depressive Episodes M (SD) 5.60 (4.60) 2.94 (3.03)  
Comorbid diagnosis:  
    Yes (1 comorbidity) n (%) 
    Yes (2+ comorbidities) n (%) 
    No n (%) 
 
7 (17.5) 
29 (72.5) 
4 (10.0) 
 
17 (24.6) 
26 (37.7) 
26 (37.7) 
 
Comorbid diagnosis:a    
    Premenstrual Dysphoric Disorder n (%) 
    Agoraphobia n (%) 
    Generalized Anxiety Disorder n (%) 
    Panic Disorder n (%) 
    Social Anxiety n (%) 
    Specific Phobia n (%) 
    Other Specified Anxiety Disorder n (%) 
    Obsessive Compulsive Disorder n (%) 
    Other Specified Obsessive Compulsive                              
    Disorder n (%) 
    Posttraumatic Stress Disorder n (%) 
    Other Specified Trauma-related Disorder n (%) 
 
4 (1.0) 
9 (2.3) 
23 (57.5) 
8 (2.0) 
21 (52.5) 
8 (20.0) 
4 (10.0) 
9 (22.5) 
0 (0.0) 
 
13 (32.5) 
7 (17.5) 
 
11 (15.9) 
5 (7.2) 
15 (21.7) 
8 (11.6) 
21 (30.4) 
10 (14.5) 
4 (5.8) 
12 (17.4) 
1 (1.4) 
 
10 (14.5) 
2 (2.9) 
 
Currently using antidepressant medication n (%):b 
     Yes n (%) 
     No n (%) 
 
19 (47.5) 
21 (52.5) 
 
16 (23.2) 
53 (76.8) 
 
0 (0.0) 
57 (100.0) 
Currently receiving therapy: 
     Yes n (%) 
     No n (%) 
     Unknown n (%) 
 
12 (30.0) 
28 (70.0) 
0 (0.0) 
 
10 (14.5) 
58 (84.1) 
1 (1.4) 
 
0 (0.0) 
57 (100.0) 
0 (0.0) 
Ever received therapy: 
    Yes n (%) 
     No n (%) 
 
31 (77.5) 
9 (22.5) 
 
40 (58.8) 
28 (41.2) 
 
3 (5.3) 
54 (94.7) 
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aPercentages total more than 100% as some individuals had multiple comorbidities. 
bAntidepressant medications in the sample included buproprion (n = 5), citalopram (n = 1), 
desvenlafaxine (n = 2), duloxetine (n = 1), escitalopram (n = 10), fluoxetine (n = 3), paroxetine 
(n =1), quetiapine (n = 3), sertraline (n = 7), trazodone (n = 4), venlafaxine (n = 4), and 
vortioxetine (n = 2). 
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depressed participants also had a greater number of symptoms than control participants (mean 
difference = 14.36, SE = 1.57, p < .001). 
There were also significant group differences in core beliefs, F(2, 162) = 55.20, p < .001, 
ηp2  = .405. Post hoc Tukey tests revealed that currently depressed individuals reported greater 
maladaptive core beliefs than remitted depressed (mean difference = 59.99, SE = 10.32, p < .001) 
and control participants (mean difference = 112.13, SE = 10.70, p < .001). The remitted 
depressed group reported greater core beliefs than the control group (mean difference = 52.13, 
SE = 9.22, p < .001). Similarly, dysfunctional attitudes also differed across diagnostic groups, 
F(2, 163) = 18.55, p < .001, ηp2  = .185, and currently depressed individuals reported greater 
dysfunctional attitudes than remitted depressed (mean difference = 21.18, SE = 6.37, p = .003) 
and control participants (mean difference = 40.17, SE = 6.61, p < .001). Remitted depressed and 
control groups also differed, with the remitted depressed group reporting greater dysfunctional 
attitudes (mean difference =18.99, SE = 5.74, p = .003). Additionally, there were significant 
group difference in trait rumination, F(2, 162) = 51.36, p < .001, ηp2  = .388, with post hoc Tukey 
tests indicating that currently depressed participants reported a significantly greater tendency to 
ruminate than both remitted depressed (mean difference = 6.85, SE = 2.32, p = .010) and control 
participants (mean difference = 22.74, SE = 2.40, p < .001). Remitted depressed participants also 
reported greater rumination than control participants (mean difference = 15.89, SE = 2.07, p < 
.001).  
Significant group differences emerged on measures of the PDST, as expected. The 
ANOVA for negative social organization revealed group differences, F(2, 140) = 12.51, p < 
.001, ηp2  = .152. Tukey tests confirmed that currently depressed participants demonstrated more 
tightly connected negative social schemas than both remitted depressed (mean difference = -0.23, 
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SE = 0.09, p = .026) and control participants (mean difference = -0.46, SE = 0.09, p < .001). 
Remitted depressed participants also showed more tightly interconnected negative social 
organization than controls (mean difference = -0.23, SE = 0.08, p = .015). Similarly, there were 
diagnostic group differences in negative achievement organization, F(2, 136) = 18.24, p < .001, 
ηp2  = .212. Again, depressed participants evinced more tightly interwoven schemas than both 
remitted depressed (mean difference = -0.42, SE = 0.10, p < .001) and control individuals (mean 
difference = -0.67, SE = 0.11, p < .001), and remitted depressed individuals demonstrated more 
tightly interconnected schemas than did control participants (mean difference = -0.25, SE = 0.10, 
p = .043).  
The majority of current and remitted depressed participants had experienced recurrent 
depressive episodes and met criteria for at least one comorbid psychiatric diagnosis. The most 
commonly reported comorbid diagnoses across both groups were generalized anxiety disorder 
and social anxiety disorder. Based on selection criteria, the non-clinical control group did not 
meet criteria for any current or remitted psychiatric diagnoses.  
Data preparation and screening. Descriptive statistics for study variables are reported 
in Table 4, and bivariate correlations among cognitive content, cognitive organization, and 
cognitive control variables are presented in Table 5. Data were screened for non-normality and, 
with the exception of cytokines (see Cytokine Screening below), all study variables were 
normally distributed.   
Self-report data. For all self-report questionnaires (i.e., BDI-II, YSQ, DAS, RRS) 
missing item data were imputed with the participant’s mean score when at least 80% of items for 
that scale were completed. If more than 20% of items for a scale were missing, participant data 
for that scale were coded as missing. Very few data (0.50% of items) were missing. No extreme   
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Table 4  
 
Descriptive Statistics of Cytokines, Depressive Symptoms, and Cognitive Measures 
 
 N Mean (SD) 
IL-6   
   Pre-stress 166 4.36 (8.93) 
   Post-stress 161 5.34 (12.50) 
IL-8   
   Pre-stress 166 540.99 (608.07) 
   Post-stress 161 852.65 (891.50) 
IL-1β   
   Pre-stress 166 61.51 (78.48) 
   Post-stress 161 96.84 (132.40) 
TNF-α   
   Pre-stress 166 1.65 (1.37) 
   Post-stress 161 2.17 (2.00) 
Depressive Symptoms at Phase 1  166 13.37 (12.23) 
Depressive Symptoms at Phase 3  161  12.79 (12.09) 
Depressive Symptoms at Phase 4 134 11.42 (12.25) 
Core Beliefs 165 238.94 (66.38) 
Dysfunctional Attitudes 166 128.41 (35.32) 
Rumination  165 53.06 (14.70) 
Negative Social Organization 143 1.11 (0.45) 
Negative Achievement Organization 139 1.19 (0.56) 
Neutral Stroop RT (ms) 165 615.70 (135.54) 
Emotional Stroop RT (ms) 165 595.80 (132.88) 
P/A Switch Costs (ms) 166 161.63 (187.41) 
N/A Switch Costs (ms) 165 261.16 (187.26) 
P/NA Switch Costs (ms) 166 158.04 (204.59) 
N/NA Switch Costs (ms) 166 75.82 (195.28) 
Pre-stress N-back Errors 160 23.94 (11.74) 
Post-stress N-back Errors 150 21.63 (11.28) 
Note. Raw values are presented, however cytokines values were log transformed before analysis. 
IL-6 = interleukin-6; IL-8 = interleukin-8; IL-1β = interleukin -1β, TNF-α = tumor necrosis 
factor- α; RT = reaction time; NS  Organization = Negative Social Organization; NA 
Organization = Negative Achievement Organization; P/A Switch Costs = Positive Affective 
Switch Costs; N/A Switch Costs = Negative Affective Switch Costs; P/NA Switch Costs = 
Positive Nonaffective Switch Costs; N/NA Switch Costs = Negative Nonaffective Switch Costs.  
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Table 5  
 
Bivariate Correlations among Cognitive Content, Organization, and Control Variables 
 
Note. NS Organization = Negative Social Organization; NA Organization = Negative Achievement Organization; RT = reaction time; 
P/A Switch Costs = Positive Affective Switch Costs; N/A Switch Costs = Negative Affective Switch Costs; P/NA Switch Costs = 
Positive Nonaffective Switch Costs; N/NA Switch Costs = Negative Nonaffective Switch Costs. 
†p < .10; *p < .05; **p < .01; ***p < .001
 1 2 3 4 5 6 7 8 9 10 11 12 13 
1. Core Beliefs -             
2. Dysfunctional Attitudes .73*** -            
3. Rumination .70*** .48*** -           
4. NS Organization -.51** -.47*** -.39*** -          
5. NA Organization .60*** -.56*** -.45*** .56*** -         
6. Neutral Stroop RT .10 .03 .19* -.08 -.10 -        
7. Emotional Stroop RT .10 .01 .20* -.06 -.07 .89*** -       
8. Pre-stress N-back  .17* .11 .17* -.06 .004 .31*** .33*** -      
9. Post-stress N-back  .19* .06 .23** .07 .12 .28** .30*** .66*** -     
10. P/A Switch Costs .06 .06 .05 -.002 -.08 .16* .08 .11 .03 -    
11. N/A Switch Costs .02 .13† .10 -.05 -.07 .04 .06 -.03 .01 .13 -   
12. P/NA Switch Costs .15† .23** .14† -.06 -.12 .06 .01 .05 .00 .20* .26** -  
13. N/NA Switch Costs .04 .04 .04 .05 .07 .16* .19* .04 .08 .27*** .15† .33*** - 
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outliers (i.e., cases with values three times greater or less than the interquartile range) were 
identified on the PDST, BDI-II, YSQ, DAS, or RRS. 
Emotional Stroop screening. Mean accuracy was 96.4% (SD = 4.1%) on the neutral 
block and 96.2% (SD = 4.2%) on the emotional block of the Stroop. Trials with inaccurate 
responses (3.6% of trials) were removed from further analysis. The influence of outliers was 
handled by replacing all trials with anticipatory responses (i.e., operationalized as a reaction time 
less than 250ms, given the time needed for stimulus perception and motor response) with a value 
of 250ms. Trials with slow reaction times that were at least 2.5 standard deviations above the 
mean were replaced with the value corresponding to 2.5 standard deviations above the mean. 
Altogether, 2.29% of trials were winsorized in this manner. This winsorizing procedure is 
consistent with other studies using reaction time data (e.g., Greenwald, Nosek, & Banaji, 2003) 
and retains the rank order of outliers while reducing their impact on mean performance. Average 
response time for neutral and emotional trials were then computed. Practice effects, as indicated 
by faster reaction times on the emotional block compared with the neutral block (t(164) = 4.06, p 
< .001) of the Stroop, were observed. Practice effects precluded a direct comparison of 
performance on the emotional block to the neutral block. As a result, interference scores, which 
demark interference resulting from inhibiting affective stimuli by taking performance when 
stimuli are not affective into account, could not be computed. Therefore, neutral and emotional 
block reaction times were examined separately in subsequent analyses. As the focus of the 
current study was on cognitive control abilities for affective stimuli, analyses of the emotional 
block of the Stroop are reported below. Analyses of the neutral block are reported in Appendix I. 
As noted in the appendix, there were not significant group differences in general inhibitory 
abilities as assessed by the neutral Stroop. Poor general inhibition was associated with greater 
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trait rumination and predicted greater resting-state inflammation. Interactions of cognitive 
vulnerability with neutral Stroop performance followed a pattern similar to other interactions, as 
described under the Summary of Moderating Effects in the Discussion.  
Affective Flexibility Task screening. Trials with inaccurate responses (8.4% of trials) 
were removed from analysis. Using the same procedure as for the Stroop, trials with reaction 
times less than 250ms were replaced with a value of 250ms, and trials with reaction times 2.5 
standard deviations above the mean were replaced with the value corresponding to 2.5 standard 
deviations above the mean. Altogether, 2.74% of trials were winsorized in this manner.  This 
procedure is consistent with other studies using the Affective Flexibility Task (Genet, Malooly, 
& Siemer, 2013) and reaction time data more broadly (e.g., Greenwald, Nosek, & Banaji, 2003). 
Specific switch costs for various trial types were then calculated.  
Emotional N-Back screening. In order to reduce the influence of participants who did 
not understand the task, expended low effort, or responded randomly, all outliers (defined as 
cases with values one and a half times greater or less than the interquartile range for their 
diagnostic group) were removed from analyses. Six individuals (3.61% of the sample) were 
classified as outliers on the first administration of the N-back, and 12 (7.23%) were classified as 
outliers on the second administration. This cutoff for removal of outliers was used in order to 
capture individuals performing significantly worse than chance based on a binomial distribution. 
Cytokine screening. Due to the characteristic skewness and kurtosis of cytokine data, all 
pre- and post-stress cytokine variables were logarithmically transformed before analysis. This 
resolved issues with skew, although IL-6 remained somewhat leptokurtic (pre-stress kurtosis = 
2.50, SE = .38, post-stress kurtosis = 2.52, SE = .38). Correlations among cytokines are reported 
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in Table 6, and correlations of cytokines with other main study variables are presented in Table 
7. 
Hypothesis 1: Group differences in Cognitive Control  
Given group differences in the proportion of participants of each sex, a series of analysis 
of covariance (ANCOVA) tests were run to assess group differences in cognitive control while 
controlling for sex. As the same pattern of findings emerged without controlling for sex, the 
more parsimonious models excluding sex as a covariate are presented. 
Emotional Stroop. Consistent with hypotheses, a one-way ANOVA assessing the 
relation of depression to reaction time for the emotional word block of the Stroop indicated that 
reaction times significantly differed across groups, F(2, 162) =  3.13, p = .046, hp2 = .037. An 
inspection of group means indicated that currently depressed individuals had the slowest reaction 
times (M = 638.27; SD = 149.94), followed by remitted depressed individuals (M = 591.35; SD = 
129.99). Control participants had the fastest reaction times (M = 571.31; SE = 117.94). Follow-
up Tukey tests indicated that depressed participants had significantly longer reaction times than 
control participants (mean difference = 66.96, SE = 27.06, p = .038). Remitted depressed 
participants did not differ significant from currently depressed (mean difference = -46.92, SE = 
26.14, p = .175) or control participants (mean difference = 20.05, SE = 23.56, p = .672).  
Affective Flexibility Task. A one-way multivariate ANOVA was conducted to examine 
group differences in performance on the Affective Flexibility Task, as indicated by negative 
affective switch costs, positive affective switch costs, positive nonaffective switch costs, and 
negative nonaffective switch costs. Contrary to hypotheses, there was no effect of diagnostic 
group on task performance, Wilk’s l = .96, F(8, 318) = 0.55, p = .549, hp2 = .021.  
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Table 6  
 
Correlations among Cytokines 
 
 1 2 3 4 5 6 7 8 
1. Pre-stress IL-6 -        
2. Post-stress IL-6 .90*** -       
3. Pre-stress IL-8 .51*** .51*** -      
4. Post-stress IL-8 .45*** .57*** .91*** -     
5. Pre-stress IL-1β .60*** .63*** .58*** .53*** -    
6. Post-stress IL-1β .59*** .69*** .53*** .62*** .90*** -   
7. Pre-stress TNF-α .73*** .65*** .57*** .48*** .63*** .57*** -  
8. Post-stress TNF-α .68*** .81*** .57*** .66*** .68*** .75*** .75*** - 
Note. IL-6 = interleukin-6; IL-8 = interleukin-8; IL-1β = interleukin -1β, TNF-α = tumor necrosis 
factor- α.  
***p < .001. 
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Table 7  
 
Bivariate Correlations Between Cytokines and Cognitive Content, Organization, and Control Variables 
 
 Pre-stress  
IL-6 
Post-stress  
IL-6 
Pre-stress  
IL-8 
Post-stress  
IL-8 
Pre-stress  
IL-1β 
Post-stress  
IL-1β 
Pre-stress 
TNF-α 
Post-stress 
TNF-α 
Core Beliefs .03 -.01 .01 .04 -.09 -.09 -.10 -.11 
Dysfunctional Attitudes -.05 -.12 .06 -.20 -.08 -.10 -.08 -.15† 
Rumination -.04 -.09 .15† .06 -.06 -.11 -.06 -.12 
NS Organization -.15† -.10 -.15† -.05 -.05 -.01 -.07 -.02 
NA Organization -.11 -.09 -.27** -.20* -.10 -.03 -.05 -.05 
Neutral Stroop RT .16* .24** .22** .28*** .27*** .34*** .18* .28*** 
Emotional Stroop RT .11 .18* .19* .24** .23** .31*** .11 .22** 
P/A Switch Costs .11 .22** .13 .21** .11 .15† .03 .21** 
N/A Switch Costs -.12 -.09 -.02 -.02 -.08 -.05 -.05 -.04 
P/NA Switch Costs .04 .01 .08 .03 -.09 -.09 .08 .002 
N/NA Switch Costs .16* .14† .08 .10 .05 .09 .13† .09 
Pre-stress N-Back Errors .05 .09 .17* .19* .15† .19* .04 .15† 
Post-stress N-Back Errors -.02 .00 .06 .07 .08 .12 -.03 .08 
Note. IL-6 = interleukin-6; IL-8 = interleukin-8; IL-1β = interleukin -1β, TNF-α = tumor necrosis factor- α; NS  Organization = 
Negative Social Organization; NA Organization = Negative Achievement Organization; P/A Switch Costs = Positive Affective Switch 
Costs; N/A Switch Costs = Negative Affective Switch Costs; P/NA Switch Costs = Positive Nonaffective Switch Costs; N/NA Switch 
Costs = Negative Nonaffective Switch Costs.  
†p < .10; *p < .05; **p < .01; ***p < .001
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Emotional N-back. A one-way ANOVA was conducted to assess group differences in 
number of errors on the N-back at baseline. As predicted, number of errors differed significantly 
across groups, F(2, 157) = 6.11, p = .003, hp2 = .072. Post-hoc pairwise comparisons using 
Tukey tests indicated that the control group made significantly fewer errors (M = 21.40; SD = 
10.61) than did the currently depressed group (M = 29.36; SD = 13.66; mean difference = -7.96, 
SE = 2.36, p = .003). The number of errors the remitted depressed group made was intermediate 
between the current depressed and control groups (M = 22.91; SD =10.49), and differed 
significantly from currently depressed participants (mean difference = -6.45, SE = 2.31, p = 
.016), but not from control participants (mean difference = 1.50, SE = 2.07, p = .749). 
Similarly, a one-way ANOVA was conducted to examine group differences in number of 
errors on the N-back after the TSST.  Again, number of errors differed significantly across 
groups, F(2, 147) = 7.23, p = .001, hp2 = .090. Tukey tests indicated that currently depressed 
individuals made more errors (M = 27.44; SD = 13.46) than both remitted depressed participants 
(M = 20.64; SD = 9.65; mean difference = 6.81, SE = 2.28, p = .009) and controls (M = 18.81; 
SD = 10.13; mean difference = 8.63, SE = 2.34, p = .001). Remitted depressed participants did 
not differ significantly from the control group (mean difference = 1.83, SE = 2.04, p = .642). 
Hypothesis 2: Association of Deficits in Cognitive Control with Rumination 
A series of bivariate correlations were conducted to examine the relation of cognitive 
control deficits with rumination (see Table 5). Consistent with hypotheses, greater rumination 
was associated with longer reaction times on the emotional block of the Stroop, (r[164] = .20, p 
= .010). Furthermore, greater pre-stressor (r[159] = .17, p = .030) and post-stressor (r[149] = .23 
p = .005) N-back errors were associated with higher rumination. Positive nonaffective switch 
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costs were marginally associated with rumination (r[165] = .14, p = .068), whereas negative 
nonaffective, positive affective, and positive affective switch costs were not, all ps > .05. 
Hypothesis 3: Decreased Updating Abilities Following the Stressor 
Stress induction manipulation check. The validity of the stress induction was evaluated 
by assessing whether participants reported greater levels of negative affect and lower positive 
affect after the TSST. Participants reported significantly greater negative affect after the TSST 
(M = 22.38, SD = 9.61) compared with before the TSST (M = 16.10, SD = 6.10), t(161) = -10.54, 
p < .001, d = -0.83. Participants also reported significantly lower positive affect following the 
TSST (M = 22.93, SD = 8.84) compared with before the TSST (M = 25.08, SD =7.54), t(161) = 
3.77, p < .001, d = 0.30. Together, these results indicate that the TSST elicited a subjective stress 
response. 
Two 3(group) x 2(pre-stress vs. post-stress) repeated measures ANOVAs were conducted 
to examine diagnostic group differences in affective response to the stressor. For changes in 
negative affect, there was a significant main effect of group F(2, 159) = 14.89, p < .001, hp2 = 
.158. This was qualified by a significant interaction of stress with group, Wilk’s l = .95, F(2, 
159) = 4.04, p = .019, hp2 = .048. To facilitate interpretation of this significant interaction, 
follow-up univariate ANOVAs were run separately with group as the independent variable for 
pre- and post-stress negative affect. Groups differed significantly in negative affect before the 
TSST, F(2, 163) = 10.78, p < .001, hp2 = .117. Follow up Tukey tests indicated that currently 
depressed participants reported greater negative affect (M = 19.25; SD = 7.03) than remitted 
depressed (M = 16.42; SD = 5.86; mean difference = 2.83, SE = 1.15, p = .039) or control 
participants (M = 13.74; SD = 4.61; mean difference = 5.51, SE = 1.19, p < .001) at baseline. 
Furthermore, remitted depressed individuals reported greater negative affect than controls (mean 
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difference = 2.68, SE = 1.04, p = .028). There were also significant group differences in negative 
affect after the TSST, F(2, 159) = 13.16, p < .001, hp2 = .142. Follow-up Tukey tests revealed 
that control participants (M = 17.77; SD = 7.33) reported significantly lower negative affect than 
currently depressed (M = 26.95; SD = 10.03; mean difference = -9.17, SE = 1.89, p = .009) or 
remitted depressed individuals (M = 23.76; SD = 9.56; mean difference = -5.99, SE = 1.61, p = 
.001) following the stressor. In contrast to baseline negative affect, remitted depressed 
individuals did not differ from currently depressed participants in negative affect following the 
TSST (mean difference = -3.18, SE = 1.83, p = .194). 
The 3(group) x 2(pre-stress vs. post-stress) repeated measures ANOVA for positive affect 
indicated a significant main effect of group F(2, 159) = 8.40, p < .001, hp2 = .096. This was 
qualified by a significant interaction of stress with group, Wilk’s l = .90, F(2, 159) = 8.99, p < 
.001, hp2 = .102. Separate follow-up univariate ANOVAs were conducted with group as the 
independent variable for pre- and post-stress positive affect. In the first ANOVA examining pre-
stress positive affect, there were no significant group differences in positive affect, F(2, 163) = 
2.26, p = .108, hp2 = .027. However, group means for positive affect fell in the expected 
direction, with control participants reporting high positive affect (M = 26.61; SD = 7.05), 
followed by remitted depressed (M = 24.59; SD = 8.15) and currently depressed participants (M 
= 23.45; SD = 7.08). Significant group differences did emerge on positive affect following the 
TSST, F(2, 159) = 13.75, p < .001, hp2 = .147.  Control participants had significantly higher 
positive affect (M = 27.53; SD = 9.31) than currently depressed (M = 20.39; SD = 7.56; mean 
difference = 7.14, SE = 1.73, p < .001) and remitted depressed (M = 20.47; SD = 7.54; mean 
difference = 7.06, SE = 1.47, p < .001) individuals. However, similar to findings for negative 
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affect, currently depressed and remitted depressed individuals did not differ with regard to 
positive affect following the stressor (mean difference = -0.08, SE = 1.68, p = .999).  
Changes in updating following stress. A 3(group) ´ 2(pre-stress vs. post-stress) 
repeated measures ANOVA was conducted to examine whether there were increases in N-back 
errors after the stressor. Contrary to hypotheses, there was no main effect of stress on N-back 
errors, Wilk’s l = .99, F(1, 145) = 1.56, p = .214, hp2 = .011, nor was there an interaction on 
stress with diagnostic group, Wilk’s l = .99, F(2, 145) = .62, p = .541, hp2 = .008.  
Hypothesis 4: Cognitive Content and Structure Predicting Stress-Induced Change in N-
Back Performance 
Associations of changes in N-back performance with changes in negative and positive 
affect were examined using partial correlations. Controlling for baseline N-back errors and 
baseline negative affect, greater post-stress N-back errors were significantly associated with 
increased post-stress negative affect, r(144) = .20, n = 148, p = .016.  However, controlling for 
both baseline N-back errors and baseline positive affect, stress-induced changes in N-back errors 
were not related to positive affect following the stressor, r(144) = .02, n = 148, p = .792.   
A hierarchical linear regression was conducted to examine the role of negative cognitive 
content and structure in predicting stress-induced changes in performance on the N-back (Table 
8). Because a goal was to assess how N-back performance changed following stress, pre-stressor 
N-back errors were entered in Step 1 to control for baseline performance. Diagnostic group was 
also entered as a covariate in Step 1 since it is associated with updating abilities. Negative affect 
at pre-stress and at post-stress were entered in Step 2 to control for the influence of changes in 
affect on N-back task performance. Negative affect was entered separately from diagnostic status 
so that group effects could be examined independently given that diagnostic group was   
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Table 8  
 
Hierarchical Linear Regression with N-Back Errors Before Stress Induction, Negative Cognitive 
Content and Negative Cognitive Organization Predicting Post-Stressor N-Back Errors 
 
Variable   B   SE 95% CI    b     t       p 
Step 1       
     Pre-stress N-back Errors .60 .08 [.45, .75] .58 7.77 <.001 
     Diagnostic Group       
         Currently Depressed vs. Controls 4.23 2.07 [.12, 8.33] .18 2.04 .044 
         Remitted Depressed vs. Controls -1.52 1.87 [-5.22, 2.19] -.07 -0.81 .419 
Step 2       
     Pre-stress N-back Errors .56 .08 [.41, .72] .55 7.28 <.001 
     Diagnostic Group       
         Currently Depressed vs. Controls 2.87 2.20 [-1.48, 7.23] .12 1.31 .194 
         Remitted Depressed vs. Controls -2.34 1.89 [-6.08, 1.40] -.11 -1.24 .217 
     Pre-stress Negative Affect -.11 .15 [-.41, .18] -.07 -0.76 .449 
     Post-stress Negative Affect .23 .11 [.02, .44] .20 2.19 .031 
Step 3       
     Pre-stress N-back Errors .50 .07 [.36, .65] .49 6.79 <.001 
     Diagnostic Group       
         Currently Depressed vs. Controls 3.52 2.47 [-1.38, 8.43] .15 1.42 .158 
         Remitted Depressed vs. Controls -2.21 1.92 [-6.00, 1.59] -.10 -1.15 .252 
     Pre-stress Negative Affect -.15 .14 [-.43, .14] -.09 -1.01 .317 
     Post-stress Negative Affect .27 .10 [.06, .47] .23 2.61 .011 
     Core Beliefs .04 .02 [.002, .09] .26 2.08 .040 
     Dysfunctional Attitudes -.01 .03 [-.07, .05] -.04 -0.42 .679 
     Negative Social Organization 5.23 2.14 [.98, 9.48] .21 2.44 .016 
     Negative Achievement Organization     4.47 1.86 [.77, 8.16] .22 2.40 .018 
Model R2 DR2   DF      p   
      Step 1 .44 .44 28.03 <.001   
      Step 2 .46 .03 2.51 .086   
      Step 3 .55 .09 5.00 .001   
Note. 95% CI = 95% confidence intervals for unstandardized coefficients (Bs). Diagnostic Group 
was dummy coded as Controls = 0, Currently Depressed = 1, and Remitted Depressed = 1. 
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associated with affective responses to the stressor. In Step 3, cognitive content (core beliefs, 
dysfunctional attitudes) and structure (negative social organization, negative achievement 
organization) variables were added.  
Findings in Step 1 indicate that pre-stress N-back errors significantly predicted post-
stress errors. Diagnostic status was associated with updating errors, such that currently depressed 
participants showed greater declines in cognitive control than controls. There were no 
differences between participants in the remitted depressed and control groups.  
Greater post-stress negative affect was related to increases in post-stress N-back errors in 
Step 2. As pre-stress negative affect was also entered in Step 2, this finding indicates that post-
stress increases in negative affect were related to stress-induced increases in N-back errors. 
Diagnostic status was no longer associated with post-stressor changes in N-back performance in 
Step 2, indicating that increases in negative affect better account for declines in updating 
following the stressor, although the inclusion of negative affect did not significantly improve the 
model, DR2 = .03, DF(2, 106) = 2.51, p = .086. 
As anticipated, the addition of cognitive content and organization variables in Step 3 
significantly improved the model, DR2 = .09, DF(4, 102) = 5.00, p = .001. The final model 
indicates that, as hypothesized, greater maladaptive core beliefs were associated with decreases 
in updating abilities following stress (i.e., greater N-back errors). Dysfunctional attitudes did not 
predict changes in updating. Unexpectedly, more diffuse negative social cognitive structure and 
more diffuse negative achievement structure predicted greater post-stress N-back errors. This 
suggests that less negative schema consolidation results in greater stress-induced declines in 
updating. Collinearity was assessed, and in the final model all tolerance values were .28 or 
higher, and VIF values were 3.61 or lower.  
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Hypotheses 5-10: Predicting Baseline Inflammation and Stress-Induced Changes in 
Inflammation 
Analytic strategy. In order to examine cytokine reactivity to the TSST, a series of latent 
change score models were conducted using structural equation modeling (SEM; Burt & 
Obradović, 2013; McArdle, 2009, see Giletta et al., 2017). In these models, a latent factor of 
inflammation was constructed at pre-stress and at post-stress and was comprised of the four 
inflammatory cytokines at each time point as indicators. A latent factor of inflammation 
represents a more reliable phenotype compared to examining each cytokine independently, and 
also has the advantage of accounting for measurement error (Burt & Obradović, 2013). To 
construct the latent inflammation factor, a series of measurement models were estimated using 
confirmatory factor analysis (CFA) in order to assess whether the four cytokines loaded on a 
common factor at both pre- and post-stress. CFA models were also used to test whether 
parameter estimates of this latent factor were equivalent (i.e., measurement invariant) across both 
time points (see Appendix J for details). Evidence was found for configural and metric 
invariance, and partial scalar invariance. Partial scalar invariance indicates that the intercepts 
(i.e., means) of some of the indicators (cytokines) changed at different rates from pre-stress to 
post-stress. Although there was a reduction in model fit statistics when constraining the 
intercepts to full scalar invariance, this approach was used due to the greater reliability of 
parameter estimates in fully constrained models. The same models constrained only to partial 
scalar invariance are presented in Appendix K and show the same general pattern of findings.  
Within-person changes in cytokines from pre- to post-stress were examined by defining a 
second-order latent change score variable. This latent change factor was defined by regressing 
the inflammation latent variable at post-stress on the pre-stress inflammation latent variable and 
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on the second-order latent change factor, with both of these paths fixed to 1. In the first 
unconditional model, pre-stressor inflammation and the latent change factor were covaried. This 
unconditional model was estimated first to assess mean changes and individual differences in 
cytokine reactivity (Figure 7).  
Next, a series of conditional models were computed to examine whether cognitive 
control, cognitive content, cognitive organization, or rumination account for individual 
differences in pre-stress cytokine levels and stress-induced changes in inflammation. In these 
models, the path from pre-stress to post-stress inflammation factors was freely estimated, 
whereas the covariance between the latent change factor and the pre-stress inflammation factor 
were set to zero (Figure 8). Constraining parameters in this manner renders the second-order 
latent change factor a ‘baseline-free’ latent change variable. Therefore, in the conditional 
models, latent change scores were predicted while taking individual differences in baseline levels 
of cytokines (which may influence the extent of reactivity to the stressor) into account. 
For each type of cognitive control, two sets of models were run. The first set of models 
assessed the role of cognitive content (i.e., core beliefs and dysfunctional attitudes) and 
rumination, cognitive control, and the interaction of cognitive content and rumination with 
cognitive control on both pre-stress inflammation and post-stress changes in inflammation. The 
second set of models assessed the role of negative cognitive structure and cognitive control and 
the interaction of negative cognitive organization with cognitive control on pre-stress cytokines 
and stress-induced changes in cytokines. Models including cognitive content and rumination 
variables assessed impacts of more surface level cognitions that represent cognitive processes 
(i.e., rumination) and cognitive products of schemas (i.e., dysfunctional attitudes, core beliefs; 
Beck & Dozois, 2014; Dozois & Beck, 2008) that were measured via item endorsement. In   
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Figure 7. Unconditional second-order latent change score model with first-order latent change 
factor of inflammation. Unstandardized estimates are reported. Model fit: χ2(19, N = 166) = 
81.44, p < .001, CFI = .955, TLI = .934 and RMSEA = .141, SRMR = .170. 
*p < .05; **p < .01; ***p < .001.  
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Figure 8. Conditional second-order latent change score model with first-order latent change 
factor of inflammation. Note that models examined either cognitive content or cognitive 
organization variables. Rumination was only included in models that also examined cognitive 
content. 
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contrast, models including cognitive organization variables assessed the structure of schemas, 
which represent deeper cognitions that individuals are not able to explicitly report on. Separate 
models were also run in order to avoid potential problems with multicollinearity or suppression 
on parameter estimates of interactions and due to the number of individuals with missing data on 
the PDST (i.e., individuals that did not obtain a score on a scale of the PDST). In order to obtain 
a score for negative achievement or negative social organization on the PDST, participants must 
endorse at least two negative adjectives as being self-descriptive. Therefore, individuals who do 
not endorse negative schematic information, which would likely include some of the less 
vulnerable participants in the sample, would be excluded from analyses. A total of 23 (13.96% of 
the sample) did not obtain a score for negative social organization, and 27 (16.27% of the 
sample) did not obtain a score for negative achievement organization. In part to minimize the 
influence of missing data, cognitive organization was analyzed independently of the cognitive 
content and rumination variables.  
Maximum likelihood estimation with robust standard errors was used, which is optimal 
for nonnormal data (e.g., cytokines), and handles missing data in the endogenous variables. 
Listwise deletion was used for exogenous variables. A series of conditional models were 
conducted to examine which demographic, biological, and health characteristics relevant to 
inflammation were associated with pre-stress inflammation or change in inflammation by 
regressing the latent factor of baseline inflammation and latent change in inflammation on each 
variable (Table 9). Salivary flow rate, or the total time taken to collect the desired volume of 
saliva, was not assessed as a potential covariate as a number of participants had difficulty 
providing the requested 2ml of saliva at one or both of the collection points. Salivary flow rate 
therefore was not a valid variable for comparison across participants.  
82 
 
Table 9  
 
Relation of Demographic, Clinical, and Health Characteristics with Latent Pre-Stressor 
Inflammation and Latent Change in Inflammation. 
 
 Pre-stress inflammation         Δ inflammation  
 β 95% CI b  β 95% CI b  
Age .26** [0.10, .41] .01  .21* [.02, .39] .004  
BMI .40*** [.25, .54] .03  .02 [-.15, .18] .00  
Ethnicity         
   White vs. Other -.12 [-.28, .04] -.15  .09 [-.10, .27] .05  
   White vs. Asian -.33*** [-.48, -.17] -.28  -.14 [-.33, .05] -.06  
Sex .04 [-.13, .20] .03  .22* [.05, .39] .09  
Depressive Symptoms .04 [-.12, .21] .001  -.10 [-.28, .08] -.001  
Diagnostic Group         
Currently Depressed vs.         
Controls 
.11 [-.08, .30] .10  -.12 [-.32, .09] -.05  
Remitted Depressed vs. 
Controls 
.11 [-.06, .28] .09  -.10 [-.28, .09] -.04  
Use of contraceptives -.06 [-.20, .09] -.05  -.16† [-.33, .02] -.07  
Time since last menstrual 
period 
.13 [-.09, .35] .06  .38** [.26, .61] .08  
Smoking Status .002 [-.19, .20] .03  .07 [-.09, .23] .04  
Number of alcoholic drinks 
consumed per week 
.07 [-.15, .29] .01  .21† [-.004, .43] .01  
Number of Hours Slept 
Before Phase 2 
.10 [-.09, .30] .03  -.06 [-.28, .16] .58  
Using ADMa .18† [-.01, .21] .18  .03 [-.14, .21] .02  
Note. Each variable was entered in a separate model. 95% CI = 95% confidence intervals for 
standardized coefficients (βs). Values of .00 are < .001. Ethnicity was dummy coded as White = 
0, Asian = 1, and Other = 1; Sex was coded as 0 = female and 1 = male; Diagnostic Group was 
coded as Controls = 0, Currently Depressed = 1, and Remitted Depressed = 1; Smoking status 
was coded as 0 = nonsmoker and 1 = current smoker; Using ADM was coded as 0 = not using 
ADM and 1 = currently taking ADM. 
aAntidepressant medication.  
†p < .10; *p < .05; **p < .01; ***p < .001  
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Consistent with past research (e.g., Giletta et al., 2017; Shields et al. 2016; Slavish et al., 
2015), age, BMI, and ethnicity emerged as key covariates of inflammation. To a lesser extent, 
sex was associated with post-stress changes in inflammation. However, inclusion of sex as a 
covariate did not result in a different pattern of findings across models. Therefore, the more 
parsimonious models that exclude sex are presented. Furthermore, menstrual cycle was 
associated with stress-induced changes in cytokines among female participants. However, given 
that analyses controlling for this covariate would exclude male participants, this variable was not 
entered as a covariate in subsequent analyses. Analyses for conditional models therefore adjusted 
for age, ethnicity, and BMI. Continuous predictor variables were centred before analyses, and 
significant and marginally significant interactions (identified at a significance level of p < .10) 
were examined by assessing simple slopes. Regions of significance were examined for 
significant interactions using the Johnson-Neyman technique (see Hayes & Rockwood, 2017). 
This analytic procedure derives values of the moderator that indicate the range, or ranges, where 
the independent variable is significantly related to the dependent variable, as well as ranges of 
the moderator where it is not. Confidence intervals are reported in both tables and figures, which 
provide an indication of the degree of precision of the parameter estimates within the current 
sample. Structural equation modeling analyses were conducted in Mplus version 8.3.  
Hypothesis 5: Increases in Inflammatory Cytokines in Response to the Stressor  
An unconditional latent change score model was constructed to examine mean changes 
and individual differences in overall cytokine reactivity to the social stressor (see Figure 7). As 
anticipated, the mean of the latent change factor of inflammation was significant (b = .19, 95% 
CI = [.16, .23], p < .001), indicating significant mean increases in the inflammatory phenotype 
following the social stressor. In addition, there was significant individual variability around the  
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latent change factor mean, (σ² = .03, 95% CI = [.02, .05], p < .001), indicating inter-individual 
differences in within-person cytokine reactivity to the stressor. 
Furthermore, a series of paired sample t-tests were conducted for each cytokine to 
examine whether an increase in cytokines following the stressor was also evident when 
examining raw change as compared to latent change. There were significant stress-induced 
increases for all four cytokines (see Table 4 for descriptive statistics), and effect sizes were 
medium to large: IL-6: t(160) = -4.40, p < .001, d = .35; IL-8: t(160) = -12.25, p < .001, d = .97; 
IL-1β: t(160) = -7.98, p < .001, d = .63; TNF-α: t(160) = -7.88, p < .001, d = .62. 
Hypothesis 6: Association of Diagnostic Group with Baseline Cytokines and Post-Stress 
Changes in Cytokines 
As shown in Table 9, a conditional model regressing pre-stress cytokines and changes in 
cytokines on diagnostic group indicated, contrary to hypotheses, that there were no significant 
group differences in baseline inflammation or on inflammatory stress reactivity. There was also 
no association of depressive symptoms with baseline or stress-induced changes in inflammation. 
Hypotheses 7-10: Prediction of Baseline Cytokines and Changes in Cytokines by Cognitive 
Control, Cognitive Content, Rumination, and Cognitive Organization 
In models assessing the role of cognitive content and rumination, it was expected that 
there would be main effects of cognitive content and rumination on changes in inflammation, 
such that greater vulnerability (i.e., greater core beliefs, dysfunctional attitudes, and rumination) 
would be associated with greater resting-state and post-stress increases in cytokines. It was also 
anticipated that poorer cognitive control would be associated with greater pre-stress and post-
stress increases in inflammation. An exception to this was for positive nonaffective switch costs, 
where greater switch costs were expected to predict lower levels of inflammation. Finally, it was 
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hypothesized that cognitive vulnerability would interact with cognitive control on inflammation, 
such that greater cognitive vulnerability in combination with poor cognitive control was expected 
to result in the highest levels of baseline or post-stress increases in cytokines.  
Similarly, in models assessing the role of negative cognitive structure, it was anticipated 
that there would be main effects of negative social and achievement schemas on inflammation, 
such that more tightly interconnected schemas would be related to greater baseline and stress-
induced changes in cytokines. Again, it was hypothesized that poor cognitive control (or in the 
case of positive nonaffective switch costs, lower switch costs) would predict greater resting-state 
and post-stress increases in cytokines. Cognitive organization was expected to interact with 
cognitive control on inflammation, such that more tightly connected schemas and poorer 
cognitive control were expected to result in the highest resting-state and post-stress increases in 
inflammation.  
Emotional Stroop. Cognitive content and rumination. Table 10 presents estimates from 
the conditional models predicting baseline and stress-induced changes in cytokines by negative 
cognitive content, rumination, and reaction times on the Emotional Stroop. Consistent with 
hypotheses, in Model 1 reaction times on the Emotional Stroop marginally predicted baseline 
inflammation, such that longer reaction times were associated with greater inflammation. 
Maladaptive core beliefs marginally predicted increases in inflammation after the stressor. 
Unexpectedly, greater rumination was associated with post-stress decreases in inflammation.  
There was no evidence of moderation between core beliefs or dysfunctional attitudes and 
Emotional Stroop performance on pre-stress inflammation or changes in inflammation in Models 
2 and 3. However, rumination marginally moderated the relation of inhibition of emotional 
stimuli with pre-stress inflammation. There was a trend for simple slopes to indicate that poor
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Table 10  
 
Prediction of Latent Pre-stress Cytokines and Latent Change in Cytokines by Emotional Stroop, Negative Cognitive Content, and 
Rumination 
 
 Pre-stress inflammation         Δ inflammation  
Model and predictor β 95% CI b  β 95% CI b  
Model 1: Main effects  R2 = .22, p < .001  R2 = .14, p = .013  
Age -.002 [-.16, .15] .00  .16 [-.05, .37] .003  
BMI .34*** [.18, .49] .02  -.03 [-.22, .16] -.001  
Ethnicity         
White vs. Other -.09 [-.25, .07] -.11  .10 [-.08, .27] .05  
White vs. Asian -.19* [-.36, -.03] -.17  -.06 [-.27, .15] -.02  
Core Beliefs -.14 [-.40, .13] -.001  .26† [-.03, .56] .001  
Dysfunctional Attitudes .05 [-.17, .26] .001  -.16 [-.41, .09] -.001  
Rumination .03 [-.18, .23] .001  -.33** [-.54, -.12] -.004  
Emotional Stroop RT .16† [-.01, .33] .05  .13 [-.06, .31] .02  
Model 2: Interaction effect R2 = .23, p < .001  R2 = .14, p = .010  
Core Beliefs × Emotional Stroop        
RT 
-.10 [-.22, .03] .00  .09 [-.06, .24] .00  
Model 3: Interaction effect R2 = .23, p < .001  R2 = .14, p = .012  
Dysfunctional Attitudes × Emotional 
Stroop RT 
-.08 [-.20, .04] -.001  -.03 [-.17, .10] .00  
Model 4: Interaction effect R2 = .24, p < .001  R2 = .14, p = .013  
Rumination × Emotional Stroop RT -.13† [-.27, .01] -.002  -.01 [-.15, .14] .00  
Note. 95% CI = 95% confidence intervals for standardized coefficients (βs). Ethnicity was dummy coded as White = 0, Asian = 1, and 
Other = 1. Values of .00 are < .001. Model fit: Model 1, χ2(67, N = 164) = 170.01, p < .001, CFI = .937, TLI = .913 and RMSEA = 
.097, SRMR = .118; Model 2, χ2(73, N = 164) = 181.19, p < .001, CFI = .936, TLI = .912 and RMSEA = .095, SRMR = .112; Model 
3, χ2(73, N = 164) = 175.23, p < .001, CFI = .939, TLI = .916 and RMSEA = .092, SRMR = .114; Model 4, χ2(73, N = 164) = 175.59, 
p < .001, CFI = .938, TLI = .915 and RMSEA = .093, SRMR = .114. 
†p < .10; *p < .05; **p < .01; ***p < .001. 
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inhibition of emotional information was associated with greater cytokine levels at baseline for 
individuals with low (b = .09, 95% CI = [.02, .16], p = .008), and not high (b = .02, 95% CI = [-
.04, .08], p = .532) tendencies to ruminate (Figure 9). Rumination did not interact with the 
Emotional Stroop on changes in inflammation.  
Cognitive organization. Results from the conditional models predicting baseline and 
stress-induced changes in cytokines by cognitive organization and Emotional Stroop reaction 
times are presented in Table 11. The first model (Model 1) examining main effects indicated 
that, consistent with hypotheses, both Negative Achievement Organization and Emotional Stroop 
reaction times predicted baseline cytokines, such that more tightly connected negative 
achievement schemas and longer reaction times on the Emotional Stroop were associated with 
greater pre-stress inflammation. Contrary to hypotheses, more dispersed negative social schemas 
marginally predicted greater increases in cytokines following stress.  
The potential moderating role of cognitive organization was explored in Models 2 and 3. 
Across both models, no significant interactions were found between reaction time on the 
Emotional Stroop and negative social cognitive structure or negative achievement structure on 
pre-stress cytokines or post-stress changes in cytokines.  
Positive Affective Switch Costs. Cognitive content and rumination. Findings from the 
conditional models predicting baseline and stress-induced changes in cytokines by negative 
cognitive content, rumination, and positive affective switch costs are presented in Table 12. In 
Model 1, main effects emerged for maladaptive core beliefs, rumination, and positive affective 
switch costs on changes in inflammation. Greater core beliefs and lower rumination predicted 
increases in inflammation. Consistent with hypotheses, positive affective switch costs predicted 
changes in cytokines, such that individuals who took longer switching to the affective  
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Figure 9. Marginally significant interaction effect between Emotional Stroop reaction time and 
rumination on pre-stress cytokines. Prestress Inflammation = latent factor of baseline 
inflammation. RT = reaction time. ‘Low’ and ‘High’ Emotional Stroop reaction time and 
rumination indicate scores one standard deviation below and above the mean, respectively. The 
thinner lines represent 95% confidence intervals.  
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Table 11  
 
Prediction of Latent Pre-stress Cytokines and Latent Change in Cytokines by Emotional Stroop and Cognitive Organization 
 
 Pre-stress inflammation         Δ inflammation  
Model and predictor β 95% CI b  β 95% CI b  
Model 1: Main effects  R
2 = .27, p < .001  R2 = .10, p = .060  
Age .05 [-.13, .24] .002  .09 [-.15, .32] .002  
BMI .25** [.09, .41] .02  -.02 [-.20, .15] -.001  
Ethnicity         
White vs. Other -.16† [-.33, .002] -.22  .07 [-.18, .31] .04  
White vs. Asian -.19* [-.38, -.002] -.17  -.12 [-.35, .11] -.05  
Negative Social Organization .12 [-.09, .31] .12  .19† [-.01, .40] .09  
Negative Achievement Organization     -.25* [-.44, -.06] -.20  .07 [-.14, .29] .03  
Emotional Stroop RT .19* [.02, .36] .06  -.01 [-.21, .19] -.001  
Model 2: Interaction effect R
2 = .28, p < .001  R2 = .10, p =.043  
Negative Social Organization × 
Emotional Stroop RT 
-.09 [-.23, .05] -.08  -.08 [-.23, .08] -.03  
Model 3: Interaction effect R
2 = .27, p < .001  R2 = .10, p =.061  
Negative Achievement Organization × 
Emotional Stroop RT 
-.04 [-.19, .11] -.02  .00 [-.17, .17] .00  
Note. 95% CI = 95% confidence intervals for standardized coefficients (βs). Ethnicity was dummy coded as White = 0, Asian = 1, and 
Other = 1. Values of .00 are < .001. Model fit: Model 1, χ2(61, N = 127) = 140.57, p < .001, CFI = .938, TLI = .914 and RMSEA = 
.101, SRMR = .134; Model 2, χ2(67, N = 127) = 143.25, p < .001, CFI = .941, TLI = .919 and RMSEA = .095, SRMR = .130; Model 
3, χ2(67, N = 127) = 143.57, p < .001, CFI = .940, TLI = .918 and RMSEA = .095, SRMR = .129. 
†p < .10; *p < .05; **p < .01; ***p < .001. 
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Table 12  
 
Prediction of Latent Pre-stress Cytokines and Latent Change in Cytokines by Positive Affective Switch Costs, Negative Cognitive 
Content, and Rumination 
 
 Pre-stress inflammation         Δ inflammation  
Model and predictor β 95% CI b  β 95% CI b  
Model 1: Main effects  R
2 = .21, p = .001  R2 = .19, p = .007  
Age .06 [-.10, .22] .003  .17† [-.03, .37] .004  
BMI .33*** [.18, .48] .02  -.05 [-.22, .12] -.002  
Ethnicity         
White vs. Other -.05 [-.21, .10] -.07  .15† [-.01, .32] .08  
White vs. Asian -.19* [-.36, -.02] -.16  -.02 [-.22, .19] -.01  
Core Beliefs -.11 [-.39, .16] -.001  .28* [.00, .57] .001  
Dysfunctional Attitudes .02 [-.20, .23] .00  -.21† [-.45, .03] -.001  
Rumination .04 [-.16, .24] .001  -.31** [-.52, -.11] -.004  
Positive Affective Switch Costs .04 [-.12, .20] .01  .25** [.07, .44] .03  
Model 2: Interaction effect R
2 = .22, p = .001  R2 = .20, p = .003  
Core Beliefs × Positive Affective 
Switch Costs 
.10 [-.07, .26] .00  -.11 [-.30, .08] .00  
Model 3: Interaction effect R
2 = .21, p = .001  R2 = .19, p = .008  
Dysfunctional Attitudes × Positive 
Affective Switch Costs 
-.04 [-.17, .09] .00  .03 [-.10, .16] .00  
Model 4: Interaction effect R
2 = .26, p < .001  R2 = .27, p < .001  
Rumination × Positive Affective 
Switch Costs 
.25** [.10, .40] .004  -.32*** [-.49, -.15] -.002  
Note. 95% CI = 95% confidence intervals for standardized coefficients (βs). Ethnicity was dummy coded as White = 0, Asian = 1, and 
Other = 1. Values of .00 are < .001. Model fit: Model 1, χ2(67, N = 165) = 170.14, p < .001, CFI = .937, TLI = .914 and RMSEA = 
.097, SRMR = .115; Model 2, χ2(73, N = 165) = 184.62, p < .001, CFI = .933, TLI = .908 and RMSEA = .096, SRMR = .111; Model 
3, χ2(73, N = 165) = 178.33, p < .001, CFI = .937, TLI = .914 and RMSEA = .094, SRMR = .112; Model 4, χ2(73, N = 165) = 179.69, 
p < .001, CFI = .937, TLI = .913 and RMSEA = .094, SRMR = .111. 
†p < .10; *p < .05; **p < .01; ***p < .001. 
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categorization rule for positive images demonstrated greater increases in cytokines following 
stress. Furthermore, and contrary to hypotheses, there was a trend whereby lower levels of 
dysfunctional attitudes were associated with decreases in inflammation after the stressor.  
There was no evidence of moderation by core beliefs or dysfunctional attitudes on the 
relation of positive affective switch costs with pre-stress or post-stress changes in inflammation 
in Model 2. However, in Model 3 significant interactions of rumination with positive affective 
switch costs on both baseline and post-stress changes in cytokines emerged. Further examination 
of the interaction on pre-stress inflammation revealed that rumination moderated the relation of 
positive affective switch costs on baseline inflammation for individuals with both high and low 
rumination. As anticipated, greater positive affective switch costs were associated with greater 
baseline inflammation in individuals high in rumination (b = .05, 95% CI = [.01, .09], p = .009), 
and, unexpectedly, greater switch costs were associated with lower baseline cytokines in 
individuals with low rumination (b = -.06, 95% CI = [-.12, -.01], p = .031; Figure 10). In 
contrast, examination of the simple slopes for the significant interaction of rumination and 
positive affective switch costs on acute inflammatory responses to stress indicated that positive 
affective switch costs were associated with greater increases in inflammation only in individuals 
with low (b = .07, 95% CI = [.04, .09], p < .001), and not high (b = -.001, 95% CI = [-.02, .02], p 
= .924) rumination (Figure 11).  
Cognitive organization. Table 13 presents estimates from the conditional models 
predicting baseline and stress-induced changes in cytokines by negative cognitive organization 
and positive affective switch costs. Consistent with findings reported above, in Model 1 there 
was a main effect of negative achievement organization on baseline inflammation such that more 
tightly connected structure was associated with greater pre-stress cytokines. There was also a  
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Figure 10. Interaction effect between Positive Affective Switch Costs and rumination on pre-
stress cytokines. Prestress Inflammation = latent factor of baseline inflammation. ‘Low’ and 
‘High’ Positive Affective Switch Costs and rumination indicate scores one standard deviation 
below and above the mean, respectively. The thinner lines represent 95% confidence intervals. 
The lower and upper bounds of the regions of significance on rumination were -0.74 SD and 0.63 
SD from the mean. These values indicate that Positive Affective Switch Costs were associated 
with greater inflammation among individuals with rumination >0.63 SD from the mean, but with 
lower inflammation among individuals with Positive Affective Switch Costs lower than 0.74 SD 
below the mean.  
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Figure 11. Interaction effect between Positive Affective Switch Costs and rumination on acute 
responses to the laboratory stressor. Change in Inflammation = latent change score for 
inflammation. ‘Low’ and ‘High’ Positive Affective Switch Costs and rumination indicate scores 
one standard deviation below and above the mean, respectively. The thinner lines represent 95% 
confidence intervals. The region of significance on rumination was 0.50 SD above the mean. 
This value indicates that Positive Affective Switch Costs were associated with increases in 
inflammation among individuals with rumination <0.50 SD above the mean, but was not 
associated with inflammation for individuals with rumination >0.50 SD above the mean. 
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Table 13  
 
Prediction of Latent Pre-stress Cytokines and Latent Change in Cytokines by Positive Affective Switch Costs and Cognitive 
Organization 
 
 Pre-stress inflammation         Δ inflammation  
Model and predictor β 95% CI b  β 95% CI b  
Model 1: Main effects  R2 = .25, p < .001  R2 = .15, p = .049  
Age .10 [-.08, .29] .004  .05 [-.16, .25] .001  
BMI .25** [.09, .41] .02  -.03 [-.20, .15] -.001  
Ethnicity         
White vs. Other -.12† [-.27, .02] -.17  .09 [-.14, .32] .05  
White vs. Asian -.19† [-.38, .01] -.16  -.10 [-.32, .13] -.04  
Negative Social Organization .11 [-.10, .31] .11  .19* [.00, .38] .08  
Negative Achievement Organization     -.24* [-.43, -.06] -.19  .09 [-.12, .29] .03  
Positive Affective Switch Costs .09 [-.08, .26] .02  .23* [.02, .44] .02  
Model 2: Interaction effect R2 = .25, p < .001  R2 = .21, p = .011  
Negative Social × Positive Affective 
Switch Costs 
-.06 [-.23, .11] -.03  .27** [.08, .45] .06  
Model 3: Interaction effect R2 = .25, p = .001  R2 = .19, p = .01  
Negative Achievement × Positive 
Affective Switch Costs 
-.03 [-.16, .10] -.01  .20* [.03, .38] .04  
Note. 95% CI = 95% confidence intervals for standardized coefficients (βs). Ethnicity was dummy coded as White = 0, Asian = 1, and 
Other = 1. Values of .00 are < .001. Model fit: Model 1, χ2(61, N = 127) = 141.17, p < .001, CFI = .937, TLI = .914 and RMSEA = 
.102, SRMR = .133; Model 2, χ2(67, N = 127) = 145.55, p < .001, CFI = .940, TLI = .917 and RMSEA = .096, SRMR = .125; Model 
3, χ2(67, N = 127) = 148.22, p < .001, CFI = .937, TLI = .914 and RMSEA = .098, SRMR = .126. 
†p < .10; *p < .05; **p < .01; ***p < .001. 
95 
 
main effect of negative social organization on changes in inflammation, such that more dispersed 
structure was related to greater increases in inflammation. Positive affective switch costs 
predicted changes in inflammation following stress, such that individuals who took longer 
switching away from using the nonaffective categorization rule to using the affective rule for 
positive images demonstrated greater increases in cytokines following stress.  
In Model 2, there was a significant interaction of negative social organization with 
positive affective switch costs on changes in inflammation. An examination of  the simple slopes 
of the interaction indicated that greater positive affective switch costs were associated with 
greater increases in cytokines in response to the laboratory stressor for individuals with loosely 
interconnected (b = .04, 95% CI = [.02, .06], p < .001), and not tightly interconnected (b = -.01, 
95% CI = [-.04, .02], p = .487), schemas (Figure 12). There was no interaction of negative social 
schemas with positive affective switch costs on pre-stress inflammation.  
Similarly, in Model 3 there was an interaction of negative achievement organization on 
changes in inflammation, but not on pre-stress inflammation. Probing the interaction revealed a 
similar pattern of findings as for negative social organization, such that positive affective switch 
costs were associated with greater increases in inflammation following stress in individuals with 
loosely connected (b = .05, 95% CI = [.03, .07], p < .001), and not tightly interconnected (b = -
.02, 95% CI = [-.05, .02], p = .307), schema structure (Figure 13). 
Negative Affective Switch Costs. Cognitive content and rumination. Parameter 
estimates from the conditional models predicting baseline and stress-induced changes in 
cytokines by negative cognitive content, rumination, and negative affective switch costs are 
presented in Table 14. There were no main effects of cognitive content, rumination, or negative 
affective switch costs on pre-stress inflammation in Model 1. However, greater maladaptive core  
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Figure 12. Interaction effect between Positive Affective Switch Costs and Negative Social 
Organization on acute responses to the laboratory stressor. Change in Inflammation = latent 
change score for inflammation. ‘Low’ and ‘High’ Positive Affective Switch Costs and Negative 
Social Organization indicate scores one standard deviation below and above the mean, 
respectively. The thinner lines represent 95% confidence intervals. The region of significance on 
negative social organization was 0.16 SD above the mean. This value indicates that Positive 
Affective Switch Costs were associated with increases in inflammation among individuals with 
negative social schemas >0.15 SD above the mean (i.e., more dispersed schemas), but was not 
associated with inflammation for individuals with social schemas <0.15 SD above the mean. 
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Figure 13. Interaction effect between Positive Affective Switch Costs and Negative 
Achievement Organization on acute responses to the laboratory stressor. Change in Inflammation 
= latent change score for inflammation. ‘Low’ and ‘High’ Positive Affective Switch Costs and 
Negative Achievement Organization indicate scores one standard deviation below and above the 
mean, respectively. The thinner lines represent 95% confidence intervals. The region of 
significance on negative achievement organization was -0.08 SD from the mean. This value 
indicates that Positive Affective Switch Costs were associated with increases in inflammation 
among individuals with negative social schemas >0.08 SD below the mean (i.e., more dispersed 
schemas), but was not associated with inflammation for individuals with social schemas <0.08 
SD below the mean. 
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Table 14  
 
Prediction of Latent Pre-stress Cytokines and Latent Change in Cytokines by Negative Affective Switch Costs, Negative Cognitive 
Content, and Rumination 
 
 Pre-stress inflammation         Δ inflammation  
Model and predictor β 95% CI b  β 95% CI b  
Model 1: Main effects  R2 = .22, p < .001  R2 = .14, p = .011  
Age .09 [-.07, .25] .004  .19† [-.01, .40] .004  
BMI .33*** [.18, .48] .02  -.06 [-.24, .12] -.002  
Ethnicity         
White vs. Other -.05 [-.20, .11] -.06  .12 [-.05, .29] .07  
White vs. Asian -.19* [-.35, -.02] -.16  -.05 [-.26, .16] -.02  
Core Beliefs -.15 [-.42, .13] -.001  .33* [.03, .63] .001  
Dysfunctional Attitudes .05 [-.16, .26] .001  -.22† [-.47, .04] -.001  
Rumination .06 [-.14, .26] .002  -.34** [-.55, -.14] -.004  
Negative Affective Switch Costs -.12 [-.27, .03] -.03  .13† [-.02, .27] .01  
Model 2: Interaction effect R2 = .22, p < .001  R2 = .14, p = .012  
Core Beliefs × Negative Affective 
Switch Costs 
.03 [-.15, .21] .00  .02 [-.15, .19] .00  
Model 3: Interaction effect R2 = .23, p < .001  R2 = .15, p = .011  
Dysfunctional Attitudes × Negative 
Affective Switch Costs 
.05 [-.11, .22] .00  .05 [-.10, .21] .00  
Model 4: Interaction effect R2 = .23, p < .001  R2 = .14, p = .011  
Rumination × Negative Affective 
Switch Costs 
.07 [-.08, .21] .001  -.03 [-.16, .11] .00  
Note. 95% CI = 95% confidence intervals for standardized coefficients (βs). Ethnicity was dummy coded as White = 0, Asian = 1, and 
Other = 1. Values of .00 are < .001. Model fit: Model 1, χ2(67, N = 165) = 163.81, p < .001, CFI = .940, TLI = .918 and RMSEA = 
.094, SRMR = .115; Model 2, χ2(73, N = 165) = 167.75, p < .001, CFI = .941, TLI = .920 and RMSEA = .089, SRMR = .111; Model 
3, χ2(73, N = 165) = 174.54, p < .001, CFI = .938, TLI = .915 and RMSEA = .092, SRMR = .111; Model 4, χ2(73, N = 165) = 167.47, 
p < .001, CFI = .942, TLI = .921 and RMSEA = .089, SRMR = .111. 
†p < .10; *p < .05; **p < .01; ***p < .001. 
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beliefs predicted increases in inflammation following stress and greater rumination predicted 
decreases in cytokines post-stress. Trends also emerged whereby greater dysfunctional attitudes 
marginally predicted decreases in inflammation and, consistent with hypotheses, greater negative 
affective switch costs marginally predicted increases in cytokines. This indicates that taking 
longer to switch away from using the nonaffective categorization rule to using the affective rule 
for negative images was marginally associated with greater increases in cytokines following 
stress. In Models 2, 3, and 4, there were no significant interactions between core beliefs, 
dysfunctional attitudes, or rumination and negative affective switch costs on inflammation, either 
before or after the stressor.  
Cognitive organization. Table 15 presents estimates from the conditional models 
predicting baseline and stress-induced changes in cytokines by negative cognitive organization 
and negative affective switch costs. In Model 1 negative achievement cognitive structure 
predicted baseline inflammation, such that a more tightly interconnected organization was 
associated with greater cytokines pre-stress. More dispersed negative social organization 
predicted increases in inflammation following the stressor, and, as anticipated, greater negative 
affective switch costs marginally predicted greater stress-induced increases in inflammation.  
In Model 2, there was a significant interaction of negative social structure with negative 
affective switch costs on changes in inflammation, but not on pre-stress inflammation. Probing 
this interaction indicated that greater negative affective switch costs were associated with greater 
increases in inflammation following the stressor in individuals with more loosely connected 
negative social cognitive structure (b = .04, 95% CI = [.02, .06], p = .001), and not in those with 
more tightly connected organization (b = -.01, 95% CI = [-.04, .02], p = .378; Figure 14). 
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Table 15  
 
Prediction of Latent Pre-stress Cytokines and Latent Change in Cytokines by Negative Affective Switch Costs and Cognitive 
Organization 
 
 Pre-stress inflammation         Δ inflammation  
Model and predictor β 95% CI b  β 95% CI b  
Model 1: Main effects  R2 = .26, p < .001  R2 = .11, p = .051  
Age .15 [-.04, .34] .01  .04 [-.18, .26] .001  
BMI .25** [.09, .41] .02  -.03 [-.21, .14] -.001  
Ethnicity         
White vs. Other -.13 [-.28, .03] -.17  .06 [-.16, .28] .04  
White vs. Asian -.18† [-.38, .01] -.16  -.13 [-.36, .11] -.05  
Negative Social Organization .09 [-.12, .31] .09  .21* [.004, .42] .09  
Negative Achievement Organization     -.25* [-.44, -.05] -.20  .06 [-.14, .27] .02  
Negative Affective Switch Costs -.13 [-.31, .05] -.03  .16† [-.02, .33] .02  
Model 2: Interaction effect R2 = .26, p < .001  R2 = .15, p = .019  
Negative Social × Negative Affective 
Switch Costs 
-.03 [-.20, .13] -.02  .22** [.06, .39] .06  
Model 3: Interaction effect R2 = .26, p < .001  R2 = .13, p = .023  
Negative Achievement × Negative 
Affective Switch Costs 
-.01 [-.19, .17] -.004  .17† [-.01, .34] .02  
Note. 95% CI = 95% confidence intervals for standardized coefficients (βs). Ethnicity was dummy coded as White = 0, Asian = 1, and 
Other = 1. Model fit: Model 1, χ2(61, N = 126) = 138.19, p < .001, CFI = .939, TLI = .916 and RMSEA = .100, SRMR = .129; Model 
2, χ2(67, N = 126) = 142.40, p < .001, CFI = .941, TLI = .918 and RMSEA = .095, SRMR = .128; Model 3, χ2(67, N = 126) = 142.89, 
p < .001, CFI = .941, TLI = .919 and RMSEA = .095, SRMR = .124. 
†p < .10; *p < .05; **p < .01; ***p < .001. 
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Figure 14. Interaction effect between Negative Affective Switch Costs and Negative Social 
Organization on acute responses to the laboratory stressor. Change in Inflammation = latent 
change score for inflammation. ‘Low’ and ‘High’ Negative Affective Switch Costs and Negative 
Social Organization indicate scores one standard deviation below and above the mean, 
respectively. The thinner lines represent 95% confidence intervals. The region of significance on 
negative social organization was 0.16 SD from the mean. This value indicates that Negative 
Affective Switch Costs were associated with increases in inflammation among individuals with 
negative social schemas >0.16 SD above the mean (i.e., more dispersed schemas), but was not 
associated with inflammation for individuals with social schemas <0.16 SD above the mean. 
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Negative achievement organization was also found to marginally interact with negative affective 
switch costs on changes in inflammation in Model 3. Similar to the findings for negative social 
structure, negative affective switch costs were related to greater increases in inflammation in 
individuals with more dispersed negative achievement organization (b = .02, 95% CI = [.01, .04], 
p = .003), and not those with highly interconnected schemas (b = -.002, 95% CI = [-.03, .02], p = 
.884; Figure 15).  Negative achievement organization did not interact with negative affective 
switch costs on pre-stress cytokines.  
Positive Nonaffective Switch Costs. Cognitive content and rumination. Table 16 
presents estimates from the conditional models predicting baseline and stress-induced changes in 
cytokines by negative cognitive content, rumination, and positive nonaffective switch costs. 
There were no significant main effects of cognitive content, rumination, or positive nonaffective 
switch costs on baseline inflammation, contrary to hypotheses. However, lower rumination 
predicted greater post-stress increases in cytokines, and greater maladaptive core beliefs 
marginally predicted post-stress increases in cytokines.  
There was no interaction of core beliefs with positive nonaffective switch costs in Model 
2. In Model 3, there was a marginally significant interaction of dysfunctional attitudes with 
positive nonaffective switch costs on pre-stress inflammation. The simple slopes were not 
significant, but the direction of findings was such that as positive nonaffective switch costs 
increased, baseline inflammation tended to increase in individuals with high dysfunctional 
attitudes (b = .03, 95% CI = [-.01, .08], p = .132). The reverse was true for those with low 
dysfunctional attitudes (b = -.03, 95% CI = [-.07, .02], p = .311; Figure 16). A significant 
interaction of dysfunctional attitudes with positive nonaffective switch costs on changes in 
inflammation also emerged in Model 3. Neither simple slope was significant (b = .01, 95% CI =  
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Figure 15. Marginally significant interaction effect between Negative Affective Switch Costs 
and Negative Achievement Organization on acute responses to the laboratory stressor. Change in 
Inflammation = latent change score for inflammation. ‘Low’ and ‘High’ Negative Affective 
Switch Costs and Negative Achievement Organization indicate scores one standard deviation 
below and above the mean, respectively. The thinner lines represent 95% confidence intervals.
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Table 16  
 
Prediction of Latent Pre-stress Cytokines and Latent Change in Cytokines by Positive Nonaffective Switch Costs, Negative Cognitive 
Content, and Rumination 
 
 Pre-stress inflammation         Δ inflammation  
Model and predictor β 95% CI b  β 95% CI b  
Model 1: Main effects  R2 = .21, p = .001  R2 = .13, p = .013  
Age .06 [-.10, .23] .003  .21* [.01, .41] .004  
BMI .33*** [.17, .48] .02  -.04 [-.23, .14] -.001  
Ethnicity         
White vs. Other -.06 [-.22, .10] -.07  .13 [-.04, .30] .07  
White vs. Asian -.20* [-.36, -.03] -.17  -.05 [-.27, .16] -.02  
Core Beliefs -.10 [-.38, .17] -.001  .29† [-.01, .59] .001  
Dysfunctional Attitudes .003 [-.21, .22] .00  -.19 [-.44, .06] -.001  
Rumination .04 [-.17, .24] .001  -.32** [-.52, -.11] -.004  
Positive Nonaffective Switch Costs .06 [-.11, .22] .01  .02 [-.15, .18] .002  
Model 2: Interaction effect R2 = .21, p = .001  R2 = .14, p = .011  
Core Beliefs × Positive Nonaffective 
Switch Costs 
-.003 [-.18, .18] .00  .10 [-.06, .26] .00  
Model 3: Interaction effect R2 = .23, p = .001  R2 = .15, p = .005  
Dysfunctional Attitudes × Positive 
Nonaffective Switch Costs 
.14† [-.02, .30] .001  .17* [.01, .32] .00  
Model 4: Interaction effect R2 = .21, p = .001  R2 = .13, p = .014  
Rumination × Positive Nonaffective 
Switch Costs 
.03 [-.14, .19] .00  .01 [-.20, .22] .00  
Note. 95% CI = 95% confidence intervals for standardized coefficients (βs). Ethnicity was dummy coded as White = 0, Asian = 1, and 
Other = 1. Model fit: Model 1, χ2(67, N = 165) = 171.64, p < .001, CFI = .936, TLI = .912 and RMSEA = .097, SRMR = .117; Model 
2, χ2(73, N = 165) = 178.18, p < .001, CFI = .936, TLI = .913 and RMSEA = .093, SRMR = .113; Model 3, χ2(73, N = 165) = 174.12, 
p < .001, CFI = .938, TLI = .916 and RMSEA = .092, SRMR = .112; Model 4, χ2(73, N = 165) = 174.11, p < .001, CFI = .938, TLI = 
.915 and RMSEA = .092, SRMR = .113. 
†p < .10; *p < .05; **p < .01; ***p < .001. 
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Figure 16. Marginally significant interaction effect between Positive Nonaffective Switch Costs 
and dysfunctional attitudes on pre-stress cytokines.Prestress Inflammation = latent factor of 
baseline inflammation. ‘Low’ and ‘High’ Positive Nonaffective Switch Costs and dysfunctional 
attitudes indicate scores one standard deviation below and above the mean, respectively. The 
thinner lines represent 95% confidence intervals.  
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[-.003, .03], p = .106 for those with high dysfunctional attitudes, b = -.02, 95% CI = [-.05, .01], p 
= .158 for those with low dysfunctional attitudes; Figure 17). However, the direction of slopes 
indicates that as positive nonaffective switch costs increased, inflammatory responses to stress 
tended to increase in those with high dysfunctional attitudes. Conversely, as switch costs 
increased, inflammatory responses to stress tended to decrease in those with low dysfunctional 
attitudes. Finally, in Model 4 there were no significant interactions of rumination with positive 
nonaffective switch costs on pre- or post-stress changes in cytokines. 
Cognitive organization. Table 17 presents estimates from the conditional models 
predicting baseline and stress-induced changes in cytokines by negative cognitive organization 
and positive nonaffective switch costs. In Model 1, there were no main effects of positive 
nonaffective switch costs on baseline or stress-induced inflammation. Consistent with the results 
presented above, tightly interconnected negative achievement cognitive organization was 
associated with lower inflammation at baseline, and loosely connected negative social 
organization was marginally associated with increases in cytokines following stress.  
In Model 2 there was no interaction of negative social organization with positive 
nonaffective switch costs on baseline or stress-induced changes in inflammation. However, in 
Model 3 there was a trend whereby negative achievement schemas marginally interacted with 
positive nonaffective switch costs on pre-stress inflammation. The simple slopes were not 
significant, however there was a trend for simple slopes to indicate that as positive nonaffective 
switch costs increased, baseline inflammation tended to increase for individuals with tightly 
connected negative achievement schemas (b = .03, 95% CI = [-.02, .07], p = .199).  For those 
with loosely interconnected negative achievement schemas, as positive nonaffective switch costs   
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Figure 17. Interaction effect between Positive Nonaffective Switch Costs and dysfunctional 
attitudes on acute responses to the laboratory stressor. Change in Inflammation = latent change 
score for inflammation. ‘Low’ and ‘High’ Positive Nonaffective Switch Costs and dysfunctional 
attitudes indicate scores one standard deviation below and above the mean, respectively. The 
thinner lines represent 95% confidence intervals. As neither simple slope was significant, regions 
of significance could not be examined.  
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Table 17  
 
Prediction of Latent Pre-stress Cytokines and Latent Change in Cytokines by Positive Nonaffective Switch Costs and Cognitive 
Organization 
 
 Pre-stress inflammation         Δ inflammation  
Model and predictor β 95% CI b  β 95% CI b  
Model 1: Main effects  R2 = .24, p < .001  R2 = .10, p = .057  
Age .12 [-.06, .30] .01  .08 [-.13, .30] .002  
BMI .25** [.09, .41] .02  -.02 [-.20, .15] -.001  
Ethnicity         
White vs. Other -.13 [-.29, .03] -.18  .06 [-.17, .30] .04  
White vs. Asian -.20* [-.39, -.002] -.17  -.12 [-.36, .11] -.05  
Negative Social Organization .11 [-.09, .31] .11  .19† [-.02, .40] .08  
Negative Achievement Organization     -.25** [-.43, -.07] -.20  .08 [-.13, .29] .03  
Positive Nonaffective Switch Costs .05 [-.13, .22] .01  .05 [-.12, .22] .01  
Model 2: Interaction effect R2 = .24, p < .001  R2 = .10, p = .041  
Negative Social × Positive 
Nonaffective Switch Costs 
-.01 [-.16, .14] -.01  -.07 [-.24, .09] -.02  
Model 3: Interaction effect R2 = .25, p < .001  R2 = .10, p = .058  
Negative Achievement × Positive 
Nonaffective Switch Costs 
-.12† [-.25, .02] -.04  .01 [-.15, .18] .002  
Note. 95% CI = 95% confidence intervals for standardized coefficients (βs). Ethnicity was dummy coded as White = 0, Asian = 1, and 
Other = 1. Model fit: Model 1, χ2(61, N = 127) = 149.73, p < .001, CFI = .931, TLI = .905 and RMSEA = .107, SRMR = .133; Model 
2, χ2(67, N = 127) = 157.75, p < .001, CFI = .930, TLI = .904 and RMSEA = .103, SRMR = .128; Model 3, χ2(67, N = 127) = 157.07, 
p < .001, CFI = .931, TLI = .905 and RMSEA = .103, SRMR = .129. 
†p < .10; *p < .05; **p < .01; ***p < .001. 
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increased, baseline inflammation tended to decrease (b = -.02, 95% CI = [-.06, .02], p = .349; 
Figure 18). 
Negative Nonaffective Switch Costs. Cognitive content and rumination. Results from 
the conditional models predicting baseline and stress-induced changes in cytokines by negative 
cognitive content, rumination, and negative nonaffective switch costs are presented in Table 18. 
Contrary to hypotheses, there were no main effects of negative nonaffective switch costs on pre-
stress or post-stress changes in cytokines in Model 1. Higher rumination was associated with 
decreases in inflammation following stress, and there was a trend whereby greater maladaptive 
core beliefs marginally predicted increases in stress.  
In Models 2 and 3, there was no evidence of interaction effects between core beliefs or 
dysfunctional attitudes and negative nonaffective switch costs on inflammation. However, in 
Model 4 there was a marginally significant interaction of rumination with negative nonaffective 
switch costs on pre-stress cytokines. The simple slopes for this marginal interaction were 
nonsignificant, although the direction of effects suggest that among individuals high in 
rumination, as negative nonaffective switch costs increase, baseline inflammation also tends to 
increase (b = .02, 95% CI = [-.01, .06], p = .240). The opposite trend emerged for those with low 
rumination (b = -.04, 95% CI = [-.09, .02], p = .180; Figure 19).  
Cognitive organization. Table 19 presents estimates from the conditional models 
predicting baseline and stress-induced changes in cytokines by negative cognitive organization 
and negative nonaffective switch costs. In Model 1 there was no main effect of negative 
nonaffective switch costs on inflammation. Tightly connected negative achievement organization 
predicted lower baseline cytokines, and loosely connected negative social organization 
marginally predicted increases in cytokines after stress. There was no evidence of interaction  
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Figure 18. Marginally significant interaction effect between Positive Nonaffective Switch Costs 
and Negative Achievement Organization on pre-stress cytokines. Prestress Inflammation = latent 
factor of baseline inflammation. ‘Low’ and ‘High’ Positive Nonaffective Switch Costs and 
Negative Achievement Organization indicate scores one standard deviation below and above the 
mean, respectively. The thinner lines represent 95% confidence intervals. 
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Table 18  
 
Prediction of Latent Pre-stress Cytokines and Latent Change in Cytokines by Negative Nonaffective Switch Costs, Negative Cognitive 
Content, and Rumination 
 
 Pre-stress inflammation         Δ inflammation  
Model and predictor β 95% CI b  β 95% CI b  
Model 1: Main effects  R2 = .21, p = .001  R2 = .14, p = .011  
Age .07 [-.09, .23] .003  .20† [.00, .39] .004  
BMI .33*** [.17, .48] .02  -.06 [-.25, .13] -.002  
Ethnicity         
White vs. Other -.06 [-.21, .10] -.07  .12 [-.05, .28] .07  
White vs. Asian -.19* [-.36, -.02] -.16  -.06 [-.27, .15] -.02  
Core Beliefs -.11 [-.38, .16] -.001  .28† [-.02, .58] .001  
Dysfunctional Attitudes .02 [-.20, .23] .00  -.18 [-.43, .06] -.001  
Rumination .04 [-.16, .24] .001  -.31** [-.52, -.11] -.004  
Negative Nonaffective Switch Costs .01 [-.15, .16] .002  .09 [-.06, .24] .01  
Model 2: Interaction effect R2 = .21, p = .001  R2 = .14, p = .010  
Core Beliefs × Negative Nonaffective 
Switch Costs 
.08 [-.09, .25] .00  -.04 [-.21, .13] .00  
Model 3: Interaction effect R2 = .21, p = .001  R2 = .14, p = .008  
Dysfunctional Attitudes × Negative 
Nonaffective Switch Costs 
.05 [-.10, .20] .00  .10 [-.04, .24] .00  
Model 4: Interaction effect R2 = .22, p < .001  R2 = .14, p = .010  
Rumination × Negative Nonaffective 
Switch Costs 
.14† [-.01, .29] .002  -.02 [-.20, .16] .00  
Note. 95% CI = 95% confidence intervals for standardized coefficients (βs). Ethnicity was dummy coded as White = 0, Asian = 1, and 
Other = 1. Values of .00 are < .001. Model fit: Model 1, χ2(67, N = 165) = 170.59, p < .001, CFI = .937, TLI = .914 and RMSEA = 
.097, SRMR = .117; Model 2, χ2(73, N = 165) = 178.14, p < .001, CFI = .937, TLI = .914 and RMSEA = .093, SRMR = .113; Model 
3, χ2(73, N = 165) = 175.69, p < .001, CFI = .939, TLI = .916 and RMSEA = .092, SRMR = .113; Model 4, χ2(73, N = 165) = 188.47, 
p < .001, CFI = .932, TLI = .907 and RMSEA = .098, SRMR = .115. 
†p < .10; *p < .05; **p < .01; ***p < .001. 
 
112 
 
 
 
Figure 19 Marginally significant interaction effect between Negative Nonaffective Switch Costs 
and rumination on pre-stress cytokines. Prestress Inflammation = latent factor of baseline 
inflammation. ‘Low’ and ‘High’ Negative Nonaffective Switch Costs and rumination indicate 
scores one standard deviation below and above the mean, respectively. The thinner lines 
represent 95% confidence intervals. 
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Table 19  
 
Prediction of Latent Pre-stress Cytokines and Latent Change in Cytokines by Negative Nonaffective Switch Costs and Cognitive 
Organization 
 
 Pre-stress inflammation         Δ inflammation  
Model and predictor β 95% CI b  β 95% CI b  
Model 1: Main effects  R2 = .24, p = .001  R2 = .10, p = .063  
Age .12 [-.06, .30] .01  .08 [-.13, .29] .001  
BMI .25** [.08, .41] .02  -.03 [-.21, .14] -.001  
Ethnicity         
White vs. Other -.13 [-.29, .03] -.18  .07 [-.16, .29] .04  
White vs. Asian -.19† [-.39, .001] -.17  -.12 [-.36, .11] -.05  
Negative Social Organization .11 [-.09, .31] .11  .19† [-.02, .39] .08  
Negative Achievement Organization     -.25** [-.44, -.07] -.20  .07 [-.14, .28] .02  
Negative Nonaffective Switch Costs .01 [-.17, .18] .002  .05 [-.13, .23] .004  
Model 2: Interaction effect R2 = .24, p = .001  R2 = .10, p = .066  
Negative Social × Negative 
Nonaffective Switch Costs 
-.02 [-.17, .14] -.01  .04 [-.14, .22] .01  
Model 3: Interaction effect R2 = .24, p < .001  R2 = .10, p = .062  
Negative Achievement × Negative 
Nonaffective Switch Costs 
-.001 [-.13, .13] .00  .01 [-.18, .20] .002  
Note. 95% CI = 95% confidence intervals for standardized coefficients (βs). Ethnicity was dummy coded as White = 0, Asian = 1, and 
Other = 1. Values of .00 are < .001. Model fit: Model 1, χ2(61, N = 127) = 140.04, p < .001, CFI = .939, TLI = .916 and RMSEA = 
.101, SRMR = .133; Model 2, χ2(67, N = 127) = 150.00, p < .001, CFI = .937, TLI = .913 and RMSEA = .099, SRMR = .129; Model 
3, χ2(67, N = 127) = 149.25, p < .001, CFI = .938, TLI = .914 and RMSEA = .098, SRMR = .128. 
†p < .10; *p < .05; **p < .01; ***p < .001. 
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effects of negative nonaffective switch costs with negative social organization (Model 2) or with 
negative achievement organization (Model 3) on pre- or post-stress changes in cytokines. 
Pre-stress N-back. Cognitive content and rumination. Estimates from the conditional 
models predicting baseline and stress-induced changes in cytokines by negative cognitive 
content, rumination, and pre-stress N-back errors are presented in Table 20. In Model 1, pre-
stress updating did not predict pre-stress or post-stress changes in cytokines, contrary to 
expectations. Greater maladaptive core beliefs and lower rumination predicted stress-induced 
increases in cytokines, and greater dysfunctional attitudes marginally predicted decreases in 
cytokines following stress. In Models 2, 3, and 4, there was no evidence of interaction effects of 
core beliefs, dysfunctional attitudes, or rumination with pre-stress N-back errors on 
inflammation. 
Cognitive organization. Table 21 presents findings from the conditional models 
predicting baseline and stress-induced changes in cytokines by negative cognitive organization 
and pre-stress cytokines. There was no main effect of pre-stress N-back errors on baseline 
cytokines or on acute inflammatory responses to the stressor in Model 1. Tightly connected 
negative achievement organization predicted greater baseline inflammation, and more dispersed 
negative social schemas predicted greater increases in inflammation following the stressor.  
In Model 2, a significant interaction between negative social organization and pre-stress 
cytokines on changes in inflammation was revealed. Examination of the simple slopes indicated 
that there was a trend whereby more errors on the N-back at baseline were related to greater 
increases in inflammation among individuals with tightly interconnected negative social schemas 
(b = .003, 95% CI = [-.001, .01], p = .095), but not those with loosely connected negative social 
organization (b = -.002, 95% CI = [-.01, .002], p = .285; Figure 20). There was no moderating
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Table 20  
 
Prediction of Latent Pre-stress Cytokines and Latent Change in Cytokines by Pre-stress N-back Errors, Negative Cognitive Content, 
and Rumination 
 
 Pre-stress inflammation         Δ inflammation  
Model and predictor β 95% CI b  β 95% CI b  
Model 1: Main effects  R2 = .21, p = .001  R2 = .16, p = .006  
Age .04 [-.13, .21] .002  .22* [.01, .43] .01  
BMI .33*** [.18, .49] .02  -.04 [-.23, .15] -.001  
Ethnicity         
White vs. Other -.04 [-.21, .12] -.05  .10 [-.08, .27] .06  
White vs. Asian -.18* [-.34, -.01] -.15  -.05 [-.26, .17] -.02  
Core Beliefs -.14 [-.43, .15] -.001  .31* [.003, .61] .001  
Dysfunctional Attitudes .02 [-.21, .24] .00  -.21† [-.46, .04] -.001  
Rumination .05 [-.16, .27] .001  -.33** [-.55, -.12] -.004  
Pre-stress N-Back Errors .09 [-.05, .24] .003  .11 [-.06, .28] .002  
Model 2: Interaction effect R2 = .21, p = .001  R2 = .16, p = .004  
Core Beliefs × Pre-stress N-Back 
Errors 
.05 [-.08, .18] .00  .08 [-.05, .22] .00  
Model 3: Interaction effect R2 = .21, p = .001  R2 = .16, p = .006  
Dysfunctional Attitudes × Pre-stress 
N-Back Errors 
.07 [-.06, .20] .00  .06 [-.09, .21] .00  
Model 4: Interaction effect R2 = .21, p = .001  R2 = .16, p = .006  
Rumination × Pre-stress N-Back 
Errors 
.04 [-.07, .16] .00  .003 [-.14, .15] .00  
Note. 95% CI = 95% confidence intervals for standardized coefficients (βs). Ethnicity was dummy coded as White = 0, Asian = 1, and 
Other = 1. Values of .00 are < .001. Model fit: Model 1, χ2(67, N = 159) = 175.34, p < .001, CFI = .932, TLI = .907 and RMSEA = 
.101, SRMR = .117; Model 2, χ2(73, N = 159) = 180.78, p < .001, CFI = .933, TLI = .909 and RMSEA = .096, SRMR = .114; Model 
3, χ2(73, N = 159) = 181.42, p < .001, CFI = .933, TLI = .908 and RMSEA = .097, SRMR = .114; Model 4, χ2(73, N = 159) = 178.85, 
p < .001, CFI = .934, TLI = .910 and RMSEA = .095, SRMR = .113. 
†p < .10; *p < .05; **p < .01; ***p < .001. 
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Table 21  
 
Prediction of Latent Pre-stress Cytokines and Latent Change in Cytokines by Pre-stress N-back Errors and Cognitive Organization 
 
 Pre-stress inflammation         Δ inflammation  
Model and predictor β 95% CI b  β 95% CI b  
Model 1: Main effects  R2 = .23, p = .002  R2 = .12, p = .036  
Age .10 [-.10, .30] .01  .09 [-.15, .33] .002  
BMI .24** [.08, .41] .02  -.01 [-.20, .18] .00  
Ethnicity         
White vs. Other -.11 [-.27, .04] -.15  .05 [-.19, .30] .03  
White vs. Asian -.17† [-.37, .03] -.14  -.13 [-.37, .10] -.05  
Negative Social Organization .10 [-.11, .31] .10  .22* [.01, .42] .10  
Negative Achievement Organization     -.23* [-.42, -.04] -.18  .08 [-.13, .30] .03  
Pre-stress N-Back Errors .12 [-.04, .29] .004  .03 [-.15, .21] .00  
Model 2: Interaction effect R2 = .23, p = .002  R2 = .14, p = .021  
Negative Social Organization × Pre-
stress N-Back Errors 
.04 [-.13, .21] .003  -.17* [-.31, -.02] -.01  
Model 3: Interaction effect R2 = .27, p = .002  R2 = .13, p = .023  
Negative Achievement Organization × 
Pre-stress N-Back Errors 
-.02 [-.20, .15] -.002  -.10 [-.25, .05] -.003  
Note. 95% CI = 95% confidence intervals for standardized coefficients (βs). Ethnicity was dummy coded as White = 0, Asian = 1, and 
Other = 1. Values of .00 are < .001. Model fit: Model 1, χ2(61, N = 121) = 143.32, p < .001, CFI = .933, TLI = .908 and RMSEA = 
.106, SRMR = .138; Model 2, χ2(67, N = 121) = 149.46, p < .001, CFI = .935, TLI = .910 and RMSEA = .101, SRMR = .135; Model 
3, χ2(67, N = 121) = 155.59, p < .001, CFI = .930, TLI = .903 and RMSEA = .105, SRMR = .135. 
†p < .10; *p < .05; **p < .01; ***p < .001. 
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Figure 20. Interaction effect between Pre-stress N-back errors and Negative Social Organization 
on acute responses to the laboratory stressor. Change in Inflammation = latent change score for 
inflammation. ‘Low’ and ‘High’ Negative Nonaffective Switch Costs and rumination indicate 
scores one standard deviation below and above the mean, respectively. The thinner lines 
represent 95% confidence intervals. As neither simple slope was significant, regions of 
significance could not be examined. 
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effect of negative social organization on baseline inflammation. Further, there was no interaction 
effect of negative achievement organization with pre-stress N-back errors on inflammation in 
Model 3.  
Post-stress N-Back. Cognitive content and rumination. Table 22 presents findings from 
the conditional models predicting baseline and stress-induced changes in cytokines by negative 
cognitive content, rumination, and post-stress N-back errors. In order to examine the influence of 
stress on updating abilities, baseline N-back errors were entered in the model as a covariate. In 
Model 1, greater maladaptive core beliefs and lower dysfunctional attitudes marginally predicted 
stress-induced increases in inflammation. Higher rumination was associated with decreases in 
inflammation following the TSST. Contrary to hypotheses, there was no main effect of post-
stress N-back errors on pre-stress or post-stress changes in cytokines. 
In Model 2, there was a marginally significant interaction of core beliefs with post-stress 
N-back errors on baseline inflammation. Examination of the simple slopes revealed a trend 
whereby increases in post-stress N-back errors was marginally associated with greater baseline 
inflammation in individuals with low (b = .01, 95% CI = [-.001, .02], p = .076), but not high (b = 
.001, 95% CI = [-.01, .01], p = .906), maladaptive core beliefs (Figure 21). Post-stress N-back 
errors did not interact with core beliefs on changes in inflammation. 
There was a significant interaction of post-stress N-back errors with dysfunctional 
attitudes on baseline cytokines in Model 3. Probing this interaction indicated that greater post-
stress N-back errors were associated with greater baseline inflammation in individuals with low 
(b = .01, 95% CI = [.00, .02], p = .044), but not high (b = -.002, 95% CI = [-.01, .01], p = .671), 
dysfunctional attitudes (Figure 22). Furthermore, there was also a marginally significant 
interaction of post-stress N-back errors with dysfunctional attitudes on post-stress changes in 
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Table 22  
 
Prediction of Latent Pre-stress Cytokines and Latent Change in Cytokines by Post-stress N-back Errors, Negative Cognitive Content, 
and Rumination 
 
 Pre-stress inflammation         Δ inflammation  
Model and predictor β 95% CI b  β 95% CI b  
Model 1: Main effects  R2 = .22, p = .001  R2 = .19, p = .003  
Age .04 [-.14, .22] .002  .21† [-.004, .43] .01  
BMI .37*** [.21, .53] .02  -.002 [-.20, .20] .00  
Ethnicity         
White vs. Other -.04 [-.20, .13] -.05  .10 [-.07, .27] .06  
White vs. Asian -.16† [-.33, .01] -.13  -.07 [-.28, .15] -.03  
Pre-stress N-Back Errors .004 [-.21, .22] .00  .06 [-.18, .31] .001  
Core Beliefs -.07 [-.37, .23] .00  .28† [-.03, .59] .001  
Dysfunctional Attitudes -.08 [-.31, .15] -.001  -.21† [-.45, .04] -.001  
Rumination .03 [-.20, .25] .001  -.35** [-.58, -.12] -.01  
Post-stress N-Back Errors .10 [-.11, .31] .004  .10 [-.20, .39] .002  
Model 2: Interaction effect R2 = .24, p = .001  R2 = .19, p = .002  
Core Beliefs × Post-stress N-Back 
Errors 
-.12† [-.25, .01] .00  -.04 [-.25, .17] .00  
Model 3: Interaction effect R2 = .24, p = .001  R2 = .21, p = .001  
Dysfunctional Attitudes × Post-stress 
N-Back Errors 
-.14* [-.27, -.01] .00  -.15† [-.32, .02] .00  
Model 4: Interaction effect R2 = .24, p = .001  R2 = .19, p = .003  
Rumination × Post-stress N-Back 
Errors 
-.13* [-.26, -.001] .00  .06 [-.11, .23] .00  
Note. 95% CI = 95% confidence intervals for standardized coefficients (βs). Ethnicity was dummy coded as White = 0, Asian = 1, and 
Other = 1. Values of .00 are < .001. Model fit: Model 1, χ2(73, N = 147) = 179.42, p < .001, CFI = .929, TLI = .903 and RMSEA = 
.100, SRMR = .122; Model 2, χ2(79, N = 147) = 190.37, p < .001, CFI = .927, TLI = .900 and RMSEA = .098, SRMR = .118; Model 
3, χ2(79, N = 147) = 189.69, p < .001, CFI = .928, TLI =.902 and RMSEA =.098, SRMR =.116; Model 4, χ2(79, N = 147) = 185.77, p 
< .001, CFI = .930, TLI = .904 and RMSEA = .096, SRMR = .119. 
†p < .10; *p < .05; **p < .01; ***p < .001. 
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Figure 21. Marginally significant interaction effect between Post-stress N-back errors and 
maladaptive core beliefs on pre-stress cytokines. Prestress Inflammation = latent factor of 
baseline inflammation. ‘Low’ and ‘High’ Post-stress N-back errors and core beliefs indicate 
scores one standard deviation below and above the mean, respectively. The thinner lines 
represent 95% confidence intervals. 
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Figure 22. Interaction effect between Post-stress N-back errors and dysfunctional attitudes on 
pre-stress cytokines. Prestress Inflammation = latent factor of baseline inflammation. ‘Low’ and 
‘High’ Post-stress N-back errors and dysfunctional attitudes indicate scores one standard 
deviation below and above the mean, respectively. The thinner lines represent 95% confidence 
intervals. The region of significance on dysfunctional attitudes was -0.98 SD from the mean. 
This value indicates that Post-stress N-back errors were associated with increases in 
inflammation among individuals with dysfunctional attitudes <0.98 SD below the mean, but was 
not associated with inflammation for individuals with dysfunctional attitudes >0.98 SD below the 
mean. 
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cytokines. Similar to the findings for baseline inflammation, there was a trend for simple slopes 
to indicate that greater post-stress N-back errors were associated with greater acute inflammatory 
responses to the stressor in individuals with low (b = .004, 95% CI = [.00, .01], p = .048), but not 
high (b = -.001, 95% CI = [-.01, .01], p = .700), dysfunctional attitudes (Figure 23). 
In Model 3, a significant interaction of post-stress N-back errors with rumination on 
baseline cytokines emerged. Examination of the simple slopes revealed a trend whereby 
increases in post-stress N-back errors were marginally associated with greater baseline 
inflammation in individuals with a low (b = .01, 95% CI = [-.001, .02], p = .070), but not high (b 
= .00,1 95% CI = [-.01, .01], p = .973), tendency to ruminate (Figure 24). Rumination did not 
interact with post-stress N-back errors on stress-induced changes in inflammation.  
Cognitive organization. Findings from the conditional models predicting baseline and 
stress-induced changes in cytokines by negative cognitive organization and post-stress N-back 
errors are presented in Table 23. Analyses controlled for baseline N-back errors in order to 
examine stress-induced changes in N-back performance. Tightly interconnected negative 
achievement organization was related to greater baseline inflammation, and more loosely 
interconnected negative social organization was associated with greater acute inflammatory 
responses to stress. There were no main effects of post-stress N-back errors on pre-stress or post-
stress changes in cytokines.  
In Model 2, there was a significant moderating effect of negative social organization with 
post-stress N-back errors on baseline inflammation. Further assessment of this interaction 
revealed that, whereas the simple slopes were not significant, the direction of association of post- 
 
1 b value is < .001. 
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Figure 23. Marginally significant interaction effect between Post-stress N-back errors and 
dysfunctional attitudes on acute responses to the laboratory stressor. Change in Inflammation = 
latent change score for inflammation. ‘Low’ and ‘High’ Post-stress N-back errors and 
dysfunctional attitudes indicate scores one standard deviation below and above the mean, 
respectively. The thinner lines represent 95% confidence intervals. 
 
Figure 24. Interaction effect between Post-stress N-back errors and rumination on pre-stress 
cytokines. Prestress Inflammation = latent factor of baseline inflammation. ‘Low’ and ‘High’ 
Post-stress N-back errors and rumination indicate scores one standard deviation below and above 
the mean, respectively. The thinner lines represent 95% confidence intervals. The region of 
significance on rumination was 0.50 SD above the mean. This value indicates that Post-stress N-
back errors were associated with increases in inflammation among individuals with rumination 
<0.50 SD above the mean, but was not associated with inflammation for individuals with 
rumination >0.50 SD above the mean.
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Table 23  
 
Prediction of Latent Pre-stress Cytokines and Latent Change in Cytokines by Post-stress N-back Errors and Cognitive Organization 
 
 Pre-stress inflammation         Δ inflammation  
Model and predictor β 95% CI b  β 95% CI b  
Model 1: Main effects  R2 = .22, p = .003  R2 = .16, p = .026  
Age .10 [-.10, .31] .01  .08 [-.16, .32] .002  
BMI .27** [.09, .44] .02  .01 [-.18, .19] .00  
Ethnicity         
White vs. Other -.10 [-.27, .07] -.14  .11 [-.12, .34] .07  
White vs. Asian -.16 [-.36, .05] -.14  -.14 [-.37, .09] -.06  
Pre-stress N-Back Errors .11 [-.14, .36] .004  -.04 [-.32, .23] -.001  
Negative Social Organization .05 [-.16, .26] .05  .20* [.002, .40] .09  
Negative Achievement Organization     -.19* [-.37, -.003] -.14  .10 [-.10, .30] .04  
Post-stress N-Back Errors .01 [-.23, .24] .00  .16 [-.19, .51] .003  
Model 2: Interaction effect R2 = .25, p = .001  R2 = .17, p = .015  
Negative Social Organization × Post-
stress N-Back Errors 
.18* [.01, .36] .02  -.13 [-.31, .05] -.01  
Model 3: Interaction effect R2 = .26, p = .001  R2 = .17, p = .021  
Negative Achievement Organization × 
Post-stress N-Back Errors 
.21** [.05, .37] .01  -.12 [-.29, .05] -.004  
Note. 95% CI = 95% confidence intervals for standardized coefficients (βs). Ethnicity was dummy coded as White = 0, Asian = 1, and 
Other = 1. Values of .00 are < .001. Model fit: Model 1, χ2(67, N = 113) = 144.51, p < .001, CFI = .933, TLI = .908 and RMSEA = 
.101, SRMR = .145; Model 2, χ2(73, N = 113) = 151.09, p < .001, CFI = .934, TLI = .910 and RMSEA = .097, SRMR = .141; Model 
3, χ2(73, N = 113) = 151.98, p < .001, CFI = .933, TLI = .909 and RMSEA = .098, SRMR = .139. 
†p < .10; *p < .05; **p < .01; ***p < .001. 
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stress N-back errors with baseline inflammation was positive in individuals with loosely 
connected schemas (b = .01, 95% CI = [-.003, .02], p = .167) and negative for those with tightly 
connected schemas (b = .-01, 95% CI = [-.02, .004], p = .178; Figure 25).  Negative social 
organization did not moderate the relation of post-stress N-back errors on changes in 
inflammation. 
Similarly, in Model 3 there was a significant interaction of negative achievement 
organization with post-stress N-back errors on baseline inflammation. The simple slopes were 
not significant, however the same pattern of findings emerged as with the interaction of negative 
social organization, in that the direction of association of post-stress N-back errors with baseline 
inflammation was positive in individuals with loosely connected schemas (b = .01, 95% CI = [-
.003, .02], p = .169) and negative for those with tightly connected schemas (b = .-01, 95% CI = [-
.02, .002], p = .119; Figure 26).  There was no interaction of negative achievement organization 
with updating on change in cytokines in Model 3.  
Hypothesis 11: Predicting Depressive Symptoms at Follow-up by Pre-stress and Stress-
Induced Changes in Inflammation 
Two conditional latent change score models were constructed to assess whether pre-stress 
inflammation or post-stress changes in inflammation predict subsequent depression at Phases 3 
(two weeks after saliva collection) and 4 (six months after saliva collection). Analyses controlled 
for baseline depressive symptoms at Phase 1. In the first model, Phase 3 depressive symptoms 
were regressed on both pre-stress cytokines and stress-induced changes in cytokines. Baseline 
depressive symptoms were significantly associated with Phase 3 depressive symptoms (b = .81; 
β = .83, 95% CI = [.76, .90], p < .001). However, neither pre-stress inflammation (b = -.08;   
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Figure 25. Interaction effect between Post-stress N-back errors and Negative Social Organization 
on pre-stress cytokines. Prestress Inflammation = latent factor of baseline inflammation. ‘Low’ 
and ‘High’ Post-stress N-back errors and Negative Social Organization indicate scores one 
standard deviation below and above the mean, respectively. The thinner lines represent 95% 
confidence intervals. As neither simple slope was significant, regions of significance could not 
be examined. 
 
Figure 26. Interaction effect between Post-stress N-back errors and Negative Achievement 
Organization on pre-stress cytokines. Prestress Inflammation = latent factor of baseline 
inflammation. ‘Low’ and ‘High’ Post-stress N-back errors and Negative Achievement 
Organization indicate scores one standard deviation below and above the mean, respectively. The 
thinner lines represent 95% confidence intervals. As neither simple slope was significant, regions 
of significance could not be examined.  
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β = -.003, 95% CI = [-.08, .07], p = .947), nor post-stress changes in inflammation (b = -.27; β = 
-.004, 95% CI = [-.10, .09], p = .933) predicted depressive symptoms at Phase 3.2  
The second model examined whether inflammation predicts depressive symptoms at 
Phase 4. Again, baseline depressive symptoms were significantly associated with follow-up 
depressive symptoms (b = .76; β = .75, 95% CI = [.66, .85], p < .001).  Baseline inflammation 
did not predict Phase 4 depressive symptoms (b = .68; β = .02, 95% CI = [-.06, .10], p = .583). 
However, lower inflammatory reactivity to the laboratory stressor unexpectedly predicted 
increases in depressive symptoms at 6-month follow-up (b = -7.81; β = -.12, 95% CI = [-.22, -
.02], p = .024).3  
Discussion 
Cognitive control, a key factor in determining individuals’ experience of and response to 
life events, has emerged as a critical construct for better understanding emotion regulation 
processes in depression (Joormann & Vanderlind, 2014). Individuals with current or remitted 
depression tend to exhibit poorer cognitive control abilities, particularly for affective content 
(Joormann & Tanovic, 2015). Difficulty inhibiting negative stimuli, shifting away from 
processing negative material, or updating the contents of current awareness to discard negative 
goal-irrelevant information, is thought to result in prolonged accessibility and processing of 
negative material. Increased processing of negative information is theorized to result in 
rumination and other emotion regulation problems. In turn, this leads to persistent negative mood 
 
2Model fit: χ2(33, N = 166) = 108.41, p < .001, CFI = .953, TLI = .936 and RMSEA = .117, 
SRMR = .149.  
 
3Model fit: χ2(33, N = 166) = 104.31, p < .001, CFI = .954, TLI = .938 and RMSEA = .114, 
SRMR = .150. 
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and eventually, a depressed state (Joormann & Stanton, 2016). Cognitive control abilities are 
required most for effective self-regulation following stressful experiences (Quinn & Joormann, 
2015b). As such, they are particularly important for determining an individual’s ability to 
respond adaptively to stress. The current study replicated and extended past research by 
examining diagnostic group differences across a battery of tasks assessing various cognitive 
control abilities, including cognitive control changes following a laboratory stressor, and the 
relation of these tasks with rumination. This study also bridged the extensive body of literature 
on cognitive vulnerability in depression with cognitive control research.  As such, it was the first 
to examine the role that schemas, in the form of maladaptive cognitive content and structure, 
play in determining stress-induced changes in cognitive control abilities. 
Cognitive control may influence depression not only via rumination, but through other 
facets of stress reactivity. An emerging body of research has found that inflammation is 
associated with depression and stress (e.g., Osimo, Baxter, Lewis, Jones, & Khandaker, 2019; 
Rohleder, 2019), and that greater levels of inflammation may explain a number of the physical 
(e.g., changes in sleep and appetite, low energy) and affective (e.g., anhedonia) symptoms of 
depression (Dantzer et al., 2008). Moreover, the Social Signal Transduction Theory of 
Depression (Slavich & Irwin, 2014; Slavich & Sacher, 2019) posits that when interpersonal life 
events are perceived as stressful or threatening, they are transduced into greater inflammation, 
eventually resulting in a pro-inflammatory state that may drive the pathogenesis of depression. 
For a social situation to be experienced as threatening and transduced to greater inflammation, 
cognition must be implicated. However, cognitive mechanisms underlying this process are not 
well understood and a paucity of research has examined the role that cognition plays in 
determining resting-state inflammation or acute inflammatory responses to stress. The current 
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study filled an important gap in the field of psychoneuroimmunology by examining how 
cognitive control, rumination, and depressotypic negative cognitive content and structure interact 
with each other and predict individuals’ baseline and laboratory stress-induced changes in 
inflammation. The association of inflammation with subsequent depressive symptoms at 2-week 
and 6-month follow-up was also examined. 
Hypothesis 1: Group differences in Cognitive Control  
The first objective of this study was to replicate past research findings that depressed 
individuals demonstrate cognitive control deficits on tasks involving affective stimuli. Less 
research has examined cognitive control in remitted depressed individuals, and findings are 
somewhat less consistent (e.g., Joormann and Gotlib, 2010; Liu et al., 2017). Therefore, another 
goal was to examine depression-related cognitive control abilities following the active phase of 
the disorder. The current study replicated past research using cognitive control tasks that have 
been previously studied in clinical samples (i.e., the N-back and Emotional Stroop) and was the 
first to test diagnostic group differences using the Affective Flexibility Task. Significant group 
differences in inhibitory abilities were found, as indicated by reaction times on the Emotional 
Stroop. Currently depressed individuals evinced the slowest reaction times, followed by the 
remitted depressed group. The control group showed the fastest reaction times, and therefore the 
greatest inhibitory ability for negative affective stimuli. Given that the remitted depressed group 
did not differ significantly from either of the other groups, it is unclear whether or not they 
demonstrated inhibitory impairment. The intermediate inhibitory abilities found in the remitted 
depressed group could be more difficult to detect without sufficient power, and therefore may 
explain inconsistencies in past research.  
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There was also evidence of updating deficits among the currently depressed group for 
both the pre- and post-stress administrations of the N-back. On both occasions, depressed 
individuals made more errors on the task than did both remitted depressed and control 
participants. There was no evidence of updating deficits among remitted depressed individuals, 
as they performed similarly to the control group. This finding suggests that updating deficits, 
both under normal conditions and following a stressor, are specific to the symptomatic phase of 
depression. Given that impairments did not emerge in the remitted depressed group after the 
stress induction, this finding also implies that updating difficulties do not constitute a latent 
vulnerability that surfaces following priming by stress or low mood in the aftermath of a 
depressive episode. 
Contrary to hypotheses, diagnostic group differences did not emerge on the Affective 
Flexibility Task. Although switch costs on this task have been found to relate to emotion 
regulation abilities highly relevant to depression, including rumination (Genet et al., 2013) and 
reappraisal (Malooly et al., 2013), this study was the first to use this task in a clinical sample. No 
group differences were detected across the four types of switch costs (i.e., positive affective, 
negative affective, positive nonaffective, and negative nonaffective switch costs). One possible 
explanation for this finding is that task switching abilities may not be strongly associated with 
depression. Although a number of past studies have found an association of shifting biases with 
depressive symptoms or diagnoses, the majority of these have used tasks that require a shift in 
focus among varying categories of stimuli (e.g., Internal Shift Task, De Lissnyder, Koster, 
Everaert, et al., 2012;  an affective switch task; De Lissnyder et al., 2010), but not a shift in task 
sets or operations, which is how shifting has been defined (Miyake et al., 2000). Another study 
examined task switching, but switches were among variations of the same task rather than 
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discrete tasks (Owens & Derakshan, 2013). Moreover, switches occurred infrequently, from one 
block of trials to the next, rather than continuously within a block. The only other study to 
examine the relation of continuous shifting between discrete tasks within a block of trials did 
find evidence of shifting deficits; currently depressed individuals were slower than remitted 
depressed or healthy controls at switching away from a task that required processing emotional 
stimuli (Quigley, 2017). However, this task differed from the Affective Flexibility Task in that 
trials alternated between switch and non-switch trials in a predictable order. In contrast, group 
differences may not be evident when switch trials occur in a pseudorandom sequence and 
individuals cannot prepare for an expected switch in tasks, as in the Affective Flexibility Task. 
This suggests that depressed individuals may have more difficulty than those who are currently 
nondepressed in mustering cognitive resources to prepare for an expected switch in tasks, but do 
not have more difficulty making unexpected switches. As such, the present findings are 
preliminary and need replication, and the nature and specificity of deficits across various forms 
and components of shifting are an important empirical question for future research to explore in 
greater detail.  
Hypothesis 2: Association of Deficits in Cognitive Control with Rumination 
Consistent with hypotheses, rumination was associated with a number of cognitive 
control impairments. Inhibitory deficits (as indicated by longer reaction times on the Emotional 
Stroop), updating deficits (as assessed by greater errors on the Emotional N-back), and stress-
induced declines in updating, were each correlated with a tendency to ruminate. These findings 
are consistent with prior research that has reported associations of inhibition and updating with 
rumination (e.g., Joormann & Gotlib, 2010; Joormann et al., 2011). Difficulty inhibiting 
irrelevant information and manipulating the contents of working memory in order to discard 
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previously-relevant content are therefore tied to a greater tendency to passively and repetitively 
think about the causes, consequences, and meaning of low mood. Individuals with these deficits 
may ruminate more because they are less able to filter negative content out of working memory, 
leading to prolonged processing of negative material. It is important to note that it is also 
possible that greater trait rumination may interfere with inhibition and updating, as the process of 
negative repetitive thought may consume cognitive resources, thereby overwhelming the ability 
to effectively control the contents of working memory. However, as the current findings are 
cross-sectional, the direction of this link is unclear. Whereas cognitive theories have focused on 
the role of cognitive control on rumination (e.g., Joormann & Tanovic, 2015), a bidirectional link 
is possible, and should be considered in future studies.  
Positive nonaffective switch costs were marginally associated with greater rumination. 
However, contrary to hypotheses, positive affective, negative affective, and negative 
nonaffective switch costs were not associated with rumination. The current findings for negative 
affective and positive nonaffective switch costs are in contrast to those of Genet and colleagues 
(2013), who found that greater negative nonaffective switch costs were associated with greater 
daily rumination, and greater positive nonaffective switch costs were related to decreased daily 
rumination. Rather than assessing a general tendency to ruminate about the causes, 
consequences, and meaning of low mood as was done in the current study, Genet and colleagues 
assessed daily stress-reactive rumination in response to the worst event of the day over the 
course of six days. If replicable, these findings indicate that negative nonaffective switch costs 
are predictive of stress-reactive rumination about specific life events, and not of a more general 
tendency to respond to low mood with ruminative thinking. This may be because individuals are 
confronted with explicit negative stimuli during a negative life event that they need to switch 
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focus away from in order to prevent stress-reactive rumination. This is not necessarily the case 
for trait rumination, where the focus of ruminative thoughts may be less concrete. 
The current finding of a positive association between positive nonaffective switch costs 
and rumination is more surprising. Although only marginally significant, the effect was in the 
opposite direction of what Genet et al. (2013) reported. Positive nonaffective switch costs may 
be protective in reducing stress-reactive rumination because difficulty disengaging from the 
affective features of positive stimuli may prevent individuals from allocating cognitive resources 
to the negative elements of an event. This may result in less negative material for stress-reactive 
rumination to center on. Conversely, cognitive inflexibility, even when it involves difficulty 
disengaging from positive affective information, may reinforce general ruminative thinking, 
particularly in a clinical sample. After all, difficulty switching from processing the positive 
elements of stimuli does not necessarily indicate that the individual is engaging in adaptive 
thinking about that stimuli. In contrast, it is possible that the individual may be engaging in 
negative ruminative thinking (e.g., making upward social comparisons). Again, this finding was 
only marginally significant, and should be interpreted with caution prior to replication in future 
research.  
The current findings were consistent with Genet et al. (2013) in that positive and negative 
affective switch costs were not associated with rumination. In other words, an ability to flexibly 
switch to processing the affective elements of stimuli does not seem to be relevant to rumination. 
As rumination primarily involves difficulty disengaging from negative information for protracted 
periods of time (Joormann & Gotlib, 2010), rather than initial engagement with affective 
material, the lack of association of affective switch costs with rumination corresponds with 
theory. 
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Hypothesis 3: Decreased Updating Abilities Following the Stressor 
The Trier Social Stress Test (TSST) was effective in producing an affective stress 
response, in that participants with current and remitted depression showed the lowest positive 
affect and highest negative affect after the stress induction as compared to controls. However, as 
pre- and post-stress N-back errors did not significantly differ from each other, there was not 
evidence for a stress-induced decline in updating abilities following the stressor. This finding is 
consistent with two previous studies (Quinn & Joormann, 2015a, 2015b) that also asked 
participants to complete the emotional N-back before and after the TSST. Despite experiencing 
an affective response to the TSST, participants may, on average, perform similarly on the post-
stress administration of the N-back as a result of practice effects or habituation to the emotional 
words presented in the task, thereby obscuring stress-induced decreases in updating. One way for 
future research to mitigate against the issue of habituation would be to use different words on the 
second administration of the N-back that are matched to words used in the first administration 
for word length, frequency, and emotional intensity. Although an overall decrease in updating 
abilities was not observed, there was still meaningful individual variability in post-stress changes 
in updating ability as reported in the findings discussed directly below.  
Hypothesis 4: Cognitive Content and Structure Predicting Stress-Induced Changes in N-
Back Performance 
Cognitive control abilities immediately following a stressor, when they are most needed 
for self-regulation, are critical for understanding differences in stress reactivity. For example, 
stress-induced declines in cognitive control determine the degree to which individuals develop 
depressive symptoms following stressful life events (Quinn & Joormann, 2015b). However, 
mechanisms underlying stress-induced changes in cognitive control have not been examined. 
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The current study was the first to elucidate predictors of post-stress changes in updating abilities 
by investigating whether greater maladaptive cognitive content and structure interfere with 
cognitive control abilities following a stressful experience.  
Controlling for baseline updating, individuals with current depression demonstrated 
greater post-stress errors than did control participants. Furthermore, the current findings revealed 
that individuals who experienced greater negative affect following the laboratory stressor also 
evinced greater stress-induced decreases in updating, as indicated by greater errors on the N-
back. As anticipated, maladaptive core beliefs were associated with a decline in updating 
following the stressor. During a stressful experience such as the TSST, negative cognitive 
content is primed and becomes accessible to working memory. Individuals with maladaptive 
core beliefs about themselves and others have greater negative cognitive content, including 
thoughts and memories, that can be activated by stress (Dozois & Beck, 2008). This activation 
results in more information becoming accessible to, and active in, the contents of current 
awareness following a stressor (e.g., Loeffler, Myrtek, & Peper, 2013). Greater accessibility and 
processing of this information adds an additional load of material to be monitored and 
manipulated by executive functions, likely overwhelming cognitive resources, and thereby 
leading to greater errors on the updating task. It is important to note that, although individuals 
with greater maladaptive core beliefs may be more likely to experience the TSST as upsetting, a 
stronger emotional response to the stressor does not fully explain the relation of core beliefs with 
decreases in updating, as increases in negative affect were controlled statistically. In other words, 
maladaptive core beliefs result in stress-induced declines in updating over and above the impact 
that post-stress increases in negative affect have on updating changes.  
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Dysfunctional attitudes did not predict changes in updating. This finding suggests that it 
may be deeper negative beliefs about oneself and others that are primed by the TSST, activate a 
network of congruent thoughts that become accessible to working memory, overload cognitive 
resources, and ultimately, interfere with efficient updating. While the Dysfunctional Attitudes 
Scale (DAS) assesses negative cognitive content, it is a measure of conditional assumptions, and 
therefore is an index of more intermediate cognitions than the Young Schema Questionnaire 
(YSQ), which was used to assess core beliefs (Dozois & Beck, 2008). Moreover, although 
conditional assumptions may have been primed by the TSST, they may not activate as large a 
network of negative information, thoughts, and memories as do deeper core beliefs. This may be 
particularly true given the more restricted content areas that the DAS assesses (i.e., importance 
of social approval, perfectionistic standards, conditions for happiness) as compared to the YSQ, 
which examines more nuanced beliefs about self, others, and interpersonal relationships. 
Negative social and negative achievement cognitive organization both predicted stress-
induced changes in updating above and beyond the impact of diagnostic status and negative 
emotional reactivity to the TSST. This underscores the importance of deeper cognitive structures 
in determining cognitive control following stress. Unexpectedly, more loosely connected social 
and achievement self-schemas were associated with greater increases in errors on the N-back 
task. In contrast, individuals with more tightly interconnected schemas were hypothesized to 
show the greatest post-stress reduction in updating abilities. These individuals were expected to 
have more consolidated negative cognitions that would be primed by the stressor and would in 
turn facilitate retrieval of other, closely interconnected negative content. The activation of this 
network of negative thoughts and memories was anticipated to result in greater information 
entering working memory and overloading cognitive control abilities. However, it is important to 
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note that, in order to obtain a score for either negative social or achievement cognitive 
organization, participants had to endorse at least two negative adjectives as self-relevant on that 
scale. Therefore, individuals who did not obtain a score on a scale of the Psychological Distance 
Scaling Task (PDST) were the least vulnerable in the sample in terms of cognitive organization. 
Those individuals with more loosely connected negative schema structures, who did endorse 
negative adjectives as self-relevant, reported a degree, albeit relatively small, of cognitive 
vulnerability. Given their more dispersed negative cognitive structure, these individuals may 
have experienced the TSST as more dissonant with their expectations, experiences, and sense of 
self than those individuals with tightly interconnected negative self-schemas. Expectancy 
violations can increase the salience of a stimulus (Craske, Treanor, Conway, Zbozinek, Vervliet, 
2014). Therefore, a violation of expectations may have rendered the TSST a more potent prime 
for these individuals, effectively activating their less consolidated negative schema structure, and 
resulting in greater interference on the post-stress N-back.  
Diagnostic group was no longer associated with stress-induced changes in updating after 
negative affect and cognitive vulnerability were accounted for. The current findings suggest that 
it is affective reactivity and negative cognitive content and how it is structured, rather than 
diagnostic status in and of itself, that account for stress-induced changes in cognitive control. 
Hypothesis 5: Increases in Inflammatory Cytokines in Response to the Stressor 
As hypothesized, the TSST elicited an immune response, as indicated by increases in a 
pro-inflammatory phenotype comprised of the salivary cytokines IL-8, IL-6, IL-1β, and TNF-α. 
This replicates past findings that individuals react to social-evaluative stressors with an immune 
system response (e.g., Carroll et al., 2011; Dickerson et al., 2009; Moons et al., 2010). Slavich 
and Irwin (2014)’s Social Signal Transduction Theory of Depression posits that when individuals 
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interpret a social interaction as threatening, the sympathetic nervous system upregulates the 
production and distribution of cytokines in order to prepare for potential wounding and infection 
should a physical altercation occur. This evolutionarily adaptive process is referred to as the 
CTRA (conserved transcriptional response to adversity). Importantly, there was also significant 
inter-individual variability in the degree of post-stress change in cytokines. In the current study, 
cognitive control and cognitive vulnerability (i.e., dysfunctional attitudes, core beliefs, 
rumination, and cognitive structure) were expected to be important in determining an 
individual’s experience of the stressor and to predict differences in inflammatory reactivity. 
Hypothesis 6: Greater Baseline and Post-Stressor Cytokines in Individuals with Depression 
and Remitted Depression 
In contrast to Hypothesis 6, there were no differences in baseline cytokines across 
currently depressed, remitted depressed, and control participants. Depressive symptoms also 
were not associated with resting-state inflammation. This is in contrast to a number of meta-
analyses that have documented greater baseline IL-6 and/or TNF-α in individuals with MDD as 
compared to healthy controls (Dowlati et al., 2010; Haapakoski, Mathieu, Ebmeier, Alenius, & 
Kivimäki, 2015; Hiles et al., 2012; Howren et al., 2009; Köhler et al., 2017). Notably, meta-
analyses have reported no differences in resting-state IL-1β and IL-8 among individuals with 
MDD and healthy controls (Dowlati et al., 2010; Eyre et al., 2016; Köhler et al., 2017), 
consistent with the current findings. However, it is important to note that existing meta-analyses 
examined cytokine levels in peripheral blood and not in saliva, which could account for 
differences in the current findings. Studies have yielded inconsistent findings in terms of whether 
cytokines in blood and saliva correlate (Byrne et al. 2013; Minetto et al., 2007; Rahnama, 
Jastrzebska, Jamrogiewicz, & Kocki, 2013; Riis et al., 2014; Williamson, Munro, Grap, & 
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Elswick, 2012).  Furthermore, while salivary cytokines are a valid marker of inflammation 
(Slavish et al., 2015), the processes that underlie the relation of salivary cytokines with cytokines 
in plasma or serum are still not fully understood. It is noteworthy that the current study is among 
the first to examine differences in salivary cytokines in a clinical sample of individuals with 
depression. One other study examined differences in adolescents with and without a depressive 
diagnosis, and similarly found no diagnostic group differences in cytokines (Byrne et al. 2013). 
Taken together, extant findings suggest that depression may be more closely associated with 
specific immune markers (e.g., IL-6, TNF-α) of peripheral systemic inflammation, for which 
blood is the gold standard for assessment, than more localized oral inflammation as assessed 
with saliva.   
Similarly, there were no diagnostic group differences in stress-induced changes in 
cytokines. Depressive symptoms also were not related to post-stress changes in inflammation. 
This is in contrast to past research that found greater increases in plasma TNF-α and/or IL-6 in 
individuals with MDD compared to healthy controls following the TSST or a variant of it (Pace 
et al., 2006; Weinstein et al., 2010). However, in direct contrast, Niemegeers and colleagues 
(2016) found reductions in serum IFN-γ (a pro-inflammatory cytokine) and TNF-α, and no 
changes in IL-6, after the TSST in both remitted depressed and healthy control participants. No 
group differences in post-stress changes in cytokines were evident, and the authors attributed 
reductions in inflammation to increases in the glucocorticoid cortisol (which has anti-
inflammatory properties) following the stressor. Similarly, Miller et al. (2005) did not find 
differences in circulating serum TNF-α and IL-6, or endotoxin-stimulated production of TNF-α 
and IL-6, between women with and without depression following a variant of the TSST. These 
investigators note this may have been due to the relatively shorter post-stress time period in 
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which they collected blood samples. However, differences did emerge in white blood cell 
sensitivity to the anti-inflammatory properties of glucocorticoids following the stressor, in that 
sensitivity declined among individuals with depression (which would allow for greater 
downstream expression of cytokines), and increased in nondepressed individuals, following the 
stressor. This indicates a pathway through which stress may lead to dysregulation of immune 
mediators. In sum, findings for group differences in post-stressor changes in inflammation are 
inconsistent, and differences may arise from type of biological sample assessed (serum/plasma 
vs. saliva), timing of post-stressor sample collection, and sample characteristics (e.g., currently 
vs. remitted depressed). Miller et al. (2005)’s findings highlight that even in the absence of 
changes in circulating cytokine levels, other differences in immune response may be present, 
which could result in increased expression and dysregulation in cytokines over time. In this vein, 
it is possible that greater post-stress cytokines may only be evident in individuals with depression 
who have developed glucocorticoid resistance following periods of chronic or recurring stress, 
rather than in individuals with less extensive histories of life stress.  
Another reason for the lack of diagnostic group differences in salivary cytokines may be 
related to the extensive medical exclusionary criteria that were used in the current study. 
Depression is associated with a number of commonly comorbid medical conditions (e.g., Barton, 
2008; Calder, 2006), and this is thought to result from the third variable of underlying pro-
inflammatory processes. As a result of intensive pre-screening, one of the current study’s 
strengths may have also been a limitation due to the exclusion of individuals with medical 
conditions who are likely to have a chronically activated CTRA and to be characterized by a 
systemic pro-inflammatory state. Pre-screening for medication and conditions that influence 
inflammation may have therefore led to a restriction of range in cytokines. Consistent with this 
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idea, high levels of statistical heterogeneity reported in meta-analyses among studies examining 
group differences in cytokines is thought to result in part from sample differences in participants’ 
health status (Köhler et al., 2017). Although careful screening for inflammatory conditions 
reduced the number of confounds in this study, future research is needed to examine diagnostic 
differences in cytokines in a more generalizable sample that includes individuals with pro-
inflammatory medical conditions or who are taking medications that influence inflammation.  
Slavich and Irwin (2014) note that inflammation may not be necessary or sufficient in all 
cases of depression, and this may further explain the lack of diagnostic group differences in 
cytokines in the present study. Given the heterogeneity in symptoms and causes of the disorder, 
they suggest that a pro-inflammatory phenotype may only characterize a subset of patients with 
depression. Consistent with this idea, there was evidence in the current study that, amongst 
individuals with current or remitted depression, a greater number of past episodes was associated 
with greater reactivity to the stressor (b = .01; β = .24, 95% CI = [0.02, 0.46], p = .031) but not 
with baseline inflammation (b = .02; β = .20, 95% CI = [-0.09, 0.49], p = .179). This indicates 
that elevated inflammation, at least in terms of acute inflammatory responses, may be more 
relevant to highly recurrent cases than to depression more generally. Moreover, this finding 
suggests that a kindling effect (Monroe & Harkness, 2005, 2011; Post, 1992) may occur as the 
process of neuro-inflammatory sensitization unfolds over time. That is, as the neuro-
inflammatory link becomes reinforced following the experience of numerous stressors, a self-
promoting cycle of exaggerated perceptions of social threat and greater inflammatory responses 
to stress occur, and less stress is therefore needed to promote inflammation and ultimately, 
depressive episodes. It is important to note that number of episodes was assessed using the 
SCID-5. Given that this variable is sensitive to memory biases, however, its reliability and 
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validity are limited. Further research is therefore needed to examine whether neuro-inflammatory 
sensitization represents an endophenotype of depression and whether highly recurrent depression 
corresponds to a pro-inflammatory subtype of the disorder.  
Hypothesis 7: Main Effects of Deficits in Inhibition, Shifting, and Updating on Baseline and 
Stress-Induced Inflammation  
This study was the first to examine whether deficits in shifting predict cytokines, and was 
among the first to investigate whether inhibitory and updating impairments are associated with 
inflammation. Indices of cognitive control were hypothesized to predict both baseline and stress-
induced inflammation. Differences in findings across types of cognitive control for predicting 
resting-state inflammation versus acute inflammatory response to stress were examined in an 
exploratory manner.  
Poor inhibition, as indicated by longer reaction times on the Emotional Stroop, predicted 
greater baseline inflammation. Resting state-inflammation may reflect the degree to which an 
individual is in a chronically activated inflammatory state, possibly as a result of a persistently 
activated CTRA. Inhibition of negative emotional stimuli may reduce the degree to which an 
individual experiences social stressors as threatening, potentially limiting opportunities for the 
CTRA to become persistently activated over time. In contrast, inhibition was not associated with 
changes in cytokines following the stressor. This finding suggests that inhibition may influence 
inflammatory activity to stress over longer time periods, thereby shaping resting-state 
inflammation as opposed to inflammatory reactivity to acute stress. Consistent with this idea, it is 
also possible that inhibition may be more influential in shaping reactivity to chronic or ongoing 
stressors and difficult circumstances as compared to acute stressors, although this has not been 
tested.  
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In contrast to the current findings, Shields and colleagues (2016) found that poor 
performance on a faces version of the Emotional Stroop predicted greater salivary IL-1β, IL-6, 
and IL-8 reactivity among participants exposed to a stressor compared to those who completed a 
control task. It is possible that differences in findings emerged as a result of the tasks used to 
assess inhibition. By requiring participants to inhibit emotional faces, the version of the Stroop 
that Shields and colleagues used was more socially relevant, and therefore may have tapped into 
inhibitory abilities particularly important for regulating reactivity to social stress. Another key 
difference was that Shields et al. measured inhibitory abilities after the stressor, and therefore 
their measure of inhibition may have captured stress-induced declines in inhibition rather than 
trait inhibitory ability, which may be more relevant to acute inflammatory reactivity. Finally, the 
current study employed a social-evaluative stressor, whereas Shields et al. used an emotional 
stressor that involved viewing a film-clip of a crying infant being circumcised. It is possible that 
inhibition is more significant for acute reactivity to stressors relating to physical threat or harm, 
or in which there is very specific stimuli to inhibit, than to a more involved and immersive 
interpersonal stressor such as the TSST. Future research will need to examine precisely what 
components (e.g., immersive versus film clip) of various stressors (e.g., uncontrollable, 
evaluative, emotional) moderate the relation of cognitive control with cytokine reactivity.  
As hypothesized, greater positive affective switch costs were associated with greater 
increases in inflammation following the stressor. Similarly, greater negative affective switch 
costs marginally predicted greater post-stress increases in cytokines. These findings indicate that 
individuals who took longer to switch from categorizing stimuli by a nonaffective categorization 
rule to an affective categorization rule were more reactive to the stressor. The cost of switching 
to categorizing an image by its affective rule is thought to be indicative of how effective that 
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individual is at switching from processing the nonaffective aspects to the affective aspects of 
stimuli (Genet et al., 2013; Malooly et al., 2013). Flexibility in shifting the focus of one’s current 
attention and awareness to positive affective information in the environment is posited to 
facilitate emotion regulation and, along this vein, has been found to relate to greater reappraisal 
ability (Malooly et al., 2013). Individuals who have difficulty switching to processing positive 
affective information also likely had difficulty shifting their attention to positive information 
during or after the TSST. As a result, they may have been less able to integrate positive content 
in order to self-regulate, resulting in greater inflammatory reactivity. The marginal finding for 
negative affective switch costs indicates that flexibility in shifting to processing negative 
affective information may also be problematic for regulating responses to stress. Although past 
research has not found an association of negative affective switch costs with emotion regulation 
(Genet et al., 2013; Malooly et al., 2013), poor flexibility in shifting to negative affective 
information may result in it being processed less efficiently, which could contribute to greater 
stress reactivity. Given that this finding was only at trend-level, this interpretation is tentative. 
Contrary to hypotheses, positive and negative nonaffective switch costs were not 
associated with either resting-state or stress-induced changes in inflammation. As such, the cost 
of switching away from processing affective information to processing nonaffective information 
does not appear to be associated with levels of salivary cytokines. In contrast, difficulty 
disengaging from negative affective information was expected to result in prolonged processing 
of the negative features of stressors, thereby resulting in greater resting-state or stress-induced 
inflammation. Further, given that past research has found that greater positive nonaffective 
switch costs are related to better reappraisal ability, and to a reduced tendency to ruminate 
(Genet et al., 2013; Malooly et al., 2013), positive nonaffective switch costs were anticipated to 
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predict less inflammation at baseline or following stress. However, the current findings suggest 
that switching away from processing affective information (and therefore engaging in potentially 
prolonged processing of affective information) is not as important for acute immune reactivity as 
is flexibility in initiating the processing of affective information (i.e., affective switch costs). 
Reasons for this difference need to be explored further.  
Finally, there was no main effect of updating on resting state or stress-induced changes in 
cytokines either before or after the TSST. This finding suggests that updating did not have a 
marked and invariant impact on inflammation across the sample. Recent research (Quinn et al., 
2019) similarly reported no associations of baseline updating with cytokines. However, Quinn 
and colleagues found that declines in updating were associated with increases in IL-6 following a 
variant of the TSST. It is important to note that this previous study used a small sample of 16 
individuals and that key covariates, including ethnicity and BMI, were not controlled for, thereby 
increasing the probability of Type II error. However, it is also possible that differences in 
findings were due to the clinical composition of the current sample, and that the association of 
stress-induced declines in updating are only evident in less vulnerable individuals. This is 
discussed further under Hypotheses 9 and 10 below. 
While this study conceptualizes cognitive control as influencing the process of social 
signal transduction by reducing ability to regulate under stress, thereby resulting in greater 
resting-state and stress-induced changes in cytokines, other interpretations are possible. 
Inflammation is associated with SNS and HPA axis activation and the release of norepinephrine 
and glucocorticoids, which can impair cognitive control when concentrations are high in the 
prefrontal cortex. Therefore, it is also possible that greater baseline or stress-reactive 
inflammation results in lower inhibitory abilities. Giollabhui and colleagues (2019), for example, 
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assessed adolescents’ depressive symptoms, measures of executive functioning (selective 
attention and selective shifting), and IL-6 annually over three years. Results indicated that 
depression was associated with subsequent executive functioning via increases in IL-6, although 
there was no direct association of IL-6 with prospective executive functioning. Additional 
longitudinal research is needed to continue to elucidate the direction, or bidirectional nature, of 
effects of cognitive control with inflammation.  
It is also noteworthy that a number of main effects were qualified by interactions with 
cognitive content, structure, or rumination. These interactions suggest that some forms of 
cognitive control were important in determining stress reactivity only among subgroups of 
participants, even in cases where main effects were not evident. These findings are described 
under Hypothesis 9 and 10. 
Hypothesis 8: Main Effects of Cognitive Vulnerability on Baseline and Stress-Induced 
Cytokines  
This study was the first to examine depressotypic cognitive content (core beliefs and 
dysfunctional attitudes) and structure as predictors of baseline and stress-induced cytokines, and 
was among the first to examine the relation of rumination with inflammation. As predicted, 
greater maladaptive core beliefs were associated with post-stress increases in inflammation. 
Individuals’ negative core beliefs were likely activated by the stressor, and those with greater 
negative beliefs about themselves and others may have interpreted and experienced the TSST as 
more threatening and self-relevant, leading to a greater inflammatory response. This finding is 
similar to Giletta et al.’s (2017), who found that greater hopelessness predicted increases in IL-
1β following the TSST in a high risk sample of adolescents. Before the stressor, core beliefs 
were not necessarily primed, and this may explain why they did not have an impact on resting 
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state inflammation. Furthermore, a trend emerged in some analyses whereby dysfunctional 
attitudes were marginally associated with decreases in inflammation following the stressor, 
possibly indicating habituation. This was unexpected, given that greater negative content was 
hypothesized to predict greater inflammation. Again, Giletta and colleagues similarly found that 
negative cognitive style was marginally associated with decreases in IL-1β after the TSST. 
Future research is needed to examine whether some types of negative cognitive content result in 
faster habituation to the TSST.  
Tightly connected negative social and achievement cognitive organization were 
hypothesized to predict inflammation. Consistent with predictions, findings indicated that 
individuals with tightly connected negative achievement organization demonstrated greater 
baseline inflammation. Individuals with highly consolidated negative achievement schemas view 
themselves in terms of being incompetent, lazy, stupid, or a failure, and these beliefs are closely 
intertwined as a network. Given that the majority of participants were employed or were 
students, achievement schemas may have been particularly relevant to a large proportion of the 
sample. Negative achievement schemas also may be primed more regularly than negative social 
schemas in the context of daily life as a student or in the workforce. Regular priming and 
activation of these schemas may have resulted in the CTRA being activated more readily and 
regularly, leading to a chronic pro-inflammatory phenotype.  
Conversely, and in contrast to hypotheses, more loosely interconnected negative social 
organization was associated with increases in acute inflammation following the stressor. In order 
to obtain a negative social organization score, participants had to endorse at least two negative 
adjectives as self-descriptive on that scale of the PDST. As noted above, individuals who did not 
obtain a score on a scale of the PDST were the least vulnerable in the sample in terms of 
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cognitive organization. Conversely, those with more loosely connected negative schema 
structure did endorse negative adjectives as self-relevant, indicating some degree of cognitive 
vulnerability. Similar to the findings reported under Hypothesis 4, individuals with more loosely 
connected schemas may have experienced expectancy violations during the TSST, whereas those 
with more tightly interconnected social schemas may have been more likely to expect the 
evaluators in the TSST to be aloof. Incongruity between interpersonal feedback on the TSST and 
expectancies based on a more dispersed negative social self-schema organization may also have 
resulted in a sense of cognitive dissonance. This violation of expectations and dissonance was 
likely accompanied by priming of their existing negative schema structure. Together, this may 
have resulted in the TSST being perceived as more threatening, (making it more 
immunologically activating), than it was for individuals with consolidated social schemas, who 
are more likely to expect social contexts to be unpleasant and challenging. As well, the finding 
that social schemas were more relevant than achievement schemas for acute immunological 
responding conceptually fits with Social Signal Transduction Theory (Slavich & Irwin, 2014; 
Slavich & Sacher, 2019) in that social schemas are more pertinent to judging the degree of threat 
posed by a social encounter (such as the TSST). 
Finally, a lower tendency to ruminate was associated with greater stress-induced 
increases in cytokines. This is in direct contrast to the hypothesis that individuals who engage in 
prolonged negative thinking would be more likely to have a chronically activated inflammatory 
state and greater reactivity to the stressor. There are a number of viable explanations for this 
finding. Trait rumination is associated with greater cortisol reactivity or delayed cortisol 
recovery from social-evaluative stress (Zoccola & Dickerson, 2012). Given that cortisol has anti-
inflammatory effects, it is possible that heightened cortisol acted as a third variable in 
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downregulating cytokines following the stressor. Alternatively, it is possible that individuals who 
tend to engage in repetitive negative thinking may have anticipated the difficulty of the TSST 
and the unresponsive demeanor of the evaluators, resulting in greater habituation. Another 
possibility is that individuals may ruminate in an attempt to suppress more intense emotional 
responses (Liverant, Kamholz, Sloan, & Brown, 2010) which could potentially result in 
dampened biological responses to stress. For example, worry has been characterized as a 
cognitive strategy for suppressing negative affect, aversive imagery, and somatic arousal 
(Borkovec, Ray, & Stöber, 1998), and is similar to rumination in that they both involve repetitive 
negative thinking. Given that trait rumination was assessed rather than individuals’ engagement 
in state rumination during and after the TSST, it is unclear to what degree stress-reactive, state 
rumination influenced immune responding. Future research should examine this by 
experimentally manipulating use of rumination, as well as other emotion regulation strategies, 
following stress.  
Hypothesis 9 and 10: Moderation of Cognitive Content, Cognitive Structure, and 
Rumination with Cognitive Control on Inflammation 
This study was the first to examine the novel hypothesis that cognitive content, structure, 
and rumination would interact with cognitive control to predict inflammation. See Table 24 for a 
summary of findings. A fairly consistent pattern emerged whereby greater baseline or stress-
induced changes in inflammation were associated with poor cognitive control among individuals 
with low cognitive vulnerability, whereas those with high cognitive vulnerability tended to 
evince high pre-stress inflammation and dampened immunological reactivity to stress regardless 
of their cognitive control abilities. This is in contrast to the hypothesis that poor cognitive control 
abilities combined with greater cognitive vulnerability would result in the greatest inflammation. 
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Table 24  
 
Summary of Findings for Significant and Marginally Significant Interactions of Cognitive Vulnerability with Cognitive Control on 
Baseline or Stress-Induced Inflammation 
 
Cognitive 
Control Task 
Cognitive 
Vulnerability 
Mediator 
Outcome Variable Level of 
Significance 
Interpretation 
Emotional 
Stroop 
Rumination Pre-stress 
Inflammation 
<.10 Greater reaction times were associated with greater baseline 
inflammation for individuals with low, and not high, trait 
rumination. 
Positive 
Affective 
Switch Costs 
Rumination Pre-stress 
Inflammation 
<.05 Positive affective switch costs were associated with greater 
baseline inflammation for individuals with high trait 
rumination, and with lower baseline inflammation for 
individuals with low trait rumination. 
Positive 
Affective 
Switch Costs 
Rumination Change in 
Inflammation 
<.05 Positive affective switch costs were associated with greater 
increases in inflammation for individuals with low, and not 
high, trait rumination. 
Positive 
Affective 
Switch Costs 
Negative 
Social 
Organization 
Change in 
Inflammation 
<.05 Positive affective switch costs were associated with greater 
increases in inflammation for individuals with loosely 
interconnected, and not tightly interconnected, schemas. 
Positive 
Affective 
Switch Costs 
Negative 
Achievement 
Organization 
Change in 
Inflammation 
<.05 Positive affective switch costs were associated with greater 
increases in inflammation for individuals with loosely 
interconnected, and not tightly interconnected, schemas. 
Negative 
Affective 
Switch Costs 
Negative 
Social 
Organization 
Change in 
Inflammation 
<.05 Negative affective switch costs were associated with greater 
increases in inflammation for individuals with loosely 
interconnected, and not tightly interconnected, schemas. 
Negative 
Affective 
Switch Costs 
Negative 
Achievement 
Organization 
Change in 
Inflammation 
<.10 Negative affective switch costs were associated with greater 
increases in inflammation for individuals with loosely 
interconnected, and not tightly interconnected, schemas. 
Positive 
Nonaffective 
Switch Costs 
Dysfunctional 
Attitudes 
Pre-stress 
Inflammation 
<.10 Positive nonaffective switch costs were associated with 
greater baseline inflammation for individuals with high 
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dysfunctional attitudes, and with lower baseline inflammation 
for individuals with low dysfunctional attitudes. 
Positive 
Nonaffective 
Switch Costs 
Dysfunctional 
Attitudes 
Change in 
Inflammation 
<.05 Positive nonaffective switch costs were associated with 
greater increases in inflammation for individuals with high 
dysfunctional attitudes, and with decreases in inflammation 
for individuals with low dysfunctional attitudes. 
Positive 
Nonaffective 
Switch Costs 
Negative 
Achievement 
Organization 
Pre-stress 
Inflammation 
<.10 Positive nonaffective switch costs were associated with 
greater baseline inflammation for individuals with tightly 
interconnected schemas, and with lower baseline 
inflammation for individuals with loosely interconnected 
schemas. 
Negative 
Nonaffective 
Switch Costs 
Rumination Pre-stress 
Inflammation 
<.10 Negative nonaffective switch costs were associated with 
greater baseline inflammation in individuals with high trait 
rumination, and with lower baseline inflammation for 
individuals with low trait rumination.  
Pre-stress N-
back 
Negative 
Social 
Organization 
Change in 
Inflammation 
<.05 Baseline N-back errors were related to greater increases in 
inflammation for individuals with tightly interconnected, and 
not loosely interconnected, schemas.  
Post-stress N-
back 
Core beliefs Pre-stress 
Inflammation 
<.10 Post-stress N-back errors were associated with greater 
baseline inflammation in individuals with low, and not high, 
maladaptive core beliefs 
Post-stress N-
back 
Dysfunctional 
Attitudes 
Pre-stress 
Inflammation 
<.05 Post-stress N-back errors were associated with greater 
baseline inflammation in individuals with low, and not high, 
dysfunctional attitudes. 
Post-stress N-
back 
Dysfunctional 
Attitudes 
Change in 
Inflammation 
<.10 Post-stress N-back errors were associated with increases in 
inflammation for individuals with low, but not high, 
dysfunctional attitudes. 
Post-stress N-
back 
Rumination Pre-stress 
Inflammation 
<.05 Post-stress N-back errors were associated with greater 
baseline inflammation in individuals with low, but not high, 
trait rumination. 
Post-stress N-
back 
Negative 
Social 
Organization 
Pre-stress 
Inflammation 
<.05 Post-stress N-back errors were associated with greater 
baseline inflammation for individuals with loosely 
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interconnected schemas, and lower baseline inflammation for 
those with tightly interconnected schemas. 
Post-stress N-
back 
Negative 
Achievement 
Organization 
Pre-stress 
Inflammation 
<.05 Post-stress N-back errors were associated with greater 
baseline inflammation for individuals with loosely 
interconnected schemas, and lower inflammation for those 
with tightly interconnected schemas. 
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Greater negative content, more consolidated negative cognitive structure, or a greater tendency to 
ruminate were expected to render more cognitive content accessible to working memory, thereby 
overwhelming already poor cognitive control abilities.  
Inhibition. A marginal interaction of rumination with reaction times on the Emotional 
Stroop was observed. Among individuals with low trait rumination, resting-state inflammation 
increased alongside longer reaction times (i.e., poorer inhibitory abilities) on the Stroop. These 
individuals appeared to benefit the most from high inhibitory abilities in terms of lower baseline 
inflammation. In contrast, inhibitory abilities did not appear to influence baseline cytokines 
among individuals with high rumination. This finding suggests that individuals with low 
rumination may have greater capacity to benefit from inhibitory abilities, at least in terms of 
immune system activation. In contrast, those who ruminate may continue to repetitively brood 
about negative information regardless of their ability to inhibit it, thereby counteracting any 
benefits of greater cognitive control ability on cytokine levels.  
Shifting. Positive Affective Switch Costs. The association of positive affective switch 
costs with inflammation was moderated by a number of forms of cognitive vulnerability. First, 
positive affective switch costs interacted with rumination in the prediction of pre-stress 
inflammation. As hypothesized, among those with high levels of rumination, greater positive 
affective switch costs were associated with higher baseline cytokines. That is, individuals with 
greater difficulty switching away from nonaffective information to process positive affective 
information showed greater resting-state inflammation when they also had a tendency to 
ruminate. This suggests that the focus these individuals place on negative information (resulting 
from the combination of poor shifting and rumination) may contribute to the development of a 
pro-inflammatory baseline state. In direct contrast, greater positive affective switch costs were 
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associated with lower inflammation amongst individuals with a low tendency to ruminate. This 
finding was unexpected, and it is difficult to explain why individuals with low trait rumination 
would benefit from inflexibility in shifting to positive affective information. Future work is 
needed to disentangle the differential impacts of positive affective switch costs on emotion 
regulation and daily functioning amongst individuals with varying levels of vulnerability.   
Rumination, negative social schema organization, and negative achievement organization 
all interacted with positive affective switch costs to predict acute immune responses to the 
laboratory stressor. A consistent pattern of findings emerged whereby individuals with high 
vulnerability evinced no changes or small decreases in cytokines after the stressor, suggesting 
habituation, regardless of their shifting ability. This indicates that more vulnerable individuals 
evince dampened reactivity regardless of their positive affective switching ability. These 
individuals may have anticipated a socially difficult interaction given their prior experiences or 
expectations, leading to faster habituation. Other possible reasons for this finding are discussed 
in the Summary of Moderating Effects below. Individuals low in vulnerability (i.e., low 
rumination, loosely connected negative social schemas, loosely connected negative achievement 
schemas) demonstrated the hypothesized relation of cognitive control with inflammation, such 
that as positive affective switch costs increased (indicating worse cognitive control), so did post-
stress cytokines. For these less vulnerable individuals, poor switching appears to have resulted in 
greater cytokine reactivity, likely due to poor self-regulation resulting from limited cognitive 
control ability.  
Negative Affective Switch Costs. Negative social and achievement cognitive organization 
interacted with negative affective switch costs on post-stress changes in cytokines. Similar to 
findings for positive affective switch costs, individuals with tightly interconnected negative 
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social organization evinced slight decreases in cytokines after the stressor, indicating habituation 
to the TSST, regardless of their negative affective switch abilities. In contrast, among those with 
loosely interconnected negative social schemas, greater negative affective switch costs were 
associated with greater post-stress increases in cytokines. Furthermore, although the interaction 
only approached significance for negative achievement schemas, the same pattern was found 
again in that individuals with tightly connected negative achievement organization showed 
dampened reactivity to the TSST, and greater negative affective switch costs were associated 
with greater stress-induced increases in inflammation among individuals with dispersed 
achievement schemas. 
Positive Nonaffective Switch Costs. Dysfunctional attitudes marginally interacted with 
positive nonaffective switch costs on baseline inflammation, and significantly interacted with 
positive nonaffective switch costs on post-stress changes in inflammation. For both interactions, 
the opposite trend was found in individuals with high versus low dysfunctional attitudes. 
Individuals with low dysfunctional attitudes tended to show greater inflammation (including both 
pre-stress and post-stress changes in cytokines) as switch costs decreased. Past research has 
found benefits for positive nonaffective switch costs in terms of greater appraisal abilities and 
reduced state rumination (Genet et al., 2013; Malooly et al., 2013). Therefore, this finding is 
consistent with those reported above in terms of individuals with lower vulnerability tending to 
show greater inflammation when their cognitive control abilities are poor, or in this case, when 
cognitive control abilities are potentially disadvantageous to emotion regulation. Individuals with 
high dysfunctional attitudes showed the opposite pattern. It is possible that any cognitive 
inflexibility may be problematic for people with high vulnerability, including inflexibility in 
switching away from positive affective information. This may be particularly true for individuals 
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with high dysfunctional attitudes, as positive information may be connected to their rigid 
assumptions about social approval, achievement, and happiness. 
Negative achievement cognitive organization also marginally interacted with positive 
nonaffective switch costs on baseline inflammation. Similar to the findings for dysfunctional 
attitudes, individuals with more tightly connected negative achievement schemas tended to show 
greater resting-state inflammation alongside greater switching abilities, likely due to any 
inflexibility being maladaptive for them. In contrast, those with loosely connected negative 
achievement schemas showed a trend whereby greater positive nonaffective switch costs (which 
may support emotion regulation) tended to be associated with lower inflammation.  
Negative Nonaffective Switch Costs. Only rumination marginally interacted with 
negative nonaffective switch costs on baseline inflammation. There was a trend whereby greater 
switch costs were associated with greater pre-stress inflammation among individuals with high 
trait rumination. However, individuals with low levels of rumination showed lower inflammation 
alongside greater negative nonaffective switch costs. This pattern is similar to the findings for 
the interaction of rumination with positive switch costs on baseline inflammation. Again, it 
appears that poor switching combined with greater rumination is associated with a pro-
inflammatory state in those with high rumination, consistent with hypotheses. In contrast, those 
with low rumination showed lower resting-state inflammation when they also demonstrated poor 
switch costs. It is possible that among those with low trait rumination, difficulty switching from 
negative affective information allows them to better process negative stimuli that may be 
important for adaptive functioning, allowing them to maintain lower levels of inflammation. This 
interpretation is speculative, however, and further research is necessary to explore the differential 
impacts of switching ability.  
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Updating. Pre-stress N-back Errors. Only negative social organization interacted with 
pre-stress N-back errors to predict changes in inflammation. Although those individuals with 
more loosely connected negative social organization showed greater inflammatory reactivity 
overall, baseline updating did not have an impact on their immune responses to the TSST. There 
was a trend indicating that, among those more tightly connected negative social organization, 
poorer updating ability at baseline (i.e., pre-stress N-back errors) was related to greater acute 
inflammatory responses. This result is consistent with hypotheses that poor cognitive control, 
particularly in combination with greater vulnerability, would predict greater inflammatory 
reactivity.   
Post-stress N-back Errors. A number of cognitive vulnerability factors interacted with 
stress-induced changes in updating abilities on baseline inflammation. The same pattern of 
findings was evident for core beliefs, dysfunctional attitudes, and rumination. In each case, 
individuals with high vulnerability showed low to average baseline inflammation, regardless of 
updating ability. In contrast, among individuals with low vulnerability (i.e., low maladaptive 
core beliefs, low dysfunctional attitudes, low tendency to ruminate), declines in post-stress 
updating ability were associated with higher baseline inflammation, and enhanced post-stress 
updating ability was associated with lower resting-state inflammation. This was found at trend 
level for core beliefs and rumination, and was significant for dysfunctional attitudes. Altogether, 
these findings suggest that individuals low in maladaptive core beliefs, dysfunctional attitudes, 
and rumination benefit from good updating abilities under stress in terms of maintaining lower 
resting-state inflammation. This may indicate that their CTRA is activated less often. However, 
declines in updating ability under stress were related to a pro-inflammatory state, possibly due to 
difficulty responding to stressors over time gradually leading to overall upregulation in 
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cytokines. In contrast, individuals with higher cognitive vulnerability (i.e., greater maladaptive 
core beliefs, dysfunctional attitudes, and tendency to ruminate) showed average to low baseline 
inflammation regardless of their updating abilities. This finding suggests that, in contrast to 
hypotheses, updating abilities under stress may have limited influence on baseline inflammation 
in those with higher vulnerability. For these individuals, updating abilities under stress may not 
have an impact on their resting-state inflammation in part because their habitual patterns of 
negative thinking may overshadow any potential benefits of cognitive control. 
A similar finding was revealed for the marginal moderating effect of dysfunctional 
attitudes with post-stress updating on changes in inflammation. Individuals with high 
dysfunctional attitudes showed no post-stress changes in cytokines, denoting habituation to the 
TSST, regardless of updating abilities. In contrast, greater post-stress updating errors were 
associated with increases in cytokines after stress among those with low dysfunctional attitudes. 
Negative social and negative achievement organization also interacted with post-stress 
updating abilities on baseline inflammation. In both cases, greater post-stress updating errors 
tended to be associated with more cytokines at baseline among individuals with lower 
vulnerability (those with more loosely connected cognitive structure), consistent with other 
findings. In contrast, those with more tightly connected negative social and achievement schemas 
showed the opposite pattern. One possible interpretation is that individuals with tightly 
interconnected negative cognitive structure may benefit from declines in updating abilities under 
stress. Poor updating may result in less negative information from their current stressful context 
entering working memory, which, given how negative their thinking is, may be beneficial in 
terms of how frequently their CTRA is activated over time.   
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It is interesting that stress-induced changes in updating appear to be more relevant to 
resting-state inflammation than to acute inflammatory reactivity. Findings suggest that updating 
abilities following acute stress may not have a major influence on acute reactivity to that 
particular stressor, except in the case of individuals with low dysfunctional attitudes. Conversely, 
changes in updating abilities following stress appear to be more influential in shaping resting 
state cytokines among those with lower cognitive vulnerability. Habitual patterns of cognitive 
control under stress may therefore influence an inflammatory phenotype more gradually over 
time. 
Summary of moderating effects. Altogether, there was evidence for moderating effects 
of cognitive vulnerability on the association of cognitive control with inflammation. A fairly 
consistent pattern of findings indicated that cytokine levels are influenced by cognitive control 
abilities among individuals with lower vulnerability, whereby resting state cytokines or stress-
induced changes in cytokines increased with poorer cognitive control. In the case of positive 
nonaffective switch costs, greater switch costs were associated with decreased inflammation, 
which was unsurprising given evidence that positive nonaffective switch costs facilitate emotion 
regulation. This set of findings suggests that poor cognitive control results in greater 
immunological reactivity to a stressor or to greater resting state inflammation, likely 
characterized by a more chronically activated pro-inflammatory state, among those with lower 
cognitive vulnerability. Poor cognitive control may result in greater inflammation as a result of 
reduced capacity for emotion regulation, leading to enhanced stress reactivity. As noted above, it 
is also possible that inflammation may contribute to lower cognitive control abilities as a result 
of SNS and HPA axis activation.  
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In contrast, cognitive control was not associated with differences in baseline or stress-
induced changes in inflammation among individuals with higher vulnerability, who tended to 
have average to high baseline inflammation and dampened reactivity to stress. There are a 
number of potential reasons for reduced influence of cognitive control on cytokines and 
dampened acute immune responding in these more vulnerable individuals. Given that these 
cognitively vulnerable individuals already exhibited negative thinking, for example, they may 
have anticipated the interpersonally aversive nature of the TSST, resulting in faster habituation 
regardless of cognitive control ability. The TSST may have been less discrepant with their views 
of themselves and others as compared to less vulnerable individuals, leading to lower cognitive 
dissonance. Moreover, the TSST may have validated these individuals’ maladaptive self-relevant 
cognitions, resulting in greater comfort with the experience compared to those with more 
adaptive thinking. This explanation is consistent with Self-verification Theory (Swann, 1983; 
Swann, Stein-Seroussie, & Giesler, 1992), which posits that individuals prefer to receive 
feedback that is consistent with their self-concept. Another possibility is that the immune states 
of vulnerable individuals were less influenced by cognitive control due to learned helplessness 
(Seligman, 1972). Learned helplessness, or an unwillingness to attempt to avoid aversive stimuli 
resulting from repeated exposure to uncontrollable stressors, may reduce engagement of 
cognitive control abilities under duress, resulting in reduced impact of cognitive control on 
inflammation. Learned helplessness may have also dampened individuals’ immunological 
reactivity to the stressor. A similar interpretation is based on Selye’s (1936) general adaptation 
syndrome, whereby after an initial stressor, organisms first enter an alarm phase (activation of 
the autonomic nervous system), followed by a resistance phase (activation of the 
parasympathetic nervous system while the organism remains alert), and after chronic or recurrent 
161 
 
stress, the exhaustion stage (depletion of resources). It is possible that individuals with low 
vulnerability may have exhibited immune activation consistent with the alarm and resistance 
phases, whereas those with higher vulnerability exhibited exhaustion. Finally, another possibility 
is that individuals with greater vulnerability may have exhibited excessive cortisol responses, 
which, given the anti-inflammatory effects of glucocorticoids, could have downregulated 
cytokines. Slavich and Irwin (2014) suggested that over time, a chronically activated immune 
state may result in glucocorticoid desensitization, thereby allowing glucocorticoids and cytokines 
to be upregulated simultaneously. However, as noted above, exclusion of individuals with 
medical conditions in the current study may have precluded assessment of those most likely to be 
characterized by significant problems with a pro-inflammatory phenotype and concomitant 
glucocorticoid desensitization, in whom upregulation of both cytokines and cortisol may be 
expected. As cortisol was not assessed in the current study, it is unclear to what extent it may 
have influenced the observed pattern of interactions, and future research is needed to explore its 
role.  
There were some exceptions to the general pattern of moderating effects. These emerged 
for the interaction of rumination with positive affective and negative nonaffective shifting on 
baseline inflammation, the interaction of pre-stress updating with negative social schemas on 
changes in inflammation, and the interaction of post-stress updating with negative social and 
achievement schemas on baseline inflammation. It is unclear why the general pattern of findings 
differed for the interactions of rumination with some types of shifting, and for negative schemas 
with updating. Furthermore, it is uncertain why particular cognitive vulnerabilities interacted 
with some types of cognitive control and not others. It is possible that some vulnerabilities are 
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more or less disruptive to specific types of cognitive control, although this is an empirical 
question that requires further investigation.  
Hypothesis 11: Predicting Depressive Symptoms at Follow-up by Pre-stress and Stress-
Induced Changes in Inflammation 
Surprisingly, dampened reactivity to the laboratory stressor was associated with increases 
in depression six months later. The CTRA is an evolutionarily adaptive response, and it is 
frequent or persistent activation of the CTRA rather than a single acute response that is 
depressogenic. It is possible that in the current sample, reactivity to a single acute stressor 
represented an adaptive response that may have been somewhat exaggerated in a subset of 
participants with poor cognitive control and/or particular cognitive vulnerabilities. On the other 
hand, dampened reactivity may have belied greater cortisol responses, or some of the deleterious 
processes described above (e.g., habituation, learned helplessness, exhaustion). Studies 
examining other indices of immunological responding, including endotoxin-stimulated 
production of cytokines and white blood cell sensitivity to glucocorticoids, as well as 
longitudinal studies examining the relation of acute inflammatory responses to stress with 
depression over time, would further inform processes underlying this finding.  
Strengths and Limitations  
This study has a number of notable strengths and methodological features that bolster 
conclusions drawn from these findings. First, a clinical sample was recruited from the 
community, and diagnoses were made using the SCID-5, the gold-standard semi-structured 
diagnostic interview. This procedure allowed for comparisons to be made among diagnostic 
groups, and for differences in cognitive control abilities and inflammation in the symptomatic 
versus remitted phases of depression to be explored. Use of a clinical sample also allowed for 
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extensions of past research that have examined cognitive control and/or inflammation in 
nonclinical populations, thereby increasing the clinical relevance and generalizability of findings 
to those with diagnosed depression. Second, the sample size was determined using an a priori 
power analysis and was considerably larger than most studies of cognitive control or 
psychoneuroimmunology, particularly amongst those using clinical samples. A large sample 
enhances reliability and increases the likelihood that findings are replicable as compared to past 
research using smaller samples. 
Furthermore, the current study used a comprehensive strategy to evaluate cognition. To 
assess cognitive vulnerability, a multi-method, multi-trait approach was used to assess both 
cognitive content, using two self-report questionnaires, and cognitive structure, using a task-
based measure of both achievement and social schemas. Examining moderating effects of 
various measures of cognitive vulnerability with cognitive control on inflammation revealed 
similar patterns of findings using both measurement approaches, further supporting the 
replicability and validity of findings. In a similar vein, this study was among the first to use a 
comprehensive battery of cognitive control measures to assess inhibition, shifting, and updating 
abilities among a single sample of clinically depressed and remitted depressed individuals. 
Updating was assessed both at baseline and after the stressor, which was manipulated using a 
highly controlled, well-validated social-evaluative stressor. This methodology allowed for an 
examination of both trait updating and stress-induced changes. Together, this comprehensive 
assessment of multiple facets of cognitive control facilitated a more nuanced investigation of 
depression-related cognitive control deficits. This procedure also allowed for an investigation of 
the specificity of various types of cognitive control in shaping baseline and/or stress-induced 
changes in cytokines.  
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Optimal methods for saliva collection, storage, and assays were used in the present study, 
effectively reducing the impact of potential confounds and enhancing the quality of cytokine 
data. Participants, who were screened for medical conditions or medications that could influence 
their inflammation, received detailed instructions on preparation for saliva collection in order to 
reduce the impact of behaviours known to influence cytokine levels or sample quality (e.g., 
eating or drinking before the appointment). Saliva was collected using the passive drool method. 
Passive drool is the gold standard method for saliva collection as it avoids collecting only 
localized secretions from specific salivary glands, resulting in a more consistent specimen. It also 
avoids compromising samples with the use of absorbent materials, as with other collection 
methods. Protease inhibitor was added to samples before freezing to minimize breakdown of 
cytokines, and saliva was assayed in duplicate to ensure reliability using the highest sensitivity 
multiplex assay optimized for saliva available.  
The present study also used sophisticated statistical methods for assessing and analyzing 
both baseline and stress-induced changes in cytokines using latent change score models. These 
structural equation models reduce the influence of measurement error, which is particularly 
important when multiple time points are used to assess change. By creating latent factors to 
represent an inflammatory phenotype, models are more robust and reliable than an independent 
analysis of each cytokine. Moreover, and in contrast to more traditional statistical methods (e.g., 
repeated measures ANOVA), latent change score models allowed for ‘baseline-free’ change to 
be assessed. This means that changes in cytokines take participants’ initial cytokine levels into 
account (which likely have an impact on the degree of stress-induced change observed; Giletta et 
al., 2017). Given that baseline inflammation and stress-induced inflammation showed different 
relations with cognitive vulnerability, cognitive control, and subsequent depression, they likely 
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represent different constructs that are regulated by different cognitive (and very likely biological) 
processes. It is important that future research attends to both of these indices of inflammation 
using appropriate analytic techniques. Finally, the study also included a longitudinal component 
as two-week and six-month follow-up data were collected on depressive symptoms, allowing for 
the longer-term impact of inflammation on depressive symptoms to be assessed.  
The current findings should also be interpreted, however, in the context of this study’s 
limitations. First, the large number of interactions tested may have increased the Type I error 
rate. After a family-wise Bonferroni correction was conducted for each type of cognitive control, 
only 45% of previously statistically significant interactions remained significant. However, it is 
important to note that although a large number of tests were conducted, these were based on a 
priori hypotheses. Moreover, a number of the moderation effects evinced the same or similar 
pattern, resulting in replication within the same sample. Additionally, it is possible that some of 
the interactions, particularly those that were marginally significant, were underpowered. 
However, marginally significant findings were still interpreted given that categorical rejection of 
the alternative hypothesis when the effect is consistent with other findings could lead to Type II 
errors, and introduce confusion to the literature. Importantly, confidence intervals are reported in 
both tables and figures, which provide an indication of the degree of precision of the parameter 
estimates within the current sample.  
As noted above, participants were thoroughly screened for medical eligibility, and while 
this reduced the number of potential confounding factors, it also limits the generalizability of 
findings to relatively physically healthy individuals. Moreover, this study assessed inflammation 
using saliva, and while salivary cytokines are a valid indicator of inflammation that allow for 
assessment of rapid responses to stress (Slavish et al., 2015), blood is the gold standard measure 
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of peripheral inflammation. Furthermore, saliva was collected at only one time point post-
stressor, which precluded an examination of recovery from the stressor.  
Several limitations related to the assessment of cognitive variables are noted. Individuals 
did not receive a mood prime before assessment of cognitive vulnerability variables (i.e., core 
beliefs, dysfunctional attitudes, cognitive organization). Although research has found these 
measures to be valid without the use of mood primes (see Rnic & Dozois, 2017, for review), it is 
possible that some individuals, particularly those in the remitted depressed group, may have 
underreported dormant cognitive vulnerabilities. Furthermore, this study did not examine 
updating and shifting abilities using neutral stimuli, which precluded determining whether 
individuals with poor cognitive control demonstrated biases for affective stimuli as opposed to 
more general deficits. Although the Emotional Stroop did include a neutral block, interference 
scores could not be calculated. Interference scores are computed by subtracting reaction times for 
neutral stimuli from reaction times for emotional stimuli. This produces an outcome score that is 
indicative of interference on the task specifically resulting from difficulty inhibiting the affective 
aspects of stimuli, as general performance when stimuli are not emotional is accounted for in the 
score. However, in the current study, practice effects were evident on the emotional block, which 
precluded a direct comparison of performance on the emotional block to the neutral block. 
Future research should employ a multi-block version of the Stroop task that alternates emotional 
and neutral blocks so that both are equally impacted by practice effects, which would better 
allow for interference scores to be computed. Additionally, since the study employed emotional 
stimuli in cognitive control tasks, it is possible that these may have elicited a stress response in 
some individuals (e.g., cognitive activation). Although the timing and ordering of tasks was kept 
constant across participants, it is possible that some individuals may have begun to upregulate 
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cytokines before the TSST as a result of viewing emotional stimuli. This may be another 
explanation for habituation to the TSST that was observed in more cognitively vulnerable 
individuals.  
Finally, the groups of individuals with current or remitted depression were comprised of a 
greater proportion of women than the control group. To an extent, this difference likely reflects 
higher base rates of depression among females (e.g., Kessler et al., 2003). Group differences in 
the proportion of males and females was mitigated against by statistically controlling for sex in 
analyses. Where including sex as a covariate did not alter the pattern of findings, more 
parsimonious models were presented. Additionally, while not significant, there appeared to be a 
greater proportion of Asian participants in the control group and relatively fewer in the currently 
depressed group. There is a possibility that this difference may have arisen in part due to cultural 
differences in depression self-stigma (Shamblaw, Botha, & Dozois, 2015). As there was no prior 
theoretical or empirical basis to expect ethnicity to relate to cognitive control, it was not included 
as a covariate in analyses examining cognitive control as an outcome variable. However, given 
that ethnicity is an important covariate of inflammation, all models examining cytokines 
included ethnicity. Differences in proportions of female or Asian participants across diagnostic 
groups may also reflect bias in scope and response to recruitment methods, and further research 
is needed that better stratifies diagnostic groups by major demographic differences.  
Theoretical and Clinical Implications 
The current results have key implications for cognitive and psychoneuroimmunological 
theories of depression. This study was among the first to comprehensively examine inhibition, 
updating, and shifting in a single clinical sample, and was the first to examine stress-induced 
updating deficits in currently and remitted depressed individuals. Deficits in inhibition and 
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updating of affective stimuli were found in the currently depressed group, corroborating findings 
of a number of past studies (e.g., Epp et al., 2012; Joormann & Gotlib, 2010; Levens & Gotlib, 
2010). This study also made a novel contribution to the literature by finding evidence for stress-
induced updating deficits in depressed individuals.  
Limited prior research has examined whether cognitive control deficits are apparent 
among remitted depressed individuals, and findings have been somewhat mixed. Evidence for 
inhibitory deficits in remitted depressed individuals was equivocal in the present study. Although 
their performance fell between the control and currently depressed groups, it was not 
significantly different from either group. This may indicate that more minor difficulties with 
inhibition may occur outside of the symptomatic phase of depression, which could explain why 
diagnostic group differences are not always detected. This study also contributes to the small 
body of research on updating in remitted individuals. Results suggest that individuals with 
remitted depression do not have difficulty with the continuous updating of negative information. 
While it is possible that cognitive control biases become latent vulnerabilities that need to be 
primed to be observed among individuals with remitted depression, the current study does not 
support this hypothesis as no evidence for post-stress updating deficits was found. Although 
dormant cognitive control biases cannot be ruled out for other forms of cognitive control, the 
current results indicate that updating deficits improve along with the remission of other 
symptoms following an active episode of depression.  
The current findings suggest that there are no diagnostic group differences in shifting, at 
least for task switches that are unpredictable. In contrast, past research has found evidence for 
deficits in mental set shifting or predictable task switching (e.g., De Lissnyder, Koster, Everaert, 
et al., 2012; Quigley, 2017). This study was the first to assess continuous and unpredictable task 
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switching, and, although requiring replication, suggests that shifting biases in depression may be 
more specific to particular types of shifting than previously thought.  
One pathway through which cognitive control biases are thought to increase risk for 
depression is by increasing the accessibility and processing of negative information. Difficulty 
inhibiting negative stimuli, discarding it from working memory, and shifting away from it allows 
negative material to enter and remain in working memory for prolonged periods, which is 
thought to lead to greater rumination. The process of rumination results in greater negative mood 
and eventually, a depressed state. The current study further supports theory and past research on 
the cognitive control deficit-rumination link as it found associations of trait rumination with 
deficits in inhibition, trait updating, and stress-induced updating deficits. Contrary to prior 
research, only one aspect of shifting was marginally associated with trait rumination, further 
underscoring key differences among different forms of shifting. 
Cognitive control deficits are thought to be particularly important during times of stress, 
when abilities are most needed to facilitate self-regulation. This study bridged research on 
cognitive control with the literature on cognitive vulnerability. This was accomplished by testing 
how core beliefs, dysfunctional attitudes, and cognitive organization influence an individuals’ 
updating abilities after stress, above and beyond the impact of diagnostic status or change in 
affect. Findings support cognitive theories that posit that stress activates networks of negative 
thoughts, memories, and beliefs, and that their increased accessibility in working memory impair 
cognitive control abilities when they are most needed.  
Findings from this study are among the first to demonstrate that cognitive control and 
cognitive vulnerability influence inflammatory processes. Results underscore the role that 
cognitive vulnerability, cognitive control, and the interaction of the two have on both resting-
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state inflammation and acute inflammatory responses to stress. Cognitive risk factors appear to 
represent a mechanism through which depression-prone individuals may develop a pro-
inflammatory phenotype and associated physical symptoms although, as noted above, 
inflammation may also influence cognitive control. It is possible that cognitive control and 
cognitive vulnerability may be implicated in neuroinflammatory sensitization. Longitudinal 
research is needed to examine bidirectional, possibly self-promoting, relations of cognition and 
inflammation. Results also highlight the need to investigate not only the relation of depression 
with inflammation, but also the relation of inflammation with underlying vulnerabilities to and 
endophenotypes of depression.  
Given evidence for specificity of effects of cognitive control and vulnerability on indices 
of inflammation, as well as different associations of inflammatory indices with later depression, 
baseline and stress-induced changes in inflammation appear to demark different immune 
processes. Furthermore, findings suggest that individuals with lower vulnerability may be most 
influenced by the pernicious effects of poor cognitive control abilities (or in the case of positive 
nonaffective switch costs, cognitive control abilities that are disadvantageous to self-regulation) 
on inflammation. This study also highlights that individuals with greater vulnerability are less 
influenced by cognitive control in terms of immune functioning and that, in some cases, may 
actually show greater habituation or reduced responses to a stressor. This pattern of findings 
underscore the need for further research to investigate the cognitive-immune system link and 
differences amongst individuals of greater or lesser cognitive vulnerability. The importance of 
assessing both resting-state cytokines and stress-induced changes in cytokines for dysregulation, 
rather than simply upregulation, is apparent. 
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Results from this study have important clinical implications. Findings indicate the key 
role cognitive vulnerability plays in shaping stress-induced declines in cognitive control, which 
is critical in shaping an individual’s immediate experience as well as their ability to engage 
emotion regulation skills. In turn, findings indicate that both cognitive control and vulnerability 
(including content, process, and structure) shape inflammation. Given increasing evidence that 
inflammation may be involved in depression pathogenesis, interventions that disrupt the 
mechanisms underlying dysregulated inflammation may be important for some cases of 
depression. Although not all cases of depression may be characterized by a pro-inflammatory 
phenotype, results of the current study documented influences of cognitive vulnerability and 
cognitive control on inflammation across a sample of non-clinical healthy controls, and in 
individuals with remitted and current depression, suggesting that treatments that disrupt the 
mechanisms underlying inflammation could potentially have mental or physical health benefits 
for a range of individuals.  
A variety of treatments may be beneficial in altering depressogenic cognitive and 
immunological processes highlighted by the current findings. These include both top-down and 
bottom-up treatments. Cognitive-behavioural therapy, a top-down treatment, targets negatively 
biased thinking, including content, rumination, and ultimately, schemas (Beck & Dozois, 2011). 
It is highly effective in treating symptoms, promoting remission, and reducing relapse (e.g., Beck 
& Dozois, 2014; Cuijpers et al., 2013). More realistic and adaptive thinking may reduce 
interference on cognitive control abilities, particularly during times of stress. Cognitive control 
training, which is a bottom-up intervention that trains individuals to better inhibit, update, or 
shift from negative goal-irrelevant information, may enable individuals to better self-regulate and 
to disengage from rumination. Few effectiveness or efficacy studies have been conducted on 
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cognitive control training, and, while some have reported promising findings, effects are only 
small to moderate (see Motter et al., 2015 and Koster, Hoorelbeke, Onraedt, Owens, & 
Derakshan, 2017, for reviews). This may be explained by the reduced impact that cognitive 
control appears to have on stress reactivity among cognitively vulnerable individuals (at least in 
terms of immune responding) found in the current study. As such, cognitive control training may 
be more beneficial for individuals with relatively lower cognitive vulnerability. More adaptive 
schemas and/or enhanced cognitive control may both have an impact on immune responding by 
altering perceptions of social threat and the individual’s appraisal of their ability to manage 
social threat, as well as their actual ability to self-regulate. Consistent with this idea, a few 
studies have begun to document promising effects of psychological treatments on immune 
functioning (e.g., Moreira et al., 2015; Zabihiyeganeh et al., 2019). Future research examining 
the role of top-down or bottom-up interventions on resting-state and stress-induced inflammation 
would provide robust tests of the cognition-inflammation link and the role inflammation plays in 
the course of depression. Given the role inflammation has on a number of medical conditions, 
this also represents an exciting area for future research examining the role of psychological 
treatment on physical health.  
Conclusion 
Cognitive theories posit that cognitive control deficits promote depression by reducing 
ability to self-regulate under stress (Joormann & Tanovic, 2015). In particular, poor ability to 
inhibit negative information, discard negative material, and shift away from negative content 
may result in rumination. In addition to extending past research findings on depression-related 
cognitive control deficits and their association with rumination, this study was the first to 
investigate the effect of cognitive content and structure on cognitive control following social-
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evaluative stress. When activated by stress and accessible to working memory, negative 
cognitive content and structure were found to interfere with cognitive control abilities, resulting 
in even greater declines in executive functioning when it is most needed.  
Burgeoning evidence indicates that social stress upregulates inflammation, resulting in a 
pro-inflammatory phenotype that drives depression pathogenesis. However, cognitive 
mechanisms underlying this process are not well understood. This study filled an important gap 
in the psychoneuroimmunology literature by demonstrating that cognitive vulnerability and 
cognitive control influence baseline inflammation and reactivity to a laboratory stressor. This 
thesis also contributed novel findings to the literature by providing evidence that individuals with 
low vulnerability combined with poor cognitive control tend to show higher resting-state and 
stress-induced increases in inflammatory reactivity. Individuals with greater vulnerability were 
less influenced by cognitive control and, in some cases, appeared to show less reactivity to the 
stressor. Lower reactivity to the stressor in turn predicted greater depressive symptoms six 
months later. Altogether, these results suggest complex relations between cognition and 
inflammation that are not uniform across individuals of varying vulnerability to depression. 
Given that cognitive vulnerability and cognitive control are amenable to intervention and 
modification, these findings have key implications for treatment and for possible alteration of 
immunological mechanisms underlying the pathogenesis of depression. The current study reveals 
inflammation as a pathway through which both cognitive vulnerability and cognitive control may 
shape mental and physical health among individuals both with and without depression over time.  
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Appendix B  
Online Form for Initial Eligibility Screening 
Welcome the Western Mood Study! 
 
The Western Mood Study is exploring how mood is related to thoughts, emotions, inflammation, 
and behaviour before and after life events in individuals who have, and have not, experienced 
depression. Because we are interested in inflammation, we need to ask individuals about medical 
conditions and medications that may influence levels of inflammation. 
 
Participating in this study involves 3 lab visits and two online components, and participants will 
be asked to complete questionnaires and interviews about thoughts, emotions, behaviours, life 
events, and mood, and to engage in cognitive tasks and a task designed to induce mild stress in 
the lab. Participants will also be asked to provide two saliva samples during one of the lab visits 
to assess inflammation. Participants will be compensated $20 for each component of the study 
they participate in. For individuals who participate in all the components, the total compensation 
will be $100. Participants will also be entered in a draw to win one of four iPads.  
 
Please complete this form to let us know that you are interested in participating in the study. 
Please note you must be 18 years or older and willing to be audio- and video-recorded to 
participate. After completing the form, you will be notified whether or not you are eligible. If 
you are, one of our research assistants will call you shortly for further eligibility screening and, if 
applicable, to arrange for you to begin the study. Completion of this screening survey is 
indication of your consent to complete screening and to be contacted by us by telephone for 
further screening for the study, and does not provide consent for study participation. 
 
 
Please indicate your age:  
 
Do you have a smartphone with a data plan or regular access to wifi? _____Yes  ______No 
 
Please indicate below if any of the following apply to you.  
 
you have a current injury, cut, wound, sore, or lesion in your mouth _____Yes  
______No 
you have bleeding gums _____Yes  ______No 
you have gum disease (i.e., periodontal disease, gingivitis) _____Yes  ______No 
you have had dental work in the past two weeks  _____Yes  ______No 
you have a chronic inflammatory disease such as, but not restricted to, arthritis, thyroid 
problems, chronic active hepatitis, chronic peptic ulcer, asthma, tuberculosis, ulcerative 
colitis, Crohn’s disease, or chronic sinusitis _____Yes  ______No 
you have cancer or any other neoplastic disease _____Yes  ______No 
you are currently undergoing chemotherapy or radiation therapy _____Yes  ______No 
you have undergone an organ transplant _____Yes  ______No 
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you are taking immunosuppressant or immunomodulator medication (such as but not 
restricted to, tacrolimus, azathioprine, mercaptopurine, methotrexate, cyclosporine, 
interferon _____Yes  ______No 
you are taking any Non-Steroidal Anti-Inflammatory drugs on a daily basis (NSAIDS 
such as, but not restricted to, naproxen, aspirin, or ibuprofen) _____Yes  ______No 
you are taking any oral steroid medication (such as, but not restricted to, prednisone, 
dexamethasone, hydrocortisone) _____Yes  ______No 
you are currently pregnant, trying to become pregnant, or breastfeeding _____Yes  
______No 
you have been diagnosed with a sleep disorder, such as, but not restricted to, insomnia, 
hypersomnia or  hypersomnolence disorder, sleep apnea, narcolepsy _____Yes  
______No 
you have an acute condition such as a cold, flu, tonsillitis, bronchitis, or sinus infection, 
or you have symptoms consistent with a cold or infection  (e.g., sore throat, runny nose, 
sweating, coughing) _____Yes  ______No 
Comments: 
 
*If participants are over 18, indicate they have a smartphone, and select NO for all medical 
items, excluding the fourth or last item* 
 
Thank you for completing the form. Please provide your contact information below and one of 
our research assistants will call you shortly for further eligibility screening and, if applicable, to 
arrange for you to begin the study.  
 
Name: 
Email: 
Phone Number: 
Can we leave a voicemail? _____Yes  ______No 
Comments: E.g., preferred time of day to be called  
 
If you have any questions or concerns, please do not hesitate to contact us by email at 
XXXXX@uwo.ca or at XXX-XXX-XXXX ext. XXXXX. Please note, the Principal Investigator 
for this study is Dr. David Dozois and the Co-Investigator is Katerina Rnic. Thank you. 
 
 
*If participants are under 18, do not have a smartphone, or select YES for any medical item, 
excluding the fourth or last item’*  
 
We are sorry, but based on your responses, you are not eligible to participate in the Western 
Mood Study. The Western Mood Study will be examining the role of inflammation in 
depression, so unfortunately we cannot include individuals who are taking medications or who 
have medical conditions that could affect our measurement of markers of inflammation. If you 
have any questions or concerns, please do not hesitate to contact us by email at 
XXXXX@uwo.ca or at XXX-XXX-XXXX ext. XXXXX. Please note, the Principal Investigator 
for this study is Dr. David Dozois and the Co-Investigator is Katerina Rnic. Thank you for your 
time, and we hope you will consider participating in future studies in the Mood Lab.  
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Appendix C 
  
Description of Larger Study 
The current study was part of a larger study conducted with the additional goals of 
assessing the relation of emotion regulation and stress generation with cognitive control and 
inflammation. At Phase 1, participants completed a number of additional measures not included 
in the present study. These were the negative urgency scale of the UPPS-P Impulsivity Scale 
(Whiteside & Lynam, 2001), the Stress Reactive Rumination Scale (SRRS; Robinson & Alloy, 
2003), the Cognitive-Behavioral Avoidance Scale (CBAS; Ottenbreit & Dobson, 2004), the 
Depressive Interpersonal Relationships Inventory-Reassurance Seeking Subscale (DIRI-RS; 
Joiner, Alfano, & Metalsky, 1992), and the Emotion Regulation Questionnaire (ERQ; Gross & 
John, 2003).  
Following the Phase 2 laboratory visit, participants completed one week of ecological 
momentary assessment. Participants received 4 texts per day on their smartphone. The text 
provided them with a link to an online form, which asked them to report on any negative life 
events that occurred since the last form they completed, and to report on their affect, use of 
emotion regulation strategies and maladaptive behaviours. This portion of the study used the 
modified Stress Reactive Rumination Scale as well as items from other ecological momentary 
assessment studies (Moberly & Watkins, 2008; Ruscio et al., 2015) or adapted from standard 
instruments.  
At Phase 3 (two weeks after Phase 2), participants completed an interview with the 
principal investigator (KR) in addition to completing the BDI-II. In the interview, participants 
were queried in order to obtain contextual detail on negative life events, hassles, and difficulties 
they had reported over the previous week, in order for these to be rated using the Life Events 
Scale criteria (Alloy & Clements, 1992; Safford, Alloy, Abramson, & Crossfield, 2007), which 
provides criteria and ratings for a broad range of negative events, including minor, daily hassles.  
 Finally, at Phase 4 (6 months after Phase 2), participants completed the mood module of 
the SCID-5 to ascertain patterns of relapse and recurrence, and the Life Events and Difficulties 
Schedule (LEDS-II Bifulco et al., 1989) interview in order to assess stress generation, in addition 
to completing the BDI-II again.  
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Appendix D  
Demographic and Health Questionnaire 
Age: ________ 
 
Biological Sex: ______ Male 
                  ______ Female 
                                     ______Intersex 
Ethnicity:  
______ African Canadian or Black 
______ First Nations or Native Canadian 
______ East Asian 
______ South Asian 
______ Hispanic or Latino 
______ Native Hawaiian or other Pacific Islander 
______ White or Caucasian 
______Mixed. Please specify:_____________ 
______Other. Please specify: __________________________ 
 
What is your current marital status? Please select the item that best describes your current  
a) single and never married 
b) living with partner 
c) common-law 
d) married 
e) separated 
f) widowed 
g) divorced 
 
How many years of education have you completed? Please count beginning at grade 1 
______ 
 
What level of education have you completed? 
1= less than 7th grade 
2= junior high school, 8th or 9th grade 
3=partial high school, 10th or 11th grade 
4= high school graduate 
5=partial college, at least one year of specialized training 
6= college or university graduation 
7=graduate/professional training 
 
What kind of work do you do? ________ 
 
Approximate total household income (from all sources) before taxes last year: 
-Less than $10,000 
-$10,000 - $24,999 
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-$25,000 - $49,999 
-$50,000 - $74,999 
-$75,000 - $99,999 
-$100,000 - $149,000 
-$150,000 - $199,999 
-$200,000 or more 
-Don’t know 
-Prefer not to answer 
 
Are you taking any hormonal contraceptives ? (Such as, but not restricted to, oral birth 
control pills, hormonal intrauterine device or IUD, birth control patch) 
 
______Yes. What kind? Please list the type of contraceptive (e.g., patch, pill, 
IUD, ring) and brand name _______ 
______No 
 
Are you receiving hormone replacement treatment or therapy?  ____Yes _____No 
 
About how long ago was your last menstrual period?  
a) having it now  
b) less than 2 months ago  
c) 2-12 months ago  
d) more than 12 months ago 
 
Please list all medications you are taking, including dosage and dosing 
frequency________________ 
 
Do you smoke cigarettes? _____Yes (about how many cigarettes did you smoke per 
day?_____) 
                                       _______No  
 If no:  Did you used to smoke cigarettes? ____Yes _____No 
  If yes: When did you quit? _____(MM/YYYY). About how many 
cigarettes did you    smoke per day?_________ 
 
Approximately how many ounces of alcohol (equivalent to 1 beer, 1 glass of wine, or 1 
shot of liquor) do you drink per week? _________ 
 
Are you receiving any therapy or counseling for a psychological problem? ____Yes 
_____No 
 
Have you ever received any therapy or counseling for a psychological problem?  
____Yes _____No  
208 
 
Appendix E  
Letter of Information 
Project Title:  Western Mood Study 
Document Title: Letter of Information and Consent - Time 1 
Principal Investigator:  
David Dozois, PhD, Psychology 
Western University 
Co-Investigator: 
Katerina, MSc, Psychology 
Western University 
 
1. Invitation to Participate 
You are invited to participate in a research study exploring how mood is related to 
thoughts, emotions, inflammation, and behaviour before and after life events, and 
because you met eligibility criteria for this study. This means that you are age 18 
and older, own a smartphone (smartphones are needed to complete part of the 
study), and are currently depressed, have been depressed in the past, or have never 
been depressed. Individuals with any of the health issues or conditions listed 
below are not eligible, as the presence of certain conditions or use of particular 
medications may affect the validity of our measurements of markers of 
inflammation. If any of the below apply to you, please click the ‘I am not eligible’ 
button below. If an item applies to you only temporarily, please inform us and we 
will arrange for you to begin the study once you are eligible. 
You are not eligible to participate at this time if you: 
• have bipolar disorder (manic-depression) 
• have ever experienced psychosis (severe impairment or distortion in the 
experience of reality) 
• have a current injury, cut, wound, sore, or lesion in your mouth 
• have bleeding gums 
• have gum disease (i.e., periodontal disease, gingivitis) 
• have had dental work in the past two weeks 
• have a chronic inflammatory disease such as, but not restricted to, arthritis, 
thyroid problems, chronic active hepatitis, chronic peptic ulcer, asthma, 
tuberculosis, ulcerative colitis, Crohn’s disease, or chronic sinusitis 
• have cancer or any other neoplastic disease 
• are currently undergoing chemotherapy or radiation therapy 
• have undergone an organ transplant  
• are taking immunosuppressant or immunomodulator medication (such as 
but not restricted to, tacrolimus, azathioprine, mercaptopurine, 
methotrexate, cyclosporine, interferon) 
• are taking any Non-Steroidal Anti-Inflammatory drugs(NSAIDS such as, 
but not restricted to, naproxen, ibuprofen, aspirin)  on a regular basis  or 
24 hours before the first laboratory appointment 
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• are taking any oral steroid medication (such as, but not restricted to, 
Prednisone, dexamethasone, hydrocortisone) 
• are currently pregnant, trying to become pregnant, or breastfeeding 
• have an acute condition such as a cold, flu, tonsillitis, bronchitis, or sinus 
infection, or you have symptoms consistent with a cold or infection  (sore 
throat, runny nose, sweating, coughing) 
 
2. Why is this study being done? 
 
The purpose of this study is to learn how thinking, emotions, inflammation and 
behaviours relate to each other before and after life events. This will help us to 
better understand the factors that are involved in the onset, recurrence and 
maintenance of depression, which is an area in need of further research.  
 
3. How long will you be in the study? 
It is expected that you will be in the study for 6 months, there will be two online 
components and 3 laboratory visits during your participation in this study. 
 
4. What are the study procedures? 
If you agree to participate you will be asked to complete a number of 
questionnaires about your mood, the types of thoughts you have, and your 
tendency to engage in different types of behaviours. This portion of the study will 
be completed online. It is anticipated that this portion of the study will involve a 
time commitment of two hours, after which you will be debriefed on this portion 
of the study. In the next part of the study, you will be asked to complete a number 
of tasks in the laboratory that assess different cognitive functions. You will also 
be asked to complete a task that will cause some temporary stress, which will be 
video-recorded and will allow us to examine how you react to stress and to 
measure markers of inflammation that are secreted during stress. You cannot 
participate if you do not agree to be video-recorded. Furthermore, over the course 
of this session, you will be asked to provide saliva samples and we will measure 
your height and weight. The laboratory portion of the study will take 
approximately 2 hours. We will then ask you to report on your daily experiences, 
including daily hassles, what you are feeling, thinking and doing, 4 times per day 
for a one week period. This is the experience sampling component of the study. 
Altogether, we expect participants will spend up to 2 hours and 20 minutes over 
the entire week answering questions.  A week later, you will be asked to return to 
the laboratory to answer questions in an interview about the life events you 
experienced over the week and to report on your mood in a questionnaire, which 
will take approximately 40 minutes. Finally, you will be asked to return to the 
laboratory in 6 months to report (in a questionnaire and an interview) on your 
mood and the life events you experienced since you started the study, and this 
visit will be approximately one hour long. Altogether, we anticipate the study to 
involve a total of 8 hours of your time. Please note that all interviews will be 
audio-recorded, and you cannot participate if you do not agree to be audio-
recorded. 
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5. What are the risks and harms of participating in this study? 
Although you may experience some mild discomfort when completing the 
questionnaires and/or tasks, this should be temporary. We recognize that you may 
be experiencing symptoms of depression; however, the tasks in this study have 
been previously used with individuals with varying levels of depression and have 
not been found to result in negative effects. Further, you will be provided with a 
debriefing form at the end of the session today that provides resources online, on 
campus, and in the community that you can use if you are distressed. 
 
6. What are the benefits? 
  You may not directly benefit from participating in this study, but information  
gathered may provide benefits to society as a whole which includes learning more 
about the course of depression and associated risk factors. 
 
7. Can participants choose to leave the study? 
Participation in this study is voluntary. You may refuse to participate, refuse to 
answer any questions, or withdraw from the study at any time with no effect on 
your academic status or relationship to the university or to your referral source if 
you were referred to the study. If you decide to withdraw from the study, you have 
the right to request withdrawal of information collected about you. If you wish to 
have your information removed please let the researcher know.  
 
8. How will participants’ information be kept confidential? 
All data collected will remain confidential. All identifiable information will be 
deleted from the dataset collected so that individual participants’ anonymity will 
be protected. The de-identified data will be accessible by the study investigators 
as well as the broader scientific community. More specifically, the data may be 
posted on a specific database or made available to other researchers upon 
publication so that data may be inspected and analyzed by other researchers. The 
 data that may be shared will not contain any information that can identify you. 
Data are stored by Western University Psychology Department’s secure server 
and all forms are stored in locked filing cabinets. If the results are published, your 
name will not be used. The researcher will keep any personal information about 
you in a secure and confidential location for a minimum of 5 years. A list linking 
your study number with your name will be kept by the researcher in a secure 
place, separate from your study file. While we do our best to protect your 
information there is no guarantee that we will be able to do so. If data is collected 
during the project which may be required to report by law we have a duty to 
report. Representatives of The University of Western Ontario Non-Medical 
Research Ethics Board may require access to your study-related records to 
monitor the conduct of the research. 
 
9. Are participants compensated to be in this study? 
 You will be compensated $20 for each component of the study you participate in.  
• Time 1: Online survey: $20 + 1 entry in iPad draw 
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• Time 2: First laboratory visit: $20 + 1 entry in iPad draw 
• Time 3: Experience Sampling: $20 + 1 entry in iPad draw 
• Time 4: Second laboratory visit: $20 + 1 entry in iPad draw 
• Time 5: Third laboratory visit: $20 + 1 entry in iPad draw 
• Bonus: If you completed 80% of the smartphone alerts within 30 minutes 
of receiving them for the Experience Sampling, or Time 3, component of 
the study: $20 + 1 entry in iPad draw 
Participants who participate in every component of the study will therefore 
receive a total of $100 over the course of the study and 5 entries in a draw to win 
one of 4 iPads, and those who participate in every component of the study and 
complete 80% of their smartphone alerts on time for the experience sampling 
component of the study will receive a total of $120 and 6 entries in the iPad draw 
over the course of the study. If you do not complete the entire study you will still 
be compensated for every portion of the study you completed or began. Please 
note that you will receive your compensation for Time 1 when you come to the 
lab for your first laboratory appointment.  
 
10. What are the rights of participants? 
Your participation in this study is voluntary. You may decide not to be in this 
study.  Even if you consent to participate you have the right to not answer 
individual questions or to withdraw from the study at any time.  If you choose not 
to participate or to leave the study at any time it will have no effect on your 
academic standing if you are a student at Western, your employment status if you 
work at Western, or your care if you were referred to the study by a care provider.  
We will give you new information that is learned during the study that might 
affect your decision to stay in the study.   
You do not waive any legal right by signing this consent form. 
 
11. Whom do participants contact for questions? 
If you have any questions about this research study please contact the Principal 
Investigator: Dr. David Dozois (XXX) XXX-XXXX ext. XXXXX, email: 
XXXXXXX@uwo.ca, or Katerina Rnic (XXX) XXX-XXXX ext. XXXXX, 
email: XXXXX@uwo.ca. 
 
If you have any questions about your rights as a research participant or the 
conduct of this study, you may contact The Office of Human Research Ethics 
(519) 661-3036, email: ethics@uwo.ca.  
 
12. Consent 
Completion of the survey is indication of your consent to participate in this 
portion of the study. 
 
 
Please print or save a copy of this letter for future reference 
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Note: Participants were presented with a letter of information at the start of each phase of the 
study. Other letters of information used in the study are available from the primary investigator: 
Katerina Rnic. 
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Appendix F  
Consent Form 
Project Title:  Western Mood Study 
Document Title: Letter of Information and Consent  
Principal Investigator:  
David Dozois, PhD, Psychology 
Western University 
Co-Investigator: 
Katerina, MSc, Psychology 
Western University 
 
I have read the Letter of Information, have had the nature of the study explained to me and I 
agree to participate. All questions have been answered to my satisfaction. 
 
 
 
_____________________ _________________  ________________  
Print Name of Participant  Signature   Date (DD-MM- YYYY) 
       
 
 
My signature means that I have explained the study to the participant named above. I have 
answered all questions. 
 
 
__________________  _________________  ________________ 
Print Name of Person   Signature    Date (DD-MM- YYYY) 
Obtaining Consent        
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Appendix G  
Debriefing Form 
 
Phase 2 
 
Project Title: Western Mood Study 
Principal Investigator:  
David Dozois, PhD, Psychology 
Western University 
Co-Investigator: 
Katerina, MSc, Psychology 
Western University 
 
Thank you for participating in this study. Research has shown that depression is associated with 
difficulty controlling what information an individual is attending to at a given moment (i.e., 
“cognitive control”; see Joorman & Tanovic, 2015). Furthermore, difficulty with cognitive 
control is associated with a greater inflammatory response following stress (Shields et al., 2016), 
such that the body releases small protein molecules called cytokines. People with poor cognitive 
control may therefore show biological responses to stress that are similar to responses to 
infections. Cognitive control is also known to decrease after stress (Quinn & Joormann, 2015), 
when this ability is needed most. Furthermore, emerging evidence indicates that inflammation 
may cause or maintain some forms of depression (Slavich & Irwin, 2013), making inflammation 
a very important topic to study. However, it is unclear what types of cognitive control are most 
closely associated with increases in inflammation after stress, or whether inflammation after 
stress is also tied to changes in cognitive control after stress. It is also unclear if a combination of 
negative thoughts and difficulty with cognitive control lead to greater inflammation and even 
greater difficulty with cognitive control under conditions of stress. The tasks you completed on 
the computer assessed your cognitive control abilities, and you were asked to complete one task 
twice to assess how your abilities changed following stress. We elicited stress by asking you to 
complete a mock job interview and to perform mental arithmetic in front of a panel of 
“evaluators.” You were asked to indicate how you were feeling before and after the stress task to 
ensure that the task resulted in changes in how you felt. 
 
Please note that this study involved deception. You were led to believe that you 
would complete a mock job interview and mental arithmetic so that a committee of individuals 
from a human resources department could analyze your ability to maintain a professional 
demeanor under stress. In reality, these individuals were not evaluating you, and are not 
members of a human resources department. They are actually research assistants in the 
lab. Deception was necessary in order for you feel like you were being evaluated by other people 
in order to elicit feelings of stress. This allows us to examine how stress leads to changes in 
inflammation and cognitive control ability, which is important for helping us to understand why 
some people are more vulnerable to life stress than others, particularly in the context of 
depression. The recording of your speech will be deleted immediately. If you wish to withdraw 
your consent at this time, please notify us and we will delete all of your data from the dataset. 
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Your results are confidential to the experimenters and all results are published anonymously as 
group data. If you have any questions or concerns, please contact the Principal Investigator: Dr. 
David Dozois (XXX) XXX-XXXX ext. XXXXX, email: XXXXX@uwo.ca, or Katerina Rnic 
XXX) XXX-XXXX ext. XXXXX, email: XXXXX@uwo.ca. 
Finally, we ask that you do not leave this form out in the open and that you do not tell 
others about the true nature of this study, as others will be participating in this study, and if 
they are aware of the deception involved the validity of the study will be compromised.  
 
 
Thanks again! 
 
Katerina, MSc, Psychology 
Western University  
 
Below is a list of some readings if you would like to learn more about research on cognitive 
and behavioural vulnerability and depression. 
 
Dobson, K. S., & Dozois, D. J. (Eds.). (2011). Risk factors in depression. San Diego, CA: 
Academic Press. 
 
Gotlib, I. H., & Hammen, C. L. (Eds.). (2014). Handbook of depression (3rd ed.). New York: 
Guilford Press.  
 
Joormann, J., & Tanovic, E. (2015). Cognitive vulnerability to depression: Examining cognitive 
control and emotion regulation. Current Opinion in Psychology, 4, 86-92. 
 
Quinn, M. E., & Joormann, J. (2015a). Control when it counts: Change in executive control 
under stress predicts depression symptoms. Emotion, 15, 522-530. 
 
Slavich, G. M., & Irwin, M. R. (2014). From stress to inflammation and major depressive 
disorder: A social signal transduction theory of depression. Psychological bulletin, 140, 774. 
 
Shields, G. S., Kuchenbecker, S. Y., Pressman, S. D., Sumida, K. D., & Slavich, G. M. (2016). 
Better cognitive control of emotional information is associated with reduced pro-inflammatory 
cytokine reactivity to emotional stress. Stress, 19, 63-68. 
 
Should you have any questions or concerns about this study, please contact: 
 
Katerina Rnic or Dr. David Dozois. If you have any questions about your rights as a research 
participant, you should contact the Director of the Office of Research Ethics at 519 661-3036. 
 
Below are a variety of resources if you are interested in learning more about depression, 
how you can help yourself, or how you can arrange for professional help.  
 
Self-Help References: 
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If you would like to look up some good self-help books on changing negative thinking, please 
see: 
 
• Burns, D. D.  (1980).  Feeling good. New York: Penguin.   
• Burns, D. D.  (1989). The feeling good handbook. New York: Penguin. 
• Greenberger, D., & Padesky, C. A. (2015). Mind over mood: Change how you feel by 
changing the way you think. Guilford Press. 
• Wright, J. H., & McCray, L. W. (2011). Breaking free from depression: Pathways to 
wellness. Guilford Press 
 
Available Services 
 
There are several ways in which individuals can access psychological or psychiatric help both on 
campus and within the City of London, Ontario.  If you are feeling depressed or anxious or feel 
that you could benefit from some individual assistance, the following information may be of use 
to you. 
 
The Student Development Centre at the University of Western Ontario 
• Individual appointments are available for students. To make an appointment you can call 
661-3031, or you can make an appointment in person at the Reception Desk, Room 4100 
of the Western Student Services Building.  
• Psychological Services Staff will make every effort to respond as quickly as possible 
when an individual student requires an emergency appointment. 
• Psychological Services Staff can help you deal with a variety of issues including those 
related to Traumatic Events, Sexual or Physical Assault, Date rape, Interpersonal 
Violence, and Gay, Lesbian, Bisexual, or Transgendered situations. 
• More information about the services offered at SDC can be found on the World Wide 
Web at http://www.sdc.uwo.ca/ 
 
London Crisis Centres 
Psychological Services Staff will make every effort to respond as quickly as possible when an 
individual requires an emergency appointment. If you are in crisis when the office is closed 
please call one of the numbers listed below. 
• Reach Out: Crisis line: 519-433-2023 
o Web chat crisis support: http://reachout247.ca/ 
• Good2Talk: Crisis line: 1-866-925-5454 
• Mental Health and Addictions Crisis Centre 
o Walk-in support for individuals who do not require hospital or emergency 
services. Located at 648 Huron St. open 24 hours a day, 7 days a week. 
• Sexual Assault Centre London Crisis Line: 519-438-2272 
o Also 24 hour support line for sex trade workers: 519-438-2272 
• Women's Community House Help Line: 519-642-3000 
o Out-of-Town calls: 1-800-265-1576 
• Zhaawanong (Atenlos) Shelter: 519-432-2270 
o Outside of the London area code: 1-800-605-7477 
o 24 hour crisis line: 519-432-0122 
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• St. Joseph's Sexual Assault and Domestic Violence Centre:  519-646-6100 ext   
 64224 
 
Student Health Services Counselling Centre 
• SHS is located in Room 11, (Lower Level) University Community Centre, U.W.O.  
Main telephone line: (519) 661-3030. 
• The Student Health Services Counselling Centre provides individual counselling for 
students.  The Counselling Centre can be reached at (519) 661-3771. 
• The Counselling Centre's Hours of Operation are as follows: Monday to Friday 8:30 
a.m.- 4:30 p.m. (Please note the Counselling Centre will be closed when the university is 
closed.) 
 
Addiction Services of Thames Valley 
• Alcohol & Drug Services of Thames Valley is located at 200 Queens Ave., Suite 260, 
London, Ontario  N6A 1J3 
• A community service, funded by the Provincial Ministry of Health, Ontario Substance 
Abuse Bureau. There are currently no charges for clinical services, although fees may be 
charged for training or seminars. 
• Service is available to any resident of Middlesex, Elgin or Oxford County. There are no 
admission restrictions. 
• Provide early intervention to persons who are concerned about substance use and/or 
problem gambling.  
• ADSTV is a gay, lesbian, bisexual, transsexual, and transgender positive environment 
• Services include assessment of individuals who have an alcohol and/or drug related 
problem.  Assessments are also available for problem gambling. Based on these 
assessments the ADS will develop treatment plans for clients and assist with referrals to 
provide outpatient counselling and aftercare. 
• Hours of operation in London are as follows: Monday and Tuesday - 8:30 a.m. to 8:00 
p.m.; Wednesday 8:30 a.m. to 12:00 p.m. and 1:00 p.m. to 4:30 p.m; Thursday and Friday 
8:30 a.m. to 4:30 p.m. 
• Self-referrals are welcome, call 519-673-3242 (extension 222 for substance abuse 
services, extension 234 for problem gambling services). 
 
Emergencies After Hours 
• If you are in distress during an after-hours time, please go to the nearest hospital 
emergency room. 
• On Campus: University Hospital: 519-663-3197, 339 Windermere Rd. 
• South London: Victoria Hospital:519-685-8141, 800 Commissioners Rd. East 
• North London: St. Joseph's Hospital: 519-646-6100, 268 Grosvenor Rd. 
 
Referrals to Other Resources 
• Family physicians can provide you with counselling services, and can make referrals to 
other community resources as needed. 
• Specialized services for emotional and interpersonal problems are available, however, a 
referral from a physician is often necessary. 
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We hope that this information is helpful to those who need it. 
If you are suffering from distress, we encourage you to seek help from an appropriately qualified 
individual or service centre.  Please contact a University or Community Agency that can help 
you, or to speak with a physician who can refer you to the appropriate resource. 
 
Note: Participants were presented with a debriefing form at the end of each phase of the study. 
Other debriefing forms used in the study are available from the primary investigator: Katerina 
Rnic. 
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Appendix H  
Glossary 
Baseline/ resting-state/ pre-stress inflammation or cytokines: latent factor of the four cytokines 
IL-8, IL-6, IL-1β, and TNF-α after a relaxation period, and before the laboratory stressor. 
 
Cognitive organization/ Cognitive structure: The degree of interconnectedness of social or 
achievement self-schemas; assessed using the PDST.   
 
DAS (Dysfunctional Attitudes Scale): A self-report questionnaire assessing conditional 
assumptions of approval from others, prerequisites for happiness, and perfectionistic standards. 
 
Negative affective switch costs: The average cost of switching from the nonaffective to the 
affective categorization rule when an image is negative. This is thought to reflect difficulty 
switching to processing the negative aspects of stimuli.  
 
Negative nonaffective switch costs: The average cost of switching from the affective to the 
nonaffective categorization rule when an image is negative. This is thought to reflect difficulty 
switching away from processing the negative aspects of stimuli. 
 
PDST (Psychological Distance Scaling Task): A cognitive task that assesses self-schema 
organization/structure.  
 
Positive affective switch costs: The average cost of switching from the nonaffective to the 
affective categorization rule when an image is positive. This is thought to reflect difficulty 
switching to processing the positive aspects of stimuli.  
 
Positive nonaffective switch costs: The average cost of switching from the affective to the 
nonaffective categorization rule when an image is positive. This is thought to reflect difficulty 
switching away from processing the negative aspects of stimuli. 
 
Stress-induced/ post-stress changes in inflammation or cytokines: second order latent change 
factor of the four cytokines IL-8, IL-6, IL-1β, and TNF-α from pre- to post- laboratory stressor. 
This factor is ‘baseline-free’ in that it takes baseline levels of cytokines into account. 
 
TSST (Trier Social Stress Test): A social-evaluative laboratory stress paradigm. 
 
Young Schema Questionnaire (YSQ): A self-report questionnaire that assesses maladaptive core 
beliefs. 
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Appendix I  
Analyses of the Neutral Stroop 
Group differences in General Inhibition 
A one-way ANOVA was run for reaction time for the neutral word block of the Stroop. 
Reaction times did not differ significantly across groups, F(2, 162) =  1.92, p = .149, partial hp2 
= .023. Although differences were not significant, currently depressed participants evinced the 
slowest reaction times (M = 651.66; SD = 156.18), followed by remitted depressed individuals 
(M = 607.47; SD = 130.16), and finally, controls (M = 600.28; SD = 123.69).  
Association of Deficits in Cognitive Control with Rumination 
Consistent with hypotheses, greater trait rumination was associated with longer reaction 
times on the neutral (r[164] = .19, p = .015) block of the Stroop. 
Predicting Baseline Inflammation and Stress-Induced Changes in Inflammation 
Cognitive Content and Rumination. Table 1 presents estimates from the conditional 
models predicting baseline and stress-induced changes in cytokines by negative cognitive 
content, rumination, and Neutral Stroop reaction time. The first model (Model 1) examined main 
effects. Longer reaction times on the Neutral Stroop predicted greater inflammation at baseline. 
Rumination predicted changes in inflammation after the stressor, such that a greater tendency to 
ruminate was associated with decreased inflammation. Further, there was a trend whereby 
greater maladaptive core beliefs marginally predicted greater increases in inflammation 
following stress.  
In Model 2, core beliefs marginally moderated the effects of inhibition on pre-stress 
inflammation. An examination of the simple slopes revealed that poorer inhibitory ability (i.e., 
longer Neutral Stroop reaction times) was associated with greater baseline inflammation in
221 
 
Table 1 
 
Prediction of Latent Pre-stress Cytokines and Latent Change in Cytokines by Neutral Stroop, Negative Cognitive Content, and 
Rumination  
 
 Pre-stress inflammation         Δ inflammation  
Model and predictor β 95% CI b  β 95% CI b  
Model 1: Main effects  R2 = .25, p < .001  R2 = .13, p = .013  
Age -.07 [-.24, .10] -.003  .15 [-.08, .38] .003  
BMI .35*** [.20, .50] .02  -.02 [-.21, .16] -.001  
Ethnicity         
White vs. Other -.10 [-.25, .06] -.12  .11 [-.07, .28] .06  
White vs. Asian -.21* [-.37, -.05] -.18  -.07 [-.28, .15] -.03  
Core Beliefs -.14 [-.40, .12] -.001  .26† [-.04, .56] .001  
Dysfunctional Attitudes .05 [-.16, .25] .001  -.17 [-.42, .08] -.001  
Rumination .02 [-.18, .21] .00  -.32** [-.53, -.11] -.004  
Neutral Stroop RT .26** [.08, .44] .08  .12 [-.08, .32] .02  
Model 2: Interaction effect R2 = .27, p < .001  R2 = .15, p = .009  
Core Beliefs × Neutral Stroop RT -.13† [-.26, .01] -.001  .11 [-.04, .26] .00  
Model 3: Interaction effect R2 = .26, p < .001  R2 = .14, p = .014  
Dysfunctional Attitudes × Neutral Stroop 
RT 
-.10 [-.24, .03] -.001  -.01 [-.15, .13] .00  
Model 4: Interaction effect R2 = .27, p < .001  R2 = .14, p = .013  
Rumination × Neutral Stroop RT -.13† [-.27, .01] -.003  .02 [-.13, .17] .00  
Note. 95% CI = 95% confidence intervals for standardized coefficients (βs). Ethnicity was dummy coded as White = 0, Asian = 1, and 
Other = 1. Values of .00 are < .001. Model fit: Model 1, χ2(67, N = 164) = 166.65, p < .001, CFI = .939, TLI = .916 and RMSEA = 
.095, SRMR = .118; Model 2, χ2(73, N = 164) = 174.95, p < .001, CFI = .939, TLI = .916 and RMSEA = .092, SRMR = .112; Model 
3, χ2(73, N = 164) = 173.77, p < .001, CFI = .939, TLI = .917 and RMSEA = .092, SRMR = .114; Model 4, χ2(73, N = 164) = 171.78, 
p < .001, CFI = .940, TLI =.918 and RMSEA =.091, SRMR =.114. 
†p < .10; * p < .05; **p < .01; ***p < .001. 
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individuals reporting low (b = .12, 95% CI = [.05, .18], p < .001), but not high, (b = .05, 95% CI 
= [-.02, 0.11], p = .175), maladaptive core beliefs (Figure 1). Core beliefs did not moderate 
effects of inhibition on changes in inflammation.  
In Model 3, dysfunctional attitudes did not moderate effects of inhibition on pre-stress 
inflammation or on changes in inflammation. Finally, rumination marginally moderated the 
relation of inhibition on pre-stress inflammation in Model 4, but did not moderate the effect of 
inhibition on changes in cytokines. Simple slopes were examined for this marginally significant 
interaction. Similar to the findings for core beliefs, poor inhibition was associated with greater 
baseline inflammation in individuals with low (b = .12, 95% CI = [.06, .18], p < .001), but not 
high (b = .04, 95% CI = [-.03, 0.11], p = .253), rumination (Figure 2).   
Cognitive organization. Estimates from the conditional models predicting baseline and 
stress-induced changes in cytokines by cognitive organization and Neutral Stroop reaction time 
are presented in Table 2. In the first conditional model (Model 1), negative achievement 
organization and Neutral Stroop reaction time both predicted pre-stress inflammation. Results 
indicated that, as hypothesized, individuals with more tightly interconnected negative 
achievement-related schemas and those with longer reaction times on the Neutral Stroop 
(indicating poorer inhibitory abilities) demonstrated greater inflammation at baseline. There was 
also a trend whereby negative social organization was marginally associated with post-stress 
changes in inflammation, such that having more loosely connected negative social schemas was 
associated with greater increases in cytokines.  
In Model 2, a marginally significant interaction of negative social achievement 
organization with Neutral Stroop reaction time on pre-stress cytokines emerged. Probing this 
marginal interaction revealed that poorer inhibitory abilities for neutral stimuli were associated
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Figure 1.  Marginally significant interaction effect between Neutral Stroop reaction time and 
maladaptive core beliefs on pre-stress cytokines. Prestress Inflammation = latent factor of 
baseline inflammation. RT= reaction time. ‘Low’ and ‘High’ Neutral Stroop reaction time and 
core beliefs indicate scores one standard deviation below and above the mean, respectively. The 
thinner lines represent 95% confidence intervals.  
 
 
Figure 2. Marginally significant interaction effect between Neutral Stroop reaction time and 
rumination on pre-stress cytokines. Prestress Inflammation = latent factor of baseline 
inflammation. RT= reaction time. ‘Low’ and ‘High’ Neutral Stroop reaction time and rumination 
indicate scores one standard deviation below and above the mean, respectively. The thinner lines 
represent 95% confidence intervals. 
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Table 2  
 
Prediction of Latent Pre-stress Cytokines and Latent Change in Cytokines by Neutral Stroop and Cognitive Organization 
 
 Pre-stress inflammation         Δ inflammation  
Model and predictor β 95% CI b  β 95% CI b  
Model 1: Main effects  R2 = .31, p < .001  R2 = .10, p = .061  
Age -.04 [-.25, .18] -.002  .10 [-.15, .35] .002  
BMI .26** [.11, .42] .02  -.03 [-.20, .15] -.001  
Ethnicity         
White vs. Other -.17† [-.33, .001] -.22  .07 [-.17, .31] .04  
White vs. Asian -.23* [-.41, -.04] -.20  -.11 [-.35, .13] -.05  
Negative Social Organization .12 [-.08, .31] .12  .19† [-.01, .39] .09  
Negative Achievement Organization     -.25* [-.45, -.06] -.20  .08 [-.14, .29] .03  
Neutral Stroop RT .30** [.10, .49] .09  -.03 [-.26, .20] -.004  
Model 2: Interaction effect R2 = .32, p < .001  R2 = .10, p =.045  
Negative Social Organization × 
Neutral Stroop RT 
-.13† [-.28, .01] -.12  -.07 [-.24, .10] -.03  
Model 3: Interaction effect R2 = .31, p < .001  R2 = .10, p =.06  
Negative Achievement Organization × 
Neutral Stroop RT 
-.04 [-.19, .12] -.02  .03 [-.14, .21] .01  
Note. 95% CI = 95% confidence intervals for standardized coefficients (βs). Ethnicity was dummy coded as White = 0, Asian = 1, and 
Other = 1. Model fit: Model 1, χ2(61, N = 127) = 138.55, p < .001, CFI = .939, TLI = .916 and RMSEA = .100, SRMR = .135; Model 
2, χ2(67, N = 127) = 143.34, p < .001, CFI = .941, TLI = .919 and RMSEA = .095, SRMR = .130; Model 3, χ2(67, N = 127) = 139.85, 
p < .001, CFI = .943, TLI = .922 and RMSEA =  .093, SRMR = .129. 
†p < .10; * p < .05; **p < .01; ***p < .001. 
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with greater baseline cytokines in individuals with tightly interconnected (b = .14, 95% CI = 
[.07, .21], p < .001), and not loosely connected (b = .04, 95% CI = [-.05, .13], p = .419), negative 
social schemas (Figure 3). Finally, there was no interaction between Negative Achievement 
Organization and Neutral Stroop reaction time on either baseline inflammation or stress-induced 
changes in inflammation in Model 3. 
 
Figure 3. Marginally significant interaction effect between Neutral Stroop reaction time and 
Negative Social Organization on pre-stress cytokines. Prestress Inflammation = latent factor of 
baseline inflammation. RT = reaction time. ‘Low’ and ‘High’ Neutral Stroop reaction time and 
Negative Social Organization indicate scores one standard deviation below and above the mean, 
respectively. The thinner lines represent 95% confidence intervals.  
  
-0.4
-0.3
-0.2
-0.1
0
0.1
0.2
0.3
0.4
Low High
Pr
e-
St
re
ss
 In
fla
m
m
at
io
n
Neutral Stroop RT
Tightly Connected
Negative Social
Schemas
Loosely Connected
Negative Social
Schemas
226 
 
Appendix J  
Description of Tests of Measurement Invariance 
A series of measurement models were estimated in order to assess whether the four 
cytokines loaded on a common factor at both pre- and post-stress and, in turn, whether this latent 
factor was equivalent across both time points (i.e., measurement invariant). Five measurement 
models were evaluated using confirmatory factor analysis (CFA) with the four cytokines (IL-6, 
IL-8, IL-1β, and TNF-α) as observed indicators, and models were compared using chi-square 
difference tests. A nonsignificant Δχ2 indicates that the model constraints do not worsen the 
model fit and is therefore indicative of measurement invariance. Model fit indices and chi-square 
difference tests for the five models are shown in Table 1. 
The first model did not impose any equality constraints across the two assessments in 
order to test for configural invariance. Pre- and post-stressor measures of each cytokine were 
allowed to correlate. Next, to account for the correlation of inflammatory cytokines with each 
other and to improve model fit, IL-8 and IL-1β, as well as TNF-α and IL-6, were allowed to 
correlate with each other at each time point. The fit for the configural invariance model was 
good, and constraining the correlations to be equal across time points did not result in worse 
model fit (nonsignificant Δχ2). To test for metric invariance, the model with correlations 
constrained to be equal was compared to a model where the factor loadings were constrained to 
be equal at pre- and post-stress. Otherwise, the model was constructed the same way. There was 
support for metric invariance, as constraining the factor loadings to be equal across pre- and 
post-stress assessments did not result in significantly worse fit (nonsignificant Δχ2). Finally, to 
test scalar invariance, the metric invariance model was compared to a model in which the 
intercepts of the indicators were also constrained to be equal across the two assessments. There 
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was not support for scalar invariance, as constraining the intercepts of the indicators to be equal 
across time points significantly worsened model fit (significant Δχ2). Based on modification 
indices, IL-8 and IL-6 were unconstrained in order to test partial invariance of intercepts. A 
comparison of the partial scalar invariance model with the metric invariance model indicated that 
the model fit did not change significantly (nonsignificant Δχ2), indicating partial scalar 
invariance. 
 
 
Table 1  
 
Model Fit Indices and Model Fit Comparisons of Measurement Models of Latent Factor of 
Inflammation 
 Model fit indices  Difference test 
Model χ2 df p CFI TLI RMSEA SRMR  Δχ2 Δdf p 
Configural 
invariance 
24.60 11 .010 .990 .975 .086 .065     
Invariance of 
correlations 
26.39 13 .015 .990 .979 .079 .066  2.81 2 ns 
Metric 
invariance 
28.66 16 .026 .991 .984 .069 .054  2.98 3 ns 
Scalar 
invariance 
81.44 19 <.001 .955 .934 .141 .170  42.84 3 <.001 
Partial Scalar 
invariance 
30.49 17 .023 .990 .984 .069 .059  1.83 1 ns 
Note. Maximum-likelihood estimation with robust standard errors (MLR) was used; therefore, 
the chi-square difference tests (Δχ2) were Satorra-Bentler adjusted (Satorra & Bentler, 2001)
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Appendix K  
Predicting Baseline and Stress-Induced Changes in Inflammation Using Models Constrained to Partial Invariance 
Table 1 
  
Prediction of Latent Pre-stress Cytokines and Latent Change in Cytokines by Emotional Stroop, Negative Cognitive Content, and 
Rumination 
 
 Pre-stress inflammation         Δ inflammation  
Model and predictor β 95% CI b  β 95% CI b  
Model 1: Main effects  R2 = .22, p < .001  R2 = .15, p = .018  
Age -.01 [-.16, .15] .00  .20† [-.02, .41] .003  
BMI .32*** [.17, .48] .02  -.01 [-.22, .20] .00  
Ethnicity         
White vs. Other -.09 [-.26, .08] -.09  .09 [-.08, .27] .04  
White vs. Asian -.22* [-.38, -.05] -.16  -.01 [-.25, .22] -.004  
Core Beliefs -.11 [-.39, .17] -.001  .31† [-.01, .63] .001  
Dysfunctional Attitudes .04 [-.18, .25] .00  -.19 [-.46, .07] -.001  
Rumination .003 [-.21, .21] .00  -.33** [-.56, -.10] -.003  
Emotional Stroop RT .15† [-.02, .32] .04  .15 [-.05, .34] .02  
Model 2: Interaction effect R2 = .23, p < .001  R2 = .16, p = .012  
Core Beliefs × Emotional Stroop        RT -.11 [-.24, .03] .00  .11 [-.04, .27] .00  
Model 3: Interaction effect R2 = .23, p < .001  R2 = .15, p = .017  
Dysfunctional Attitudes × Emotional 
Stroop RT 
-.09 [-.21, .04] -.001  -.02 [-.17, .13] .00  
Model 4: Interaction effect R2 = .24, p < .001  R2 = .15, p = .019  
Rumination × Emotional Stroop RT -.13† [-.26, .01] -.002  -.03 [-.19, .13] .00  
Note. 95% CI = 95% confidence intervals for standardized coefficients (βs). Ethnicity was dummy coded as White = 0, Asian = 1, and 
Other = 1. Values of .00 are < .001. Model fit: Model 1, χ2(65, N = 164) = 120.47, p < .001, CFI = .966, TLI = .952 and RMSEA = 
.072, SRMR = .062; Model 2, χ2(71, N = 164) = 129.49, p < .001, CFI = .965, TLI = .951 and RMSEA = .071, SRMR = .060; Model 
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3, χ2(71, N = 164) = 124.67, p < .001, CFI = .968, TLI = .955 and RMSEA = .068, SRMR = .060; Model 4, χ2(71, N = 164) = 125.42, 
p < .001, CFI = .967, TLI = .954 and RMSEA = .068, SRMR = .060. 
†p < .10; *p < .05; **p < .01; ***p < .001. 
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Table 2  
 
Prediction of Latent Pre-stress Cytokines and Latent Change in Cytokines by Emotional Stroop and Cognitive Organization 
 
 Pre-stress inflammation         Δ inflammation  
Model and predictor β 95% CI b  β 95% CI b  
Model 1: Main effects  R2 = .26, p < .001  R2 = .11, p = .083  
Age .04 [-.15, .23] .002  .13 [-.15, .41] .002  
BMI .24** [.08, .40] .01  .01 [-.22, .24] .00  
Ethnicity         
White vs. Other -.17† [-.33, .01] -.18  .06 [-.20, .31] .03  
White vs. Asian -.22* [-.41, -.03] -.16  -.10 [-.38, .17] -.03  
Negative Social Organization .11 [-.09, .32] .10  .23† [-.03, .48] .08  
Negative Achievement Organization     -.24* [-.44, -.05] -.16  .05 [-.20, .30] .01  
Emotional Stroop RT .18* [.01, .35] .05  .03 [-.19, .26] .004  
Model 2: Interaction effect R2 = .27, p < .001  R2 = .11, p = .082  
Negative Social Organization × Emotional 
Stroop RT 
-.11 [-.24, .03] -.08  -.03 [-.24, .18] -.01  
Model 3: Interaction effect R2 = .27, p < .001  R2 = .11, p = .084  
Negative Achievement Organization × 
Emotional Stroop RT 
-.05 [-.19, .10] -.02  .03 [-.18, .24] .01  
Note. 95% CI = 95% confidence intervals for standardized coefficients (βs). Ethnicity was dummy coded as White = 0, Asian = 1, and 
Other = 1. Values of .00 are < .001. Model fit: Model 1, χ2(59, N = 127) = 97.09, p = .001, CFI = .970, TLI = .958 and RMSEA = 
.071, SRMR = .063; Model 2, χ2(65, N = 127) = 99.91, p = .004, CFI = .973, TLI = .962 and RMSEA = .065, SRMR = .061; Model 3, 
χ2(65, N = 127) = 100.02, p = .003, CFI = .973, TLI = .961 and RMSEA = .065, SRMR = .060. 
†p < .10; *p < .05; **p < .01; ***p < .001. 
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Table 3  
 
Prediction of Latent Pre-stress Cytokines and Latent Change in Cytokines by Positive Affective Switch Costs, Negative Cognitive 
Content, and Rumination 
 
 Pre-stress inflammation         Δ inflammation  
Model and predictor β 95% CI b  β 95% CI b  
Model 1: Main effects  R2 = .21, p = .001  R2 = .22, p = .007  
Age .06 [-.10, .22] .002  .20* [.002, .40] .003  
BMI .31*** [.16, .47] .02  -.01 [-.21, .18] .00  
Ethnicity         
White vs. Other -.05 [-.21, .11] -.06  .15† [-.02, .32] .07  
White vs. Asian -.21* [-.38, -.04] -.15  .03 [-.18, .25] .01  
Core Beliefs -.09 [-.37, .20] .00  .31* [.01, .62] .001  
Dysfunctional Attitudes .01 [-.21, .22] .00  -.24† [-.49, .01] -.001  
Rumination .02 [-.19, .22] .00  -.30** [-.51, -.08] -.003  
Positive Affective Switch Costs .03 [-.13, .19] .01  .29** [.10, .49] .02  
Model 2: Interaction effect R2 = .21, p = .001  R2 = .23, p = .003  
Core Beliefs × Positive Affective 
Switch Costs 
.08 [-.08, .25] .00  -.12 [-.33, .09] .00  
Model 3: Interaction effect R2 = .21, p = .001  R2 = .22, p = .007  
Dysfunctional Attitudes × Positive 
Affective Switch Costs 
-.05 [-.18, .09] .00  .03 [-.12, .18] .00  
Model 4: Interaction effect R2 = .26, p < .001  R2 = .33, p < .001  
Rumination × Positive Affective 
Switch Costs 
.25** [.10, .40] .003  -.37*** [-.57, -.17] -.002  
Note. 95% CI = 95% confidence intervals for standardized coefficients (βs). Ethnicity was dummy coded as White = 0, Asian = 1, and 
Other = 1. Values of .00 are < .001. Model fit: Model 1, χ2(65, N = 165) = 117.30, p < .001, CFI = .968, TLI = .955 and RMSEA = 
.070, SRMR = .060; Model 2, χ2(71, N = 165) = 131.64, p < .001, CFI = .964, TLI = .949 and RMSEA = .072, SRMR = .059; Model 
3, χ2(71, N = 165) = 124.54, p < .001, CFI = .968, TLI = .955 and RMSEA = .068, SRMR = .059; Model 4, χ2(71, N = 165) = 126.39, 
p <. 001, CFI = .967, TLI = .954 and RMSEA = .069, SRMR = .059.  
†p < .10; *p < .05; **p < .01; ***p < .001. 
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Table 4 
  
Prediction of Latent Pre-stress Cytokines and Latent Change in Cytokines by Positive Affective Switch Costs and Cognitive 
Organization 
 
 Pre-stress inflammation         Δ inflammation  
Model and predictor β 95% CI b  β 95% CI b  
Model 1: Main effects  R2 = .24, p < .001   R2 = .18, p = .063  
Age .09 [-.09, .27] .003  .09 [-.15, .33] .001  
BMI .23** [.07, .39] .01  .01 [-.21, .24] .00  
Ethnicity         
White vs. Other -.13† [-.28, .02] -.14  .09 [-.15, .33] .04  
White vs. Asian -.21* [-.41, -.02] -.15  -.07 [-.33, .19] -.02  
Negative Social Organization .11 [-.10, .31] .09  .22† [-.004, .45] .08  
Negative Achievement Organization     -.24* [-.43, -.05] -.16  .06 [-.18, .30] .02  
Positive Affective Switch Costs .09 [-.08, .26] .02  .27* [.04, .50] .02  
Model 2: Interaction effect R2 = .25, p < .001  R2 = .25, p < .001  
Negative Social × Positive Affective 
Switch Costs 
-.06 [-.23, .11] -.03  .32** [.12, .53] .06  
Model 3: Interaction effect R2 = .24, p = .001  R2 = .24, p = .009  
Negative Achievement × Positive 
Affective Switch Costs 
-.02 [-.15, .12] -.01  .25* [.05, .45] .04  
Note. 95% CI = 95% confidence intervals for standardized coefficients (βs). Ethnicity was dummy coded as White = 0, Asian = 1, and 
Other = 1. Values of .00 are < .001. Model fit: Model 1, χ2(59, N = 127) = 96.00, p = .002, CFI = .971, TLI = .959 and RMSEA = 
.070, SRMR = .064; Model 2, χ2(65, N = 127) = 98.28, p = .005, CFI = .974, TLI = .964 and RMSEA = .063, SRMR = .059; Model 3, 
χ2(65, N = 127) = 102.17, p = .002, CFI = .971, TLI = .959 and RMSEA = .067, SRMR = .061.  
†p < .10; *p < .05; **p < .01; ***p < .001. 
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Table 5  
 
Prediction of Latent Pre-stress Cytokines and Latent Change in Cytokines by Negative Affective Switch Costs, Negative Cognitive 
Content, and Rumination 
 
 Pre-stress inflammation         Δ inflammation  
Model and predictor β 95% CI b  β 95% CI b  
Model 1: Main effects  R2 = .22, p < .001  R2 = .16, p = .016  
Age .09 [-.07, .24] .003  .22* [.01, .43] .004  
BMI .32*** [.17, .47] .02  -.03 [-.24, .17] -.001  
Ethnicity         
White vs. Other -.05 [-.21, .12] -.05  .12 [-.05, .28] .05  
White vs. Asian -.21* [-.38, -.04] -.15  -.01 [-.24, .23] -.002  
Core Beliefs -.12 [-.40, .16] -.001  .38* [.06, .70] .001  
Dysfunctional Attitudes .04 [-.17, .25] .00  -.26† [-.53, .003] -.001  
Rumination .04 [-.17, .24] .001  -.34** [-.56, -.12] -.004  
Negative Affective Switch Costs -.13† [-.28, .02] -.02  .17* [.01, .33] .01  
Model 2: Interaction effect R2 = .23, p < .001  R2 = .16, p = .017  
Core Beliefs × Negative Affective 
Switch Costs 
.03 [-.15, .22] .00  .01 [-.17, .19] .00  
Model 3: Interaction effect R2 = .23, p < .001  R2 = .16, p = .017  
Dysfunctional Attitudes × Negative 
Affective Switch Costs 
.06 [-.11, .23] .00  .00 [-.17, .17] .00  
Model 4: Interaction effect R2 = .23, p < .001  R2 = .16, p = .015  
Rumination × Negative Affective 
Switch Costs 
.07 [-.08, .22] .001  -.05 [-.19, .09] .00  
Note. 95% CI = 95% confidence intervals for standardized coefficients (βs). Ethnicity was dummy coded as White = 0, Asian = 1, and 
Other = 1. Values of .00 are < .001. Model fit: Model 1, χ2(65, N = 165) = 112.96, p < .001, CFI = .970, TLI = .958 and RMSEA = 
.067, SRMR = .058; Model 2, χ2(71, N = 165) = 116.98, p = .001, CFI = .971, TLI = .960 and RMSEA = .063, SRMR = .057; Model 
3, χ2(71, N = 165) = 123.89, p < .001, CFI = .968, TLI = .954 and RMSEA = .067, SRMR = .058; Model 4, χ2(71, N = 165) = 115.94, 
p = .001, CFI = .973, TLI = .961 and RMSEA = .062, SRMR = .057.  
†p < .10; *p < .05; **p < .01; ***p < .001. 
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Table 6  
 
Prediction of Latent Pre-stress Cytokines and Latent Change in Cytokines by Negative Affective Switch Costs and Cognitive 
Organization 
 
 Pre-stress inflammation         Δ inflammation  
Model and predictor β 95% CI b  β 95% CI b  
Model 1: Main effects  R2 = .25, p < .001  R2 = .15, p = .056  
Age .15 [-.05, .33] .01  .07 [-.19, .33] .001  
BMI .23** [.07, .39] .01  .001 [-.23, .23] .00  
Ethnicity         
White vs. Other -.13 [-.29, .03] -.15  .06 [-.18, .29] .03  
White vs. Asian -.21* [-.40, -.01] -.15  -.11 [-.38, .16] -.03  
Negative Social Organization .09 [-.13, .31] .08  .25† [-.001, .51] .09  
Negative Achievement Organization     -.24* [-.44, -.04] -.16  .03 [-.20, .27] .01  
Negative Affective Switch Costs -.14 [-.32, .05] -.02  .22* [.03, .41] .02  
Model 2: Interaction effect R2 = .25, p < .001  R2 = .18, p = .021  
Negative Social × Negative Affective Switch 
Costs 
-.01 [-.18, .16] -.01  .20* [.01, .40] .04  
Model 3: Interaction effect R2 = .25, p < .001  R2 = .17, p = .016  
Negative Achievement × Negative Affective 
Switch Costs 
-.003 [-.19, .18] -.001  .20* [.01, .38] .02  
Note. 95% CI = 95% confidence intervals for standardized coefficients (βs). Ethnicity was dummy coded as White = 0, Asian = 1, and 
Other = 1. Model fit: Model 1, χ2(59, N = 126) = 94.50, p = .002, CFI = .972, TLI = .960 and RMSEA = .069, SRMR = .061; Model 2, 
χ2(65, N = 126) = 101.90, p = .002, CFI = .971, TLI = .959 and RMSEA = .067, SRMR = .063; Model 3, χ2(65, N = 126) = 98.84, p = 
.004, CFI = .974, TLI = .963 and RMSEA = .064, SRMR = .060.  
†p < .10; *p < .05; **p < .01; ***p < .001. 
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Table 7 
 
Prediction of Latent Pre-stress Cytokines and Latent Change in Cytokines by Positive Nonaffective Switch Costs, Negative Cognitive 
Content, and Rumination 
 
 Pre-stress inflammation         Δ inflammation  
Model and predictor β 95% CI b  β 95% CI b  
Model 1: Main effects  R2 = .21, p = .001  R2 = .14, p = .022  
Age .06 [-.10, .22] .002  .26* [.05, .46] .004  
BMI .31*** [.16, .47] .02  -.02 [-.23, .19] .00  
Ethnicity         
White vs. Other -.06 [-.22, .11] -.06  .12 [-.05, .30] .06  
White vs. Asian -.22* [-.39, -.05] -.16  -.01 [-.24, .23] -.002  
Core Beliefs -.08 [-.36, .20] .00  .33* [.01, .65] .001  
Dysfunctional Attitudes -.01 [-.22, .21] .00  -.22† [-.49, .04] -.001  
Rumination .01 [-.19, .22] .00  -.31** [-.53, -.09] -.003  
Positive Nonaffective Switch Costs .06 [-.11, .22] .01  .03 [-.15, .21] .002  
Model 2: Interaction effect R2 = .21, p = .001  R2 = .15, p = .018  
Core Beliefs × Positive Nonaffective 
Switch Costs 
.004 [-.18, .19] .00  .12 [-.05, .30] .00  
Model 3: Interaction effect R2 = .23, p < .001  R2 = .16, p = .008  
Dysfunctional Attitudes × Positive 
Nonaffective Switch Costs 
.14† [-.02, .30] .001  .17* [.01, .33] .00  
Model 4: Interaction effect R2 = .21, p = .001  R2 = .14, p = .025  
Rumination × Positive Nonaffective 
Switch Costs 
.02 [-.14, .18] .00  .05 [-.16, .27] .00  
Note. 95% CI = 95% confidence intervals for standardized coefficients (βs). Ethnicity was dummy coded as White = 0, Asian = 1, and 
Other = 1. Model fit: Model 1, χ2(65, N = 165) = 121.29, p < .001, CFI = .966, TLI = .951 and RMSEA = .072, SRMR = .061; Model 
2, χ2(71, N = 165) = 126.64, p < .001, CFI = .966, TLI = .952 and RMSEA = .069, SRMR = .059; Model 3, χ2(71, N = 165) = 123.64, 
p < .001, CFI = .968, TLI = .955 and RMSEA = .067, SRMR = .060; Model 4, χ2(71, N = 165) = 123.12, p < .001, CFI = .968, TLI = 
.955 and RMSEA = .067, SRMR = .059.  
†p < .10; *p < .05; **p < .01; ***p < .001. 
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Table 8 
 
Prediction of Latent Pre-stress Cytokines and Latent Change in Cytokines by Positive Nonaffective Switch Costs and Cognitive 
Organization 
 
 Pre-stress inflammation         Δ inflammation  
Model and predictor β 95% CI b  β 95% CI b  
Model 1: Main effects  R2 = .24, p = .001  R2 = .12, p = .076  
Age .11 [-.07, .29] .004  .13 [-.13, .39] .002  
BMI .23** [.07, .39] .01  .01 [-.22, .24] .00  
Ethnicity         
White vs. Other -.14† [-.30, .02] -.15  .06 [-.19, .31] .03  
White vs. Asian -.22* [-.42, -.03] -.16  -.11 [-.39, .17] -.03  
Negative Social Organization .11 [-.10, .31] .09  .22† [-.03, .48] .08  
Negative Achievement Organization     -.24* [-.43, -.06] -.16  .05 [-.20, .30] .01  
Positive Nonaffective Switch Costs .04 [-.13, .21] .01  .10 [-.10, .30] .01  
Model 2: Interaction effect R2 = .24, p = .001  R2 = .13, p = .053  
Negative Social × Positive Nonaffective 
Switch Costs 
.01 [-.15, .16] .003  -.10 [-.30, .09] -.02  
Model 3: Interaction effect R2 = .25, p < .001  R2 = .12, p = .075  
Negative Achievement × Positive 
Nonaffective Switch Costs 
-.10 [-.24, .04] -.03  .02 [-.17, .21] .003  
Note. 95% CI = 95% confidence intervals for standardized coefficients (βs). Ethnicity was dummy coded as White = 0, Asian = 1, and 
Other = 1. Model fit: Model 1, χ2(59, N = 127) = 105.37, p < .001, CFI = .964, TLI = .949 and RMSEA = .079, SRMR = .063; Model 
2, χ2(65, N = 127) = 112.65, p < .001, CFI = .963, TLI = .948 and RMSEA = .076, SRMR = .062; Model 3, χ2(65, N = 127) = 112.79, 
p < .001, CFI = .963, TLI = .948 and RMSEA = .076, SRMR = .063. 
†p < .10; *p < .05; **p < .01; ***p < .001. 
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Table 9 
 
Prediction of Latent Pre-stress Cytokines and Latent Change in Cytokines by Negative Nonaffective Switch Costs, Negative Cognitive 
Content, and Rumination 
 
 Pre-stress inflammation         Δ inflammation  
Model and predictor β 95% CI b  β 95% CI b  
Model 1: Main effects  R2 = .21, p = .001  R2 = .14, p = .021  
Age .06 [-.10, .22] .002  .25* [.04, .45] .004  
BMI .31*** [.15, .47] .02  -.03 [-.25, .19] -.001  
Ethnicity         
White vs. Other -.06 [-.22, .10] -.06  .12 [-.05, .29] .06  
White vs. Asian -.21* [-.38, -.05] -.16  -.01 [-.24, .22] -.003  
Core Beliefs -.09 [-.37, .20] .00  .33* [.01, .65] .001  
Dysfunctional Attitudes .01 [-.21, .22] .00  -.22 [-.47, .04] -.001  
Rumination .02 [-.19, .22] .00  -.31** [-.53, -.09] -.003  
Negative Nonaffective Switch Costs .03 [-.13, .18] .01  .06 [-.10, .22] .01  
Model 2: Interaction effect R2 = .21, p = .001  R2 = .14, p = .020  
Core Beliefs × Negative Nonaffective Switch 
Costs 
.07 [-.10, .24] .00  -.03 [-.21, .14] .00  
Model 3: Interaction effect R2 = .21, p = .001  R2 = .15, p = .019  
Dysfunctional Attitudes × Negative 
Nonaffective Switch Costs 
.04 [-.11, .20] .00  .09 [-.05, .23] .00  
Model 4: Interaction effect R2 = .22, p < .001  R2 = .14, p = .021  
Rumination × Negative Nonaffective Switch 
Costs 
.13† [-.01, .28] .002  -.02 [-.21, .18] .00  
Note. 95% CI = 95% confidence intervals for standardized coefficients (βs). Ethnicity was dummy coded as White = 0, Asian = 1, and 
Other = 1. Values of .00 are < .001. Model fit: Model 1, χ2(65, N = 165) = 120.46, p < .001, CFI = .966, TLI = .952 and RMSEA = 
.072, SRMR = .059; Model 2, χ2(71, N = 165) = 127.35, p < .001, CFI = .966, TLI = .953 and RMSEA = .069, SRMR = .058; Model 
3, χ2(71, N = 165) = 125.38, p < .001, CFI = .967, TLI = .954 and RMSEA = .068, SRMR = .058; Model 4, χ2(71, N = 165) = 137.44, 
p < .001, CFI = .961, TLI = .945 and RMSEA = .075, SRMR = .060. 
†p < .10; *p < .05; **p < .01; ***p < .001. 
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Table 10 
 
Prediction of Latent Pre-stress Cytokines and Latent Change in Cytokines by Negative Nonaffective Switch Costs and Cognitive 
Organization 
 
 Pre-stress inflammation         Δ inflammation  
Model and predictor β 95% CI b  β 95% CI b  
Model 1: Main effects  R2 = .24, p = .001  R2 = .11, p = .089  
Age .11 [-.07, .29] .004  .13 [-.13, .40] .002  
BMI .23** [.06, .39] .01  .001 [-.24, .24] .00  
Ethnicity         
White vs. Other -.13† [-.29, .03] -.15  .07 [-.18, .31] .03  
White vs. Asian -.22* [-.42, -.03] -.16  -.10 [-.38, .18] -.03  
Negative Social Organization .11 [-.09, .31] .09  .22† [-.03, .48] .08  
Negative Achievement Organization     -.25* [-.44, -.06] -.16  .05 [-.20, .30] .01  
Negative Nonaffective Switch Costs .02 [-.16, .20] .004  .03 [-.19, .24] .002  
Model 2: Interaction effect R2 = .24, p = .001  R2 = .11, p = .091  
Negative Social × Negative Nonaffective 
Switch Costs 
.01 [-.16, .17] .002  .01 [-.21, .23] .002  
Model 3: Interaction effect R2 = .24, p = .001  R2 = .11, p = .087  
Negative Achievement × Negative 
Nonaffective Switch Costs 
.02 [-.12, .15] .01  -.04 [-.26, .17] -.01  
Note. 95% CI = 95% confidence intervals for standardized coefficients (βs). Ethnicity was dummy coded as White = 0, Asian = 1, and 
Other = 1. Values of .00 are < .001. Model fit: Model 1, χ2(59, N = 127) = 95.62, p = .002, CFI = .972, TLI = .960 and RMSEA = 
.070, SRMR = .062; Model 2, χ2(65, N = 127) = 105.47, p = .001, CFI = .969, TLI = .956 and RMSEA = .070, SRMR = .061; Model 
3, χ2(65, N = 127) = 103.70, p = .002, CFI = .971, TLI = .958 and RMSEA = .068, SRMR = .060.  
†p < .10; *p < .05; **p < .01; ***p < .001. 
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Table 11  
 
Prediction of Latent Pre-stress Cytokines and Latent Change in Cytokines by Pre-stress N-back Errors, Negative Cognitive Content, 
and Rumination 
 
 Pre-stress inflammation         Δ inflammation  
Model and predictor β 95% CI b  β 95% CI b  
Model 1: Main effects  R2 = .20, p = .001  R2 = .16, p = .011  
Age .03 [-.13, .20] .001  .25* [.03, .47] .01  
BMI .32*** [.16, .48] .02  -.02 [-.23, .20] .00  
Ethnicity         
White vs. Other -.04 [-.21, .13] -.04  .09 [-.09, .26] .04  
White vs. Asian -.20* [-.37, -.03] -.14  -.01 [-.24, .22] -.003  
Core Beliefs -.11 [-.41, .19] -.001  .33* [.01, .66] .001  
Dysfunctional Attitudes .01 [-.22, .23] .00  -.23† [-.49, .02] -.001  
Rumination .02 [-.20, .25] .001  -.32* [-.56, -.07] -.003  
Pre-stress N-Back Errors .08 [-.06, .22] .002  .14 [-.04, .31] .002  
Model 2: Interaction effect R2 = .21, p = .001  R2 = .17, p = .010  
Core Beliefs × Pre-stress N-Back Errors .06 [-.08, .19] .00  .05 [-.10, .21] .00  
Model 3: Interaction effect R2 = .21, p = .001  R2 = .16, p = .011  
Dysfunctional Attitudes × Pre-stress N-
Back Errors 
.07 [-.06, .20] .00  .03 [-.13, .20] .00  
Model 4: Interaction effect R2 = .21, p = .001  R2 = .16, p = .011  
Rumination × Pre-stress N-Back Errors .05 [-.06, .16] .00  -.03 [-.18, .13] .00  
Note. 95% CI = 95% confidence intervals for standardized coefficients (βs). Ethnicity was dummy coded as White = 0, Asian = 1, and 
Other = 1. Values of .00 are < .001. Model fit: Model 1, χ2(65, N = 159) = 121.56, p < .001, CFI = .965, TLI = .950 and RMSEA = 
.074, SRMR = .062; Model 2, χ2(71, N = 159) = 127.23, p < .001, CFI = .965, TLI = .951 and RMSEA = .071, SRMR = .061; Model 
3, χ2(71, N = 159) = 127.58, p < .001, CFI = .965, TLI = .951 and RMSEA = .071, SRMR = .062; Model 4, χ2(71, N = 159) = 124.37, 
p < .001, CFI = .967, TLI = .953 and RMSEA = .069, SRMR = .060. 
†p < .10; *p < .05; **p < .01; ***p < .001. 
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Table 12  
 
Prediction of Latent Pre-stress Cytokines and Latent Change in Cytokines by Pre-stress N-back Errors and Cognitive Organization 
 
 Pre-stress inflammation         Δ inflammation  
Model and predictor β 95% CI b  β 95% CI b  
Model 1: Main effects  R2 = .21, p = .003   R2 = .13, p = .056  
Age .08 [-.11, .28] .003  .14 [-.15, .42] .002  
BMI .23** [.06, .40] .01  .02 [-.21, .25] .00  
Ethnicity         
White vs. Other -.12 [-.28, .05] -.13  .04 [-.22, .28] .02  
White vs. Asian -.20† [-.39, .003] -.14  -.12 [-.39, .16] -.04  
Negative Social Organization .10 [-.12, .32] .08  .24† [-.01, .49] .08  
Negative Achievement Organization     -.23* [-.42, -.03] -.15  .05 [-.19, .30] .02  
Pre-stress N-Back Errors .11 [-.05, .27] .003  .08 [-.12, .27] .001  
Model 2: Interaction effect R2 = .22, p = .003  R2 = .15, p = .043  
Negative Social Organization × Pre-
stress N-Back Errors 
.02 [-.15, .19] .002  -.14 [-.32, .04] -.004  
Model 3: Interaction effect R2 = .22, p = .002  R2 = .14, p = .049  
Negative Achievement Organization × 
Pre-stress N-Back Errors 
-.04 [-.21, .12] -.002  -.07 [-.25, .11] -.002  
Note. 95% CI = 95% confidence intervals for standardized coefficients (βs). Ethnicity was dummy coded as White = 0, Asian = 1, and 
Other = 1. Values of .00 are < .001. Model fit: Model 1, χ2(59, N = 121) = 94.06, p = .003, CFI = .972, TLI = .960 and RMSEA = 
.070, SRMR = .066; Model 2, χ2(65, N = 121) = 100.70, p = .003, CFI = .972, TLI = .960 and RMSEA = .067, SRMR = .066; Model 
3, χ2(65, N = 121) = 106.17, p = .001, CFI = .967, TLI = .954 and RMSEA = .072, SRMR = .067.   
†p < .10; *p < .05; **p < .01; ***p < .001. 
 
  
241 
 
Table 13  
 
Prediction of Latent Pre-stress Cytokines and Latent Change in Cytokines by Post-stress N-back Errors, Negative Cognitive Content, 
and Rumination 
 
 Pre-stress inflammation         Δ inflammation  
Model and predictor β 95% CI b  β 95% CI b  
Model 1: Main effects  R2 = .22, p = .001  R2 = .19, p = .010  
Age .03 [-.14, .21] .001  .25* [.02, .48] .01  
BMI .35*** [.19, .52] .02  .03 [-.20, .25] .001  
Ethnicity         
White vs. Other -.03 [-.20, .15] -.03  .08 [-.09, .24] .04  
White vs. Asian -.18* [-.35, -.01] -.13  -.02 [-.25, .22] -.01  
Pre-stress N-Back Errors .002 [-.21, .21] .00  .08 [-.19, .35] .001  
Core Beliefs -.05 [-.36, .27] .00  .31† [-.01, .63] .001  
Dysfunctional Attitudes -.08 [-.32, .15] -.001  -.23† [-.48, .02] -.001  
Rumination -.003 [-.23, .22] .00  -.33* [-.59, -.07] -.003  
Post-stress N-Back Errors .09 [-.12, .30] .003  .10 [-.24, .43] .001  
Model 2: Interaction effect R2 = .23, p = .001  R2 = .20, p = .005  
Core Beliefs × Post-stress N-Back 
Errors 
-.11 [-.24, .03] .00  -.10 [-.33, .14] .00  
Model 3: Interaction effect R2 = .23, p = .001  R2 = .23, p = .001  
Dysfunctional Attitudes × Post-stress N-
Back Errors 
-.12† [-.26, .01] .00  -.20* [-.39, -.02] .00  
Model 4: Interaction effect R2 = .23, p = .001  R2 = .19, p = .009  
Rumination × Post-stress N-Back Errors -.12† [-.25, .01] .00  .03 [-.15, .21] .00  
Note. 95% CI = 95% confidence intervals for standardized coefficients (βs). Ethnicity was dummy coded as White = 0, Asian = 1, and 
Other = 1. Values of .00 are < .001. Model fit: Model 1, χ2(71, N = 147) = 126.56, p < .001, CFI = .963, TLI = .948 and RMSEA = 
.073, SRMR = .064; Model 2, χ2(77, N = 147) = 136.69, p < .001, CFI = .961, TLI = .945 and RMSEA = .073, SRMR = .062; Model 
3, χ2(77, N = 147) = 134.86, p < .001, CFI = .962, TLI = .947 and RMSEA = .071, SRMR = .062; Model 4, χ2(77, N = 147) = 133.01, 
p < .001, CFI = .963, TLI = .949 and RMSEA = .070, SRMR = .063. 
†p < .10; *p < .05; **p < .01; ***p < .001. 
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Table 14  
 
Prediction of Latent Pre-stress Cytokines and Latent Change in Cytokines by Post-stress N-back Errors and Cognitive Organization 
 
 Pre-stress inflammation         Δ inflammation  
Model and predictor β 95% CI b  β 95% CI b  
Model 1: Main effects  R2 = .21, p = .005  R2 = .17, p = .047  
Age .09 [-.11, .29] .003  .13 [-.15, .41] .002  
BMI .25** [.07, .43] .01  .03 [-.20, .26] .001  
Ethnicity         
White vs. Other -.10 [-.27, .08] -.11  .09 [-.15, .33] .05  
White vs. Asian -.18† [-.39, .02] -.13  -.12 [-.39, .15] -.04  
Pre-stress N-Back Errors .10 [-.15, .35] .003  -.003 [-.32, .32] .00  
Negative Social Organization .05 [-.17, .26] .04  .23† [-.01, .47] .08  
Negative Achievement Organization     -.18† [-.36, .01] -.11  .06 [-.19, .30] .02  
Post-stress N-Back Errors .004 [-.23, .24] .00  .18 [-.25, .60] .002  
Model 2: Interaction effect R2 = .24, p = .002  R2 = .18, p = .030  
Negative Social Organization × Post-stress N-
Back Errors 
.17† [-.01, .34] .01  -.12 [-.34, .10] -.004  
Model 3: Interaction effect R2 = .25, p = .001  R2 = .18, p = .039  
Negative Achievement Organization × Post-
stress N-Back Errors 
.20* [.04, .36] .01  -.13 [-.34, .08] -.003  
Note. 95% CI = 95% confidence intervals for standardized coefficients (βs). Ethnicity was dummy coded as White = 0, Asian = 1, and 
Other = 1. Values of .00 are < .001. Model fit: Model 1, χ2(65, N = 113) = 99.00, p = .004, CFI = .971, TLI = .959 and RMSEA = 
.068, SRMR = .071; Model 2, χ2(71, N = 113) = 107.03, p = .004, CFI = .970, TLI = .957 and RMSEA = .067, SRMR = .071; Model 
3, χ2(71, N = 113) = 107.66, p = .003, CFI = .969, TLI = .956 and RMSEA = .068, SRMR = .069. 
†p < .10; *p < .05; **p < .01; ***p < .001. 
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• Forensic Psychology (January 2014 – April 2014) 
• Applications of Psychology (September 2013 – December 2013) 
• Research Methods – Lab Instructor (September 2012 – April 2013) 
 
Guest Lectures 
 
• Mood Disorders. Presented to Abnormal Psychopathology Course at the University of 
Western Ontario – King’s College (September 2017) 
• Introduction to Child Psychopathology. Presented to Child Psychopathology Course at 
the University of Western Ontario – King’s College (January 2015) 
• Biological and Environmental Contexts. Presented to Child Psychopathology Course at 
the University of Western Ontario – King’s College (September 2014) 
 
Research Supervision Experience 
 
Honours Thesis Research Advisor, The University of Western Ontario (2017-2018) 
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• Project title: The influence of cognitive structure on stress-induced cognitive control 
deficits in depression 
 
Honours Thesis Research Advisor, The University of Western Ontario (2014-2015) for two 
honours students 
• Project title: Rumination Mediates the Relationship Between Anxious Attachment and 
Immediate Response to Ostracism 
• Project title: Ostracism Increases Positive-Valence Theory of Mind Decoding Accuracy 
 
Honours Thesis Research Advisor, The University of Western Ontario (2013-2014) 
• Project title: Cognitive and Interpersonal Vulnerabilities to Depression 
• Winner of the W. J. McClelland Award (best Honors thesis in the Department) 
 
SUPERVISED CLINICAL EXPERIENCE 
 
Calgary Clinical Psychology Residency (September 2018 – August 2019) 
• Psychosocial Oncology  
o Supervisors: Dr. Andrea Feldstain and Dr. Guy Pelletier 
• Cognitive Behavioural Therapy Service 
o Supervisors: Dr. Barb Backs-Dermott, Dr. Gayle Belsher, and Dr. Michael Enman 
• Regional Psychological Assessment Service 
o Supervisor: Dr. Kerry Mothersill 
 
Western Mood Study Diagnostician and Clinical Interviewer (January 2018 – September 
2018) 
• Supervisor: Dr. David Dozois 
 
Private Practice, London Ontario (March 2018 – August 2018) 
• Supervisor: Dr. Charles Nelson 
 
Behavioural Medicine Service, London Health Sciences Centre, London, Ontario 
(September 2016 – June 2018) 
• Supervisor: Dr. Tony Iezzi 
 
Spinal Cord Regional Rehabilitation Service and Acquired Brain Injury Rehabilitation 
Program, Parkwood Institute, St. Joseph’s Health Care, London, Ontario (September 2017 
– February 2018) 
• Supervisor: Dr. Steven Orenczuk 
 
Private Practice, London, Ontario (May, 2017) 
• Supervisor: Dr. Lindsey Forbes 
 
Clinical Neurological Services and Epilepsy Monitoring Unit, London Health Sciences 
Centre (September 2016 – March 2017) 
• Supervisor: Dr. Sarah Vernon-Scott 
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Concurrent Disorders Services, Regional Mental Health – London, London, Ontario 
(March 2016 – August 2016) 
• Supervisor: Dr. David LeMarquand 
 
Psychological Services, Student Development Centre, University of Western Ontario, 
London, Ontario (September 2014 – April 2016) 
• Supervisor: Dr. Naomi Wiesenthal 
 
Private Practice, London, Ontario (July 2015 – December 2015) 
• Supervisor: Dr. David Dozois 
 
Child and Adolescent Mental Health Care Program, London Health Sciences Centre, 
London, Ontario (September 2015 – February 2016) 
• Supervisor: Dr. Kerry Collins 
 
Mood Disorder Unit, Regional Mental Health – London, London, Ontario (April 2015 – 
August 2015) 
• Supervisor: Dr. Mustaq Khan 
 
Southwest Centre for Forensic Mental Health, Regional Mental Health Care, St. Thomas, 
Ontario (June 2014 – August 2014) 
• Supervisor: Dr. Laura Fazakas-DeHoog 
 
Madame Vanier Children’s Services (June 2014 – August 2014) 
• Supervisor: Dr. Carla Smith 
 
Mood and Thinking Study (February 2014-April 2014) 
• Supervisor: Dr. David Dozois 
 
Psychological Services, Student Development Centre, University of Western Ontario, 
London, Ontario (May 2013 – August 2013) 
• Supervisor: Dr. Beverley Ulak and Dana Menard  
 
London Waitlist Clinic, Canadian Mental Health Association, London Ontario 
(January 2013 – August 2013) 
• Supervisor: Dr. Felicia Otchet 
 
CLINICAL SUPERVISION EXPERIENCE 
 
London Waitlist Clinic, Canadian Mental Health Association, London Ontario (September 
2016 – June 2017) 
• Supervisor: Dr. William Newby 
• Activities: 
o Co-supervised 8 novice therapists 
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Psychological Services, Student Development Centre, University of Western Ontario, 
London, Ontario (September 2014 – April 2016) 
• Supervisor: Dr. Naomi Wiesenthal 
• Activities: 
o Co-supervised a clinical psychology student (first-year MSc) with whom I co-
facilitated a Stress and Anxiety Management Group  
 
CLINICALLY RELEVANT EMPLOYMENT AND RESEARCH 
EXPERIENCE 
 
Diagnostician and Clinical Interviewer, The University of Western Ontario, London, 
Ontario (2016-2017) March 2016 – November 2017 
• Supervisor: Dr. Elizabeth Hayden 
 
Research Coordinator/ Lab Manager, The University of British Columbia, Vancouver, 
British Columbia (2011 –2012):  
• Supervisor: Dr. Wolfgang Linden 
 
Research Assistant, Queen’s University, Kingston, Ontario (2010-2011) 
• Supervisor: Dr. Kate Harkness 
 
Research Assistant, Queen’s University, Kingston, Ontario (2010 – 2011) 
• Supervisor: Dr. Leandre Fabrigar 
 
Research Assistant, Queen’s University, Kingston, Ontario (2011) 
• Supervisor: Dr. Tara MacDonald 
 
Research Assistant, Queen’s University, Kingston, Ontario (2008 – 2009) 
• Supervisor: Dr. Mark Sabbagh 
 
SERVICE ACTIVITIES 
 
Journal Reviewer  
• Journal of Abnormal Psychology – Co-reviewer with Dr. David Dozois 
• Clinical Psychological Science – Co-reviewer with Dr. David Dozois 
• Clinical Psychology: Science and Practice – Co-reviewer with Dr. David Dozois 
• Canadian Journal of Behavioural Science – Co-reviewer with Dr. David Dozois 
• Europe’s Journal of Psychology 
 
Psychology Department Colloquium Committee, University of Western Ontario (2014 – 
2018) 
• Invited professors from other institutions to UWO to present a colloquium talk; 
coordinated with speakers and UWO staff to organize travel and lodging arrangements; 
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organized itineraries for speakers’ visits, including events and meetings; hosted speakers 
during the day of their colloquium 
 
Society for Research in Psychopathology (SRP) 
• Contributor for Publication Committee (2017): conducted an interview with the Early 
Career Award winner, wrote an article about the interview for publication in the SRP 
newsletter 
 
Advocacy through Action (2012 – 2017) 
• Advocacy through Action is a graduate student organization that provides public 
education to the community of London, Ontario, through an annual series of public talks 
related to the psychology of mental health and well-being. Along with being an active 
member of this group and presenting at each series, I have also held the following roles 
and leadership positions: 
o Chair of Advocacy Committee (2016-2017): I developed and led a campaign for 
members of the public and the psychology community to send letters to their 
Members of Provincial Parliament asking for greater resources for and access to 
psychologists 
o Co-President (2013-2015): responsible for liaising with the library regarding 
scheduling of the series; monitoring and overseeing the duties of the various 
committees; coordinating members and running meetings 
o Member of the Marketing Committee (2012-2013): advertising for the annual 
series of talks through social media and by distributing posters and flyers  
 
London Regional Psychological Association (LRPA) 
• Secretary (2013-2016): recorded minutes at all executive meetings; helped to plan and 
organize continuing education talks for psychologists and psychological associates in the 
community; managed the LRPA listserv 
 
 
PROFESSIONAL AFFILIATIONS 
 
• Society for Research in Psychopathology (SRP; associate member) 
• Association for Cognitive and Behavioral Therapies (ABCT; student member) 
• Canadian Psychological Association (CPA; student member) 
• Canadian Association of Cognitive Behavioural Therapies (CACBT; student member) 
 
